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Articular Cartilage
Cartilage present in articulating joints is referred to as articular cartilage. Articular 
cartilage is highly specialized connective tissue. It is resilient, distributes forces onto 
subchondral bone, and provides smooth joint movement. Articular cartilage is avascular, 
aneural and alymphatic 1. The extracellular matrix (ECM) of cartilage is produced by 
chondrocytes which represent only a small percentage (1-5%) of the wet weight 2. 
70-75% of the cartilage is water. The most abundant protein is collagen type II, which is 
present at levels up to 60-80% by dry weight of the tissue. Proteoglycans form 20-30% 
of the proteins found in cartilage. The collagen molecules form a highly organized fibril-
lar network, defining form and tensile strength of the articular cartilage within which 
the highly hydrophilic proteoglycans are immobilized due to their large size. Many other 
structural proteins (collagens and non-collagenous proteins) enmeshed within the col-
lagen network, are present at varying but low amounts. Some of these minor proteins 
might play important roles in the assembly of a complex three-dimensional collagen 
network and cell-matrix interaction. Besides its mechanical importance, the extracellular 
matrix represents the microenvironment for the chondrocytes.
Chondrocytes
Since articular cartilage is non-vascular, nutrition of the chondrocytes is dependent on 
synovial fluid and its diffusion through the cartilage facilitated by intermittent loading 
of the cartilage 3. More recently it was discovered that the subchondral bone also plays 
a role in cartilage nutrition 4, 5. Consequently, chondrocytes exist under oxygen tensions 
as low as 1% and thus rely mainly on anaerobic metabolism. The primary function of 
chondrocytes is to produce the cartilage ECM during growth and to maintain the integrity 
of the tissue. To this purpose chondrocytes adjust their behavior in response to external 
signals such as growth factors 6, cytokines 7, 8, and ECM degradation products 9, 10.
Collagen
Collagen is the main protein in articular cartilage; approximately 60-80% of cartilage 
dry weight is collagen. On the basis of their mode of assembly and structural features, 
the collagen superfamily is subdivided into three groups: the fibril forming collagens, 
the fibril associated collagens and the non-fibrilforming collagens 11. Of the collagens 
present in articular cartilage, 95% is collagen type II, which belongs to the fibril forming 
collagens. Collagen type XI accounts for 3% of the total collagen amount, which is also 
fibril forming. Two percent is collagen type IX, which belongs to the fibril associated 
collagens.
Each collagen molecule is composed of three alpha chains and depending on the 
collagen type, the collagen molecule is either composed of three identical alpha chains 
or of two or three different alpha chains. In its mature form, each fibrillar collagen 
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molecule consists of three domains: a short amino-terminal non-triple helix domain 
(N-telopeptide), a long central triple helical domain and a short carboxy-terminal 
non-triple helix domain (C-telopeptide). Intracellular, it also contains propeptides on 
the N- and C-terminal sides of the molecule. In order for the three alpha chains to 
form a triple helix, the small amino acid glycine must be present in every third position 
of the polypeptide chain. This results in the characteristic sequence of glycine-X-Y in 
which proline most often occupies the X position and hydroxyproline the Y position 12. 
Collagen type II is a trimer composed of three α1(II) chains 13. After translation of the 
procollagen α-chain, multiple post-translational modifications take place (Figure 1.1). 
Hydroxylation of proline residues is catalyzed by prolyl-hydroxylases 14. Hydroxyproline 
stabilizes the triple helix by providing hydrogen bonds and water bridges. The pres-
ence of hydroxyproline is also required to stabilize the collagen triple helix at body 
temperature. In addition, lysine residues are hydroxylated by lysyl hydroxylases (LH) 15. 
Hydroxylysine is a requisite for covalent intermolecular cross-linking and acts as accep-
tor site for carbohydrate units. Galactose is transferred to some of the hydroxylysine 
residues and glucose to some of the galactosylhydroxylysine residues. The function of 
the hydroxylysine-linked carbohydrate units is unknown but regulating the organization 
of the collagen molecules into fibrils is suggested 16. Hydroxylation and glycosylation 
stop when the individual α-chains entwine to form the procollagen triple helix in the 
rough endoplasmatic reticulum. The procollagen is packaged into secretory vesicles and 
transported outside the cell.
In the extracellular space, the procollagen is converted to collagen by removing the 
C- and N-propeptides, steps catalysed by C- en N-proteinase 17. The removal of the 
propeptides results in a decrease in water solubility, forcing the triple helical collagen 
molecules to aggregate into fibrils. These fibrils are finally stabilized by the formation of 
covalent cross-links. In cartilage, the hydroxyallysine route is the most important route 
for the formation of cross-links. This process is initiated by oxidation of two hydroxylysyl 
residues in the telopeptide by lysyl oxidase (LOX) to form aldehyde precursors that 
spontaneously condense into difunctional cross-links 18. The formed hydroxyallysine 
reacts with a triple helical lysine residue into lysylpyridinoline (LP) or with a hydroxylysine 
residue into hydroxylysylpyridinoline (HP) to form a trifunctional crosslink that is respon-
sible for the structural integrity of the collagen network. In cartilage, HP cross-links are 
found 30-50 fold more than LP cross-links 19.
Collagen type IX molecules are attached the surface of type II collagen fibrils, par-
ticularly the thin fibrils around chondrocytes 20. Seven cross-linking sites have been 
defined in the collagen type IX molecule. These interact with type II collagen and with 
other collagen type IX molecules, functioning as an interfibrillar connector facilitating 
the formation and organization of the network 21-24. Collagen type XI molecules are 
primarily cross-linked to each other in a head-to-tail manner, and are believed to form a 
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template that constrains the lateral growth of the type II collagen hetero-fibril 25.  Other 
types of collagen found in articular cartilage include types III 26, 27, IV 28, VI 29, X (only in 
hypertrophic cartilage) 30, 31, XII 32, 33, XIII 34 , XIV 33, XXVII 35
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Figure 1.1 
 
Figure 1.  Collagen biosynthesis.  Collagen is synthesised as pro-peptide-containing α-chains (1) 
that are post-translationally modified by hydroxylation of lysine (Lys) and proline (Pro) residues and by 
glycosylation of hydroxylysyl (Hyl) residues (2). These modifications stop when the individual α-chains 
associate to form the procollagen triple helix (3). The procollagen is transported outside the cell and 
the procollagen is converted to collagen by removing the propeptides (4). The triple helical collagen 
molecules aggregate into fibrils, which are stabilised by the formation of covalent cross-links (5).
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Proteoglycans
Proteoglycans (PGs) consist of a protein core with carbohydrate side chains called 
glycosaminoglycans (GAGs). Aggrecan is the most common PG in articular cartilage 
and consists of a central core protein with several domains providing the molecule 
with specific characteristics. Highly negatively charged chondroitin sulphate (CS) and 
keratan sulphate (KS) side chains are attached to the core protein resulting in a char-
acteristic brush-like structure 36. The N-terminal region of the aggrecan core protein 
contains two globular domains (G1 and G2) of which the G1 domain interacts with 
hyaluronan 37. The G3-domain at the C-terminal side of the core protein interacts 
with other cartilage matrix constituents 38 (Figure 1.2). The GAGs are covalently joined 
to the protein core by a glycosidic bond between xylose and the hydroxyl group of a 
serine residue 39. After xylosylation of serine, linkage region synthesis occurs by the 
addition of two galactosyl moieties by galactosyltransferase I 40 and glucuronic acid by 
glucuronosyltransferase I 41. Elongation of chondroitin sulphate chains proceeds by the 
alternate transfer of N-acetylgalactosamine by N-acetylgalactosaminyltransferase and 
glucuronic acid by glucuronosyltransferase II 42. The sulphation of hexosamine moieties 
core protein
N-linked oligosaccharide
O-linked oligosaccharide
keratan sulphate
chondroitin sulphate
G1-domain G2-domain G3-domain
 
 
Figure 1.2 
 
Figure 1.2. Schematic structure of aggrecan.  Aggrecan consists of a core protein with mainly chon-
droitin sulphate side chains. In addition, the core protein also contains keratan sulphate and linked 
oligosaccharides. Two globular domains (G1 and G2) are present at the N-terminal side of the aggrecan 
core protein, one (G3) at the C-terminal side of the core protein.
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Figure 1.3 Figure 1.3. The linkage of chondroitin sulphate side chains to the protein core and chain elongation. 
After xylosylation of serine (l), linkage region synthesis occurs by the addition of two galactosyl moieties 
(2 and 3) and glucuronic acid (4). Elaboration of chondroitin sulfate chains proceeds by the alternate 
transfer of N-acetylgalactosamine (5) and glucuronic acid (6). The sulfation of hexosamine moieties 
occurs (7) by the transfer of sulfate from phosphoadenylylsulfate.
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occurs by the transfer of sulphate from phosphoadenylylsulfate 43 (Figure 1.344). Each 
core protein contains approximately 100 CS chains and 50 KS chains. Aggrecan associ-
ates with hyaluronan and a small glycoprotein, link protein, to form aggregates. These 
multimolecular structures can contain over 100 molecules of both aggrecan and link 
protein associated with a single hyaluronan chain. The aggregates are hydrated due to 
their high fixed negative charge resulting from the very large numbers of polyanionic 
glycosaminoglycan chains on aggrecan, providing cartilage with a high water content 
(about 70% by wet weight of the tissue) 45, 46.
A small fraction of the total mass of proteoglycans within the cartilage ECM com-
prises small leucine-rich proteoglycans. These small proteoglycans include decorin, 
fibromodulin, perlecan, and biglycan. Decorin and fibromodulin interact with collagen 
type II and are suggested to play a role in the formation and maintenance of the col-
lagen fibrils 20, 47. Biglycan and perlecan are found mainly in the pericellular matrix of 
the chondrocyte 48, 49.
Other matrix constituents
Finally, a small fraction of the total weight of cartilage ECM is formed by other matrix 
constituents. One of them is cartilage oligomeric matrix protein (COMP), which is a 
homo-pentameric protein originally found in cartilage 50 but is also present in a large 
variety of other tissues such as tendon 51, synovium and skin 52. Subunits are joined 
close to their N-terminus, creating a five-stranded coiled coil that is stabilized by two 
disulphide bonds 53. COMP is suggested to play an important role in matrix assembly 
and its response to external stimuli because it interacts with several components of the 
extracellular matrix such as collagen type I, II 54 and IX 55 and aggrecan 56. In addition, 
COMP was found to influence the fibril formation of collagen type I and II leading to 
more and organized collagen fibrils in vitro. However, COMP was not associated with 
mature collagen fibrils suggesting a role as catalyst in fibrillogenesis for COMP 57.
The matrilins form a four-member family of modular, multi-subunit matrix proteins, 
which are expressed in cartilage but also in many other forms of extracellular matrix. 
They participate in the formation of fibrillar or filamentous structures and are often 
associated with collagens. They mediate interactions between collagen-containing fibrils 
and other matrix constituents, such as aggrecan. Matrilin-1 was first discovered from 
bovine cartilage 58. Matrilin-3 is the smallest family member and is mostly co-expressed 
with matrilin-1 59, 60. Recent studies have revealed that matrilin-1, -3, and -4 form com-
plexes with biglycan and decorin 61, bind to COMP 62, and that matrilin-3 interacts with 
collagen IX 63. These matrilin-containing molecular complexes are in turn connected to 
collagen fibrils via COMP and collagen IX 61, 64 (Figure 1.4).
Other non-collagenous proteins found in articular cartilage include fibronectin 65, 66 
and cartilage intermediate layer protein (CILP) 67.
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Matrix turnover
Even though the half-life of cartilage collagen is more than 100 years 68, the cartilage 
matrix (including collagen) slowly remodels. Cartilage matrix turnover is a process of 
synthesis and degradation, which is balanced in healthy individuals. The Ca2+- and Zn2+-
dependent matrix metalloproteinases (MMPs), members of a larger metalloprotease 
superfamily, are involved in the degradation of the cartilage ECM. Due to their wide 
substrate specificity, the MMP family is able to degrade virtually all components of 
the ECM 69. MMP activity is controlled by the endogenous inhibitor α2-Macroglobulin 
(α2M) 
70 and by Tissue Inhibitors of Matrix Metalloproteinases (TIMPs) 71. Growth fac-
tors, hormones and cytokines regulate the expression of the MMPs and TIMPs 72.
The ADAMs family (A Desintegrin and Metalloproteinase) includes proteinases of the 
subfamily ‘A Desintegrin and Metalloproteinase with Trombospondin motifs’ (ADAMTS) 
and is also involved in cartilage matrix turnover. ADAMTSs are involved in the cleavage 
of the propeptide from procollagen. ADAMTS -1, -4, -5, -8, -9, and -15 are able to 
cleave aggrecan at four different sites. Aggrecanase 1 and Aggrecanase 2 (ADAMTS-4 
and ADAMTS-5 respectively) are the best studied aggrecanases and are able to cleave 
aggrecan at an additional site 73.
In addition, serine proteinases such as elastase and cathepsin G from polymorpho-
nuclear granulocytes play a critical role in articular cartilage degradation. Not only as 
proteolytic enzymes able to degrade the extracellular matrix 74 but also by additionally 
modulating the level of active MMPs 75.
Functioning of articular cartilage
Articular cartilage normally functions as a low friction, wear-resistant, load-bearing 
material that facilitates joint motion. Because of this function, cartilage experiences 
      
collagen type II
collagen type IX
COMP
matrilin 3
aggrecan
hyaluronan
 
Figure 1.4 Figure 1.4. Interaction of a few of the cartilage matrix constituents. Collagen type IX is bound to the 
collagen type II fibrils. The aggrecan-hyaluronan complexes reside within the collagen network. COMP, 
matrilin 3 and collagen type IX interact with each other and with collagen type II and aggrecan forming 
the typical cartilage ECM network
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intermittent loading and deformation. Loading and deformation of cartilage will gener-
ate a combination of tensile, compressive and shear stresses in the material. The response 
of cartilage to these stresses is determined by the tissue’s unique composition and 
structural organization. The proteoglycans in articular cartilage are negatively charged 
due to the presence of carboxyl and sulphate groups on the glycosaminoglycans, result-
ing in a net negative charge of the extracellular matrix. To balance this negative charge, 
cations are drawn into the tissue, generating a large osmotic potential. As a result, 
cartilage is highly hydrophilic with the tendency to retain fluid in order to maintain 
chemical equilibrium. The resulting large swelling force is balanced by the confining 
influence of the collagen network. This property contributes to the mechanical function 
of articular cartilage by generating a large swelling pressure which facilitates load sup-
port and tissue recovery from deformations 76. Resistance to tensile and compressive 
deformations and loads is generated principally by the intrinsic stiffness of the collagen 
fibers and depends on the density and orientation of the collagen fibers, and the type or 
amount of collagen cross-links 77-82. The tensile modulus reflects the flow-independent 
properties of the cartilage solid matrix when determined from stress-strain data at 
equilibrium 83. Conversely, the hydraulic permeability of cartilage is more associated 
with the proteoglycan content 79, 84. Nevertheless, the collagen network has also been 
suggested to play a role in determining the hydraulic permeability 85. In addition, the 
swelling and deformation of cartilage is highly associated with the amount of degraded 
collagen molecules 86.
Osteoarthritis
Osteoarthritis (OA) is the most prevalent disorder that affects diarthrodal joints 87. The 
prevalence of OA based on radiographic evidence has been recorded as high as 70% 
in people aged >65 88. Joint degeneration seen in OA is characterized by cartilage and 
bony changes, which lead to impaired joint motion, pain and disability. Macroscopically, 
cartilage degeneration has been described such as fibrillation of the articular surface, 
the presence of cracks or fissures, and partial or complete loss of the tissue 89. Additional 
signs of OA include an increase in cartilage hydration, joint space narrowing, subchon-
dral bone changes, and osteophyte formation. Moreover, OA is associated with an 
inflamed synovial membrane with evident vascularisation, infiltration of T lymphocytes 
and mononuclear cells, and proliferation of synovial cells 90, 91. Although the etiology 
of OA is unknown, many risk factors for OA are identified. These include age, gender, 
obesity, genetic predisposition, and trauma 92, 93.
In early OA, synthetic activity is increased, which is considered as a possible attempt 
to regenerate the matrix 94-96.  In addition, collagen type III (which is present at low 
levels in normal cartilage), the chondroprogenitor splice variant of the collagen type II 
gene (type IIA) and collagen type X, have been detected in OA cartilage. This indicates, 
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next to an increase in cell proliferation, a change in phenotype of the chondrocyte 
during the OA process.
Increased production of proteinases, including the metalloproteinases (MMPs), 
MMP-1, MMP-3, MMP-13, and the aggrecanases, mainly ADAMTS-5, is associated with 
cartilage damage 97, 98. Local loss of proteoglycans and cleavage of type II collagen 
occurs initially at the cartilage surface resulting in an increase in water content and loss 
of tensile strength in the cartilage matrix as the lesion progresses. The limited intrinsic 
repair capacity of cartilage is most probably due to the difficulties to repair the cartilage 
collagen network whereas proteoglycan depletion is often reversible. Collagen turnover 
is low in normal adult cartilage and increased in OA 68, 99, which is consistent with the 
presence of type II collagen propeptides in both healthy and osteoarthritic cartilage 96. 
In OA, increased collagen turnover is accompanied by increased collagen denaturation, 
suggesting ineffective repair 100. These data strongly support the idea that collagen 
turnover can be increased in healthy adult cartilage which can result in a normal col-
lagen network.
It is believed that cytokines and growth factors also play a role in the pathophysiology 
of OA.  Cytokines with destructive properties for articular cartilage are Interleukin-1 
(IL-1) 101, 102, Tumor Necrosis Factor α (TNFα) 103, 104, and the more recently discovered 
IL-17 105. These cytokines have a pronounced suppressive effect on chondrocyte 
proteoglycan synthesis, and also stimulate the chondrocyte to release destructive pro-
teases, which then mediate cartilage breakdown. IL-1 and TNFα are mainly produced 
by chondrocytes 106 or activated macrophages in the synovium 107, whereas IL- 17 is a 
T-cell-derived interleukin 108.
Anti-inflammatory cytokines such as IL-4, IL-10 and IL-13 inhibit the destructive 
properties of these pro-inflammatory cytokines via the upregulation of inhibitors of IL-1 
(e.g. IL-1 receptor antagonist) and TNFα (soluble TNFα receptor), or TIMPs 109, 110.
Growth factors are able to counteract the catabolic effect of IL-1. IGF-1 (Insulin-like 
Growth Factor-1) is the main anabolic growth factor for adult articular cartilage under 
physiological conditions but signaling is altered in OA. Enhanced levels of IGF-1 binding 
proteins (IGFBPs) 111 or inadequate signaling by the IGF-1 receptor on the chondrocyte 112 
results in suppressed chondrocyte proteoglycan synthesis and enhanced breakdown of 
proteoglycans. In contrast, blockade of IGFBPs restores IGF-1-dependent proteoglycan 
synthesis in OA cartilage 113.
Transforming Growth Factor-β (TGFβ) is expressed in high levels in normal cartilage, 
but low in OA cartilage 114. Blocking TGFβ makes cartilage more susceptible to dam-
age 115. TGFβ is a potent inducer of cartilage ECM synthesis 116 and a very potent 
counteracting agent of IL-1 actions 117-119. Therefore, lack of TGFβ causes a reduction 
in ECM deposition and suppression of catabolic stimuli is drastically reduced. Next to 
IGF-1 and TGFβ, a range of other growth factors can stimulate chondrocyte activity, 
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including Fibroblast Growth Factor (FGF) and Platelet Derived Growth Factor (PDGF). 
Since their important role in OA, their effect on cartilage matrix production and chon-
drocyte behavior, the above mentioned growth factors are often used in cartilage repair 
strategies 106, 120-123.
Aims and outline of this thesis
The recommended management for OA consist of non-pharmacological treatments 
such as weight loss 124-127, then pharmacological intervention, and then, if necessary, 
surgery 128-130. Pharmacological intervention includes non-steroidal anti-inflammatory 
drugs (NSAIDs) and opioid analgesics for pain management 131. However, all these 
interventions aim at pain management but no therapy is yet available to repair cartilage 
damage in OA.
Even though cartilage has a low turnover and is often thought to have no repair 
capacities, matrix production including collagen type II is upregulated in OA suggesting 
a potential for repair. This indicates that regeneration is possible and lead to the follow-
ing goal:
Identification of biochemical factors that modulate 
cartilage metabolism focusing on a functional collagen 
type II network
Cartilage repair strategies often include the use of growth factors. IGF-1, FGF-2 (also 
known as basic FGF) and TGFβ are frequently used growth factors that also play a 
significant role in joint development and matrix homeostasis 132-134. In chapter 2, we 
examined the effect of these three growth factors on cartilage matrix deposition, col-
lagen cross-linking and functionality of the newly formed matrix using bovine chondro-
cytes cultured in alginate beads as a model.
One of these growth factors, TGFβ, is known to be a potent inducer of fibrosis. 
Increased amounts of TGFβ are found in fibrotic lesions 135, 136 and administration 
of TGFβ to laboratory animals leads to the development of fibrosis 137, 138. Fibrosis is 
a complex process finally resulting in excessive deposition of highly cross-linked col-
lagen 139, 140. In our growth factor study with chondrocytes we observed contrasting 
effects of TGFβ, mainly in collagen cross-linking. Since TGFβ is a widely used growth 
factor in cartilage repair strategies on a large variety of culture substrates, we decided 
to investigate the effect of TGFβ on chondrocytes and their matrix production in more 
detail in chapter 3. Here, we used four different cell populations in two very different 
physical environments; primary and expanded chondrocytes and fibroblasts (as a control) 
embedded in alginate gel and attached to tissue culture plastic.
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Since collagen cross-links are essential for cartilage matrix production and functional-
ity, we inhibited an enzyme involved in collagen cross-linking in our third study. How 
this temporary cross-linking affected collagen turnover (synthesis and MMP-mediated 
degradation) and functionality of the matrix was examined in chapter 4.
Collagen fibrils interact with all other cartilage matrix molecules, directly or indirectly. 
Modifying matrix components next to collagen might influence collagen deposition 
and function. In addition, previous disruption of the proteoglycan network resulted in 
enhanced integrity of the collagen network 141. In chapter 5, proteoglycan synthesis 
was inhibited by prevention of the linkage of GAG side chains to the protein core of the 
proteoglycans. How this influenced the collagen deposition, distribution and functional-
ity was described there.
Next to proteoglycans, other matrix components such as COMP and collagen type 
IX are likely required for the formation of the collagen fibrils and the structure and 
integrity of the network. To get more insight into these requirements and their contribu-
tion in matrix regeneration, we investigated COMP and collagen type IX in more detail 
in chapter 6 and 7. The effect of the previously used growth factors (chapter 2) on 
COMP deposition was examined next to the effect of COMP overexpression on collagen 
biochemistry in chapter 6.
In chapter 7, COMP and collagen type IX were absent in chondrocyte cultures from 
double knock-out mice. How the absence of these to matrix molecules influenced matrix 
production and functionality in vitro, was investigated here.
In chapter 8, some of our previously used approaches are combined to examine their 
effect on cartilage matrix production as investigated earlier. In parallel, cartilage explants 
were also used to examine the effect of the combinations on cartilage integration.
Finally, chapter 9 presents the general discussion; summarizing and discussing the 
results of the work performed and elaborating on future applications for cartilage repair 
in osteoarthritis.
2 Biochemical and functional modulation of the cartilage 
collagen network by IGF1, TGFβ2 
and FGF2
Yvonne M. Jenniskens, Wendy Koevoet, Anton C.W. de 
Bart, Harrie Weinans, Holger Jahr, Jan A.N. Verhaar, Jeroen 
DeGroot, Gerjo J.V.M. van Osch
Osteoarthritis and Cartilage. 2006 Nov;14(11):1136-46.
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Abstract
Background
Examine effects of IGF1, TGFβ2 and FGF2 on proteoglycan and collagen network and 
biomechanical properties of the newly formed cartilage matrix.
Methods
Bovine articular chondrocytes were cultured in alginate beads for three weeks with 
or without FGF2, TGFβ2 or IGF1 in the presence of 10% FCS. Proteoglycan content, 
collagen content, hydroxylysylpyridinoline cross-links (HP) and overall MMP activity in 
the culture medium were measured. Alginate disks cultured for five weeks were used 
to evaluate the effect of growth factors on mechanical properties of the construct by 
determining the equilibrium aggregate modulus and secant modulus.
Results
IGF1 increased collagen and proteoglycan deposition. FGF2 mainly decreased collagen 
deposition and TGFβ2 proteoglycan deposition. A decrease in cross-links was observed 
in matrix produced by chondrocytes cultured in the presence of TGFβ2. IGF1 and FGF2 
had no influence on the number of cross-links per collagen molecule. Overall MMP-
activity was significantly higher in culture medium of cells cultured with FGF2. TGFβ2 
and IGF1 had no effect on MMP-activity. After 35 days of culture, the matrix produced 
under influence of IGF1 had a lower permeability and a trend to increase stiffness. FGF2 
showed a trend to lower both properties. TGFβ2 had no effect on these parameters.
Conclusion
IGF1, TGFβ2 and FGF2 had differential effects on collagen network formation. Of the 
three growth factors tested, IGF1 seems to be best in promoting the formation of a 
functional collagen network since it increased proteoglycan and collagen deposition 
and improved the mechanical properties.
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Introduction
Once damaged, adult articular cartilage has a poor repair capacity, which is probably 
due to the ineffective repair of the collagen network, since proteoglycan depletion is 
often reversible 142. Although collagen turnover is increased in osteoarthritis, this does 
not lead to the formation of a functional network 26, 68, 96, 143-145. A similar phenomenon 
is seen in cartilage tissue engineering both in vitro and in vivo, where proteoglycans are 
abundantly produced but the amount of collagen produced is limited, probably impair-
ing functional properties of the newly formed matrix 146.
Type II collagen belongs to the fibril-forming collagens and accounts for more than 
90% of the collagenous protein in adult articular cartilage, where it defines the basic 
architecture and provides tensile strength 25, 147. Together with type IX and XI, collagen 
type II forms fibrils 20, 25, which are stabilized by the formation of intermolecular pyridi-
noline cross-links. In cartilage, collagen molecules are cross-linked via the hydroxyallysine 
route, which is mediated by enzymes such as lysyl hydroxylases (LH) and lysyl oxidase 
(LOX) 148, resulting in lysylpyridinoline (LP) or hydroxylysylpyridinoline (HP) 19, 149. HP and 
LP are chemical variants of a mature trifunctional collagen cross-link 150, both giving 
strength to the cartilage.  In cartilage, HP is found at 30-50 fold higher levels than LP.
In healthy cartilage, the extracellular matrix is continuously remodeled although 
slowly: this is a balance between enzymatic degradation of matrix components and de 
novo synthesis by chondrocytes. One group of matrix degrading enzymes is the matrix 
metalloproteinases (MMP) family. Members of the MMP family are capable of degrading 
practically all components of the extracellular matrix including collagen and aggrecan 
in their substrates 69. A variety of cells including chondrocytes secrete MMPs and their 
production can be influenced by several factors including growth factors 151.
Generation of new cartilage repair tissue can also be influenced by growth factors. In 
previous studies, growth factors have demonstrated to influence proteoglycan produc-
tion and deposition. In culture, Insulin-like Growth Factor 1 (IGF1) stimulates proteo-
glycan production in a dose-dependent manner 152. Fibroblast Growth Factor 2 (FGF2) 
has pleiotropic effects: both stimulation and inhibition of proteoglycan deposition have 
been described, depending on the FGF-2 concentration 153, but also on the presence or 
absence of fetal calf serum 154 or the employed cell culture system (monolayer versus 
alginate) 154, 155. Transforming Growth Factor β2(TGFβ2) also has variable effects when 
used in in vitro studies; while a dose-dependent inhibition of proteoglycan production 
is observed; a stimulation has also been described, depending on the culture condi-
tions 152, 156.
While most studies focus on proteoglycan metabolism, we are interested in the 
effects of growth factors on the functional quality of the matrix and therefore choose 
collagen as our main focus in this study. Specifically, we investigated the amount of 
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collagen and proteoglycan synthesized, the number of collagen cross-links formed and 
the mechanical properties of the formed matrix as a consequence of IGF1, TGFβ2 and 
FGF2 addition to bovine chondrocytes.
Materials and Methods
Cell culture
Articular cartilage was harvested from the metacarpophalangeal joints of calves aged 
6–12 months. To isolate chondrocytes, full-thickness slices of non-calcified articular 
cartilage were subjected to pronase (2 mg/ml, Sigma, St. Louis, MO, USA) digestion 
for two hours followed by overnight collagenase B (1.5 mg/ml, Roche Diagnostics) 
digestion. The chondrocytes were resuspended in 1.2% (w/v) low viscosity alginate 
(Keltone) in 0.9% NaCl (Sigma) at a concentration of 4 × 106 cells/ml and beads were 
made as describes previously 157, 158. Briefly, the cell-alginate suspension was pressed 
through a 22-gauge needle in 105 mM CaCl2. Beads were washed with 0.9% NaCl 
and Dulbecco’s Modified Eagle Medium (DMEM)/F12 (GibcoBRL, Gaithersburg, MD, 
USA) and inspected visually. Beads that appeared smaller or larger were not included in 
the experiment. After transfer to a six-well plate (BD Falcon, Bedford, MA, USA) they 
were cultured in 75 µl/bead DMEM/F12 supplemented with 10% fetal bovine serum 
(GibcoBRL), 50 µg/ml L-ascorbic acid 2-phosphate (Sigma), 50 µg/ml gentamicin and 1.5 
µg/ml fungizone (both GibcoBRL). Cells were cultured with and without 2.5 ng/ml or 25 
ng/ml FGF2 (Serotex, Oxford, UK), TGFβ2 (recombinant human, R&D systems, Abington, 
UK) or IGF1 (Sigma) and harvested after 11, 20 and 35 days of culture. Growth factors 
and their concentrations were chosen based on previous results 123, 152, 159. Part of the 
cell containing beads was used immediately for RNA extraction; the rest was stored at 
−20 °C until further biochemical analyses.
Biochemical assays
Alginate beads were digested overnight at 56°C in papain buffer (200 µg/ml papain 
in 50 mM Ethylene Diamintetraacetate (EDTA) and 5 mM L-cystein). Glycosaminogly-
can (GAG) amount in de digest was quantified using dimethylmethylene blue (DMB) 
assay 160. The metachromatic reaction of GAG with DMB was monitored with a spec-
trophotometer, and the ratio A540:A595 was used to determine the amount of GAG 
present, using chondroitin sulfate C (Sigma) as a standard. The amount of DNA in each 
papain-digested sample was determined using Hoechst 33258 dye 161 with calf thymus 
DNA (Sigma) as a standard.
For high-performance liquid chromatography (HPLC) of amino acids (hydroxyproline, 
Hyp) and collagen cross-links (hydroxylysylpyridinoline, HP and lysylpyridinoline, LP), the 
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papain digest was hydrolyzed (108°C, 18-20 h) with 6 M HCl. The hydrolyzed samples 
were dried and redissolved in 200 µl water containing 2.4 mM homoarginine (internal 
standard for amino acids) (Sigma). Samples were diluted 25-fold with 50% (v/v) acetic 
acid for cross-link analysis and diluted 250-fold with 0.1 M sodium borate buffer pH 
8.0 for amino acid analysis. Additionally, to determine hydroxyproline, amino acids were 
labeled with 9-fluorenylmethyl chloroformate. Reversed-phase high-performance liquid 
chromatography of amino acids and cross-links were performed as described previ-
ously 162, 163. The quantities of cross-links were expressed as the number of residues per 
collagen molecule, assuming 300 Hyp residues per triple helix.
Immunohistochemical staining for collagen type I and II
To prepare histochemical cytospins, three alginate beads cultured for 35 days were dis-
solved in 55 mM sodium citrate acid. They were fixed in cold acetone and pre-treated 
with 1% hyaluronidase (Sigma). The cytospins were incubated with monoclonal anti-
bodies against either type I collagen (1:100, M28; Developmental Studies Hybridoma 
Bank), or type II collagen (1:100, II-II6B3; Developmental Studies Hybridoma Bank) 
at room temperature for 2 h, followed by incubation with anti-mouse Fab-fragments 
conjugated with alkaline phosphatase (GAMAP; 1:100; immunotech, Marseille, France) 
for 30 minutes and mouse monoclonal alkaline phosphatase anti-alkaline phosphatase 
(APAAP; 1:100; Dakopatts, Copenhagen, Denmark; 1:100) for 30 minutes. Freshly 
prepared neo-fuchsin substrate was used to achieve staining.
After staining, cytospins were scored for the number of cells positive for collagen 
types I and II per 100 cells in four fields of sight per specimen, resulting in a percentage 
of positive cells. An arbitrary scoring system from 1 to 5 was used, with 1 representing 
less than 10% of the cells positive, 2 representing 10-40% positive, 3 representing 
40-60% positive, 4 representing 60-90% positive and 5 representing more than 90% 
of the cells positive. A cell was considered positive, when the matrix around the cell or 
the cytoplasm was stained red.
Gene expression analysis
For total RNA isolation, alginate beads were dissolved in 150 µl/bead 55 mM sodium 
citrate acid. Cell pellet was suspended in 1000µl RNA-BeeTM (TEL-TEST, Inc.; Friend-
swood, TX, USA) per million cells according to manufacturer’s guidelines, and subse-
quently precipitated with 2-propanol and purified with lithium chloride. Total RNA was 
quantified using RibogreenTM reagent (R-11490, Molecular Probes Europe BV, Leiden, 
the Netherlands) according to manufacturer’s instructions, and 500 ng total RNA of 
each sample was reverse transcribed into cDNA using RevertAidTM First Strand cDNA 
Synthesis Kit (MBI Fermentas, Germany).
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For Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and aggrecan, each cDNA 
sample was amplified using specific primers and specific probe (Table 2.1, Eurogentec, 
Seraing, Belgium). For Collagen type 2 (COL2), Matrix Metalloproteinase-1 (MMP-1), 
Lysyl Oxidase (LOX) and Lysyl Hydroxylase 2b (LH2b), each cDNA sample was amplified 
using specific primers and specific molecular beacons (Table 2.2, Biolegio, Nijmegen, The 
Netherlands). All amplifications were done in a total reaction volume of 25 µl containing 
1×PCR buffer, 0.4 mM of each dNTP, Mg2+ (3.5 mM for the molecular beacons and 5 
mM for the probes), 0.5 unit of Taq polymerase (all from Eurogentec) and each primer 
and probe or beacon. PCR was performed in an ABI PRISM® 7000 (Applied Biosystems, 
Foster City, CA, USA) sequence detection system and consisted of a 5-min interval at 
95 °C followed by 40 cycles of 95 °C for 30 s and 60°C for 1 min for hydrolysis probe 
assays and 40 cycles of 95 °C for 30 s, 56 °C for 40 s, and 72 °C for 30 s for beacon 
assays. Data were analyzed using Sequence Detector version 1.7 (Applied Biosystems) 
software and normalized for GAPDH expression and expression in the control condition 
without growth factors 164.
Total MMP assay
The culture medium was used to determine general MMP activity as described earlier 165. 
General MMP activity was measured using 5 µM (all concentrations are final) fluorogenic 
substrate TNO211-F (Dabcyl-Gaba-Pro-Gln-Gly-Leu-Cys[Fluorescein]-Ala-Lys-NH2) in the 
presence or absence of 12.5 µM BB94 (a general MMP inhibitor). Medium samples 
were diluted (final dilution 1/2) in MMP buffer (50 mM Tris [pH 7.5], 5 mM CaCl2, 150 
mM NaCl, 1 µM ZnCl2, 0.01% Brij-35, 0.02% NaN3) containing a general proteinase 
inhibitor (Complete, EDTA-free, one tablet in 12.5 ml, Roche). The MMP activity in 
Table 2.1: sequences of primers and probes for real-time PCR.
Primers Probe
GAPDH Forward: GTCAACGGATTTGGTCGTATTGGG
Reverse: TGCCATGGGTGGAATCATATTGG
Fam-TGGCGCCCCAACCAGCC-Tamra
Aggrecan Forward: GGACACTCCTTGCAATTTGAGAA
Reverse: CAGGGCATTGATCTCGTATCG
Fam-CCATCA CCATCT TCCAGG AGCG AGA-Tamra
Table 2.2: sequences of primes and beacons real-time PCR.
Primers Beacon
PLOD2 Forward: 
TTAAAGGAAAGACACTCCGATCAGAGATGA
Reverse: 
AATGTTTCCGGAGTAGGGGAGTCTTTTT
Fam-cgtgcg CGTGAT AAACTG GATCCT GATATG 
GCTCTT cgcacg-Dabcyl
LOX Forward: GTGGCCGACCCCTACTACATCC
Reverse: AGCAGCACCCTGTGATCATAATCTC
Fam - cgtgcc ATGCGC GGCGGA GGAAAA CTG 
ggcacg- Dabcyl
MMP-1 Forward: ACCCCAGACCTGTCAAGAGCA
Reverse: TCCCCTGACAAAGGATATCATTAT
Fam-cgtgcc AAAGCC TTTCAA CTCTGG AGCAAT 
GTCAC ggcacg-Dabcyl
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each sample was calculated as the difference in the initial rate of substrate conversion 
(linear increase in fluorescence in time, expressed as relative fluorescence units (RFU) per 
second) between samples with and without BB94 addition. Fluorescence was measured 
for six hours at 30°C using a Cytofluor 4000 (Applied Biosystems, Foster City, CA, USA). 
This assay is considered to represent overall metalloproteinase activity.
Mechanical testing
For mechanical characterization, we used 4 × 106 cells/ml in 1.2% (w/v) alginate con-
structs of 3 mm thick and 6 mm in diameter. The constructs were prepared as previously 
described by Wong et al.166. Directly after making the cell containing alginate disks, 
samples were taken for mechanical testing at day 0, which is indicative for the mechani-
cal strength of the alginate. Constructs were mounted on a materials testing machine 
(type LRX, Lloyd Instrument, Farnham, UK) in a radially unconfined stress relaxation 
test with the construct between impermeable platens, and hydrated in 0.9% saline 
with protease inhibitor Complete (Sigma). A 20% uniaxial compressive strain was then 
applied within 10 seconds at a ramped displacement strain rate of 2% s-1, based on the 
measured thickness. The strain was maintained constant at this plateau for 30 min with 
the load recorded at a sampling frequency of 20 Hz using a 10 N load cell. The applied 
load recorded by the load cell was divided by the cross-sectional area of the construct 
to calculate the applied stress. The secant modulus was calculated as stress/strain at 10 
seconds, where the stress had its peak response and the strain reached its maximum 
plateau. At the end of the test, the equilibrium aggregate modulus was determined 
again as stress/strain at 30 minutes creep.
Data analysis
The experiments at day 11 were repeated twice with 3 samples of 7 beads per experi-
mental condition for biochemical analysis and one sample of 10 beads per experimental 
condition for gene expression analysis. The experiments at day 20 were repeated four 
times with 3 samples of 7 beads per experimental condition for biochemical analysis 
and one sample of 10 beads per experimental condition for gene expression analysis. 
The experiments at day 35 were repeated three times with a total of 10 samples for the 
control, IGF1 and TGFβ2 condition and 8 samples for the FGF2 condition. Overall MMP 
activity in the culture medium and collagen type I and II deposition with cytospins was 
determined in 1 experiment in triplicate.
Statistical analysis was performed using SPSS 11.5 (SPSS Inc. Chicago, IL) software. 
All data are presented as mean ± standard deviation, except for the gene expression 
data, which are presented as boxplots with the median and the 25th and 75th quartile. 
Control groups without growth factors and groups supplemented with growth factors 
were compared using a Kruskall-Wallis H test with a post hoc Mann–Whitney U test.
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Results
Effects of growth factors on matrix deposition and 
cross-links
To investigate the effect of different growth factors on matrix deposition, we cultured 
chondrocytes in 3D alginate beads in the presence of growth factors. The amount of 
DNA was determined in the alginate beads, to give an indication of the number of 
chondrocytes present in the beads. Between the experiments, the amount of DNA at 
day 0 was 0.18 µg DNA/bead ± 0.025 µg/bead. After 20 days, the amount of DNA in 
the control condition was 0.27 µg/bead ± 0.04. In time, the used growth factors had 
no significant effect on the amount of DNA per bead compared to the control condition 
without growth factors. Addition of IGF1 resulted in 97%, TGFβ2 in 95% and FGF2 in 
112% of the amount of DNA compared to the control condition at day 20. Because 
the used growth factors had no differential effects on the cell proliferation and we were 
interested in the overall matrix production, not in the matrix production per cell, results 
of matrix deposition is expressed per alginate bead.
Chondrocytes in alginate produced considerable amounts of proteoglycans over the 
three weeks culture period, resulting in a proteoglycan concentration in the control con-
dition of 8.1 µg/bead at day 11 and 29.9 µg/bead at day 20. Cultured in the presence 
of 25 ng/ml IGF1, the chondrocytes deposited more proteoglycans than in the control 
condition resulting in 1.4-fold increase of proteoglycans at day 11 and 1.8-fold increase 
of proteoglycans at day 20 (Figure 2.1). 2.5 ng/ml IGF1 resulted in more proteoglycans 
at day 20 but not at an earlier time point. Addition of TGFβ2 to the culture medium 
of chondrocytes resulted in less proteoglycans at both time points, although the effect 
was not significant with 25 ng/ml TGFβ2 at day 20. Cells stimulated with 2.5 ng/ml 
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Figure 2.1. Effect of growth factors on proteoglycan deposition in 3D chondrocyte cultures. Proteo-
glycan deposition is shown after A) 11 days of culture (n=6) and B) 21 days of culture (n=12). * indicates 
p<0. 1 and # indicates p<0.05 compared to the control condition without growth factors, which is set 
at 100% (sd = 8.2% at day 11 and sd = 6.8% at day 21). Data are presented as mean % ± SD.
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FGF2 deposited more proteoglycans at both time points whereas 25 ng/ml FGF2 had no 
significant effect on the deposition (Figure 2.1).
The effect of growth factors on collagen, the other main constituent of cartilage, 
was also investigated in our study. Chondrocytes in alginate beads produced 4.8 µg 
collagen /bead at day 11 and 8.3 µg collagen/bead at day 20. Addition of IGF1 resulted 
in approximately the same effect as that seen on proteoglycan deposition; 1.6-times 
more collagen at day 11 and 1.8-times more collagen at day 20 with 25 ng/ml IGF1. 
With 2.5 ng/ml IGF1 the upregulation was only significant at day 20. At day 11, TGFβ2 
had no effect on collagen deposition but by day 20, both concentrations resulted in 
25% less collagen. FGF2 had a bi-directional effect on collagen deposition; 2.5 ng/ml 
FGF2 resulted in more collagen deposition, although this was not significant at day 20; 
whereas 25 ng/ml resulted in less collagen deposition, up to a 1.75-fold downregulation 
at day 20 (Figure 2.2).
0
50
100
150
200
250
2.5 ng/ml 25 ng/ml 2.5 ng/ml 25 ng/ml 2.5 ng/ml 25 ng/ml
IGF1 TGFβ2 FGF2
%
 c
ol
la
ge
n 
co
m
pa
re
d 
to
 c
on
tro
l *
day 21
B
* *
*
#
0
50
100
150
200
250
2.5 ng/ml 25 ng/ml 2.5 ng/ml 25 ng/ml 2.5 ng/ml 25 ng/ml
IGF1 TGFβ2 FGF2
%
 c
ol
la
ge
n 
co
m
pa
re
d 
to
 c
on
tr
ol
#
#
*
day 11
A
 
Figure 2.2 
 
0
50
100
150
200
250
2.5 ng/ml 25 ng/ml 2.5 ng/ml 25 ng/ml 2.5 ng/ml 25 ng/ml
IGF1 TGFβ2 FGF2
%
 c
ol
la
ge
n 
co
m
pa
re
d 
to
 c
on
tro
l *
day 21
B
* *
*
#
0
50
100
150
200
250
2.5 ng/ml 25 ng/ml 2.5 ng/ml 25 ng/ml 2.5 ng/ml 25 ng/ml
IGF1 TGFβ2 FGF2
%
 c
ol
la
ge
n 
co
m
pa
re
d 
to
 c
on
tr
ol
#
#
*
day 11
A
 
Figure 2.2 Figure 2.2. Effect of growth factors on collagen deposition in 3D chondrocyte cultures.  Collagen 
deposition is shown after A) 11 days of culture (n=6) and B) 21 days of culture (n=12). * indicates p<0.01 
and # indicates p<0.05 compared to the control condition without growth factors, which is set at 100% 
(sd = 2.5% at day 11 and sd = 16.1% at day 21). Data are presented as mean % ± SD.
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Figure 2.3 Figure 2.3. Effect of growth factors on collagen cross-linking. Hydroxylysylpyridinoline (HP) crosslinks 
in newly formed collagen are shown after 20 days of culture (n=12). * indicates p<0.01 Data are pre-
sented as mean ± SD.
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After 20 days of culture, HP cross-links were present in the collagen network in 
contrast with LP cross-links, which were almost undetectable in the extracellular matrix. 
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Figure 2.4  
 
igure 2.4  Immunohistochemical analysis of produced matrix. Collagen type II deposition in a) cells 
cultured in the presence of IGF1 b) TGFβ2 and c) FGF2 and d)cells cultured without growth factors; 
e) collagen type I is mainly only present in large cell clusters, not in matrix of single cells, f) is the 
isotype control. Magnification is 100 times, with a 400 times inset. Positive cells are indicated arrows, 
arrowheads indicate negative cells.
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During the 20 days of culture, IGF1 and FGF2 had no significant effect on the HP-cross-
links. On the other hand, the use of 2.5 or 25 ng/ml TGFβ2, unexpectedly downregulated 
HP cross-links per collagen molecule 2.5 times and 3.1 times, respectively (Figure 2.3).
Type of collagen production
To confirm whether the appropriate type of collagen (collagen type II) is made in our 
alginate system, a immunostaining for collagen type I and type II was performed on 
cytospins at the end of the experiment after 35 days of culture. 60-90% of the cells 
cultured in the presence of 25 ng/ml IGF1 (Figure 2.4A) and TGFβ2 (Figure 2.4B) were 
positive for collagen type II , in contrast to the control and the FGF2 condition where 
IGF1 TGFß2 FGF2
-30 
-10
-3
1
relative collagen type II expression
* * *
IGF1 TGFß2 FGF2 
relative aggrecan core protein expression
*
*
-10
-3 
1
3
IGF1 TGFß2 FGF2
relative LOX expression
*
-10
-3
1
3
IGF1 TGFß2 FGF2 
relative TLH expression
time of sample
11 days
20 days
*
*
-10
-3
1
3
A
D
B
C
1 ys
ays
R lati e collagen type II expression R lati e a grecan core protein expression
Relative LOX expre sion R l ti  LH2b expression
I TGF F F2 IG 1 TGF2 F
IGF1 TGF2 F IGF1 TGF2 F
 
Figure 2.5 Figure 2.5. Gene expression analysis after 11 and 20 days of culture as n-fold change compared to the 
untreated control. A) collagen type II, B) aggrecan, C) LOX, and E)LH2b expression. * indicates p<0.01 
compared to control.  Data are presented as boxplots with median, 25th and 75th quartile for the gene 
expression with the control condition without growth factors set at 1.
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approximately 40-60% of the cells were positive for collagen type II (Figure 2.4C and 
4D). In every condition, approximately 10-40% of the cells stained positive for collagen 
type I of which a representative example is shown in Figure 2.4E.
Gene expression of matrix constituents and collagen 
modifying enzymes
To examine early regulation in matrix deposition and collagen cross-linking, gene 
expression of collagen type II (COL2), aggrecan, LOX and LH2b was determined after 
11 days and 20 days of culture. COL2 expression was not influenced by 25 ng/ml IGF1 
at both time points (Figure 2.5A). Furthermore, there was almost no effect of IGF1 on 
aggrecan, LOX and LH2b expression at day 11 (Figure 2.5B, C and D). At day 20, on 
the other hand, aggrecan expression is 2.7 times upregulated compared to the control 
(Figure 2.5B).
Expression of the matrix constituents collagen type II and aggrecan was considerably 
downregulated when cells were cultured in the presence of TGFβ2 for 11 days (Figure 
2.5A and B), in contrast to the culture after 20 days where TGFβ hardly had an effect on 
COL2 and aggrecan expression. In contrast to the expectations, 25 ng/ml TGFβ2 had no 
apparent effect on the enzymes LOX and LH2b involved in collagen cross-linking during 
the culture period (Figure 2.5C and D).
25 ng/ml FGF2 downregulated COL2 expression up to 23 times at day 20 (Figure 
2.5A) and had little or no effect on aggrecan expression. The expression of the collagen 
cross-linking enzymes LH2b and LOX was also downregulated in the presence of FGF2.
MMP activity and gene expression
Because MMPs influence matrix quality and content, we determined overall MMP activ-
ity in the culture media and gene expression for the specific collagenase MMP-1 at day 
20. Because we were interested in possible breakdown of collagen type II, we did not 
analyze the MMP-2 expression since this is a gelatinase, which can only cleave unwound 
collagen, following initial cleavage by a collagenase. MMP-8 and MMP-13 were not 
examined because of their minor role in normal chondrocytes. 25 ng/ml IGF1 and TGFβ 
had no significant effect on the MMP activity in the culture medium at day 20 compared 
to the control. On the other hand, 25 ng/ml FGF2 increased the overall MMP activity 
(Figure 2.6A). Gene expression at day 11 and day 20 of MMP-1, the most important 
collagenase in healthy cartilage, was downregulated when chondrocytes were cultured 
with IGF1 and even more with TGFβ2, up to 20 times less at day 11. FGF2 had no effect 
on MMP-1 expression at both day 11 and day 20 (Figure 2.6B).
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Association between biochemical and biomechanical 
properties
To test whether the growth factors could influence mechanical properties via their effect 
on amount of extracellular matrix, its composition and cross-linking, we examined the 
effect of the three growth factors on the equilibrium aggregate modulus and the secant 
modulus. Direct after making the cell containing alginate disks, the mechanical proper-
ties indicated by the equilibrium aggregate modulus and the secant modulus were 0.36 
kPa and 2.1 kPa respectively, in concordance to previous results167. After five weeks of 
culture, matrix production contributed to the mechanical properties, indicated by the 
increase of the equilibrium aggregate modulus to 1.5 kPa and the secant modulus to 
7.0 kPa in the control condition.
Cultures with IGF1 resulted in an upregulation of the secant modulus and a trend 
to upregulation of the equilibrium aggregate modulus. The proteoglycan and collagen 
content (Figure 2.7C and D) in these mechanically tested constructs was also higher than 
in the control condition without growth factors. The number of cross-links per collagen 
molecule (Figure 2.7E) was equal compared to the control. When chondrocytes were 
cultured in the presence of TGFβ2 for 5 weeks, both mechanical properties were unaf-
fected compared to the control (Figure 2.7A and B), while the proteoglycan deposition 
and the number of cross-links per collagen molecule were greatly reduced in the same 
alginate disks  (Figure 2.7C and 2.7E).  After five weeks of culture with TGFβ2, collagen 
deposition was unaffected (Figure 2.7D). FGF2, on the other hand, resulted in decreased 
mechanical properties, although not significant compared to the control (Figure 2.7A 
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Figure 2.6 
Figure 2.6. Overall MMP activity and MMP-1 expression. a)Overall MMP activity was measured in the 
culture medium after 20 days of culture together with b) the gene expression of the specific collagenase 
MMP-1 after 11 and 20 days of culture. * indicates p<0.01 and # indicates p<0.05 compared to the 
control condition.  Data are presented as mean ± SD for the overall MMP activity and as boxplots with 
median, 25th and 75th quartile for the gene expression with the control condition without growth factors 
set at 1.
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Figure 2.7 Figure 2.7. Relation between mechanical properties and matrix constituents after 35 days. Biochemical and biomechanical properties of tested alginate disks after 35 days of culture as percentage compared 
to the control with a)the equilibrium modulus of the newly formed matrix (control is 100 ± 26%) b)the 
secant modulus of the newly formed matrix (control is 100 ± 23%), c)proteoglycan deposition (control 
is 100 ± 11%) d)collagen deposition (control is 100 ± 12%) and e)HP-crosslinks per collagen molecule 
(control is 100 ± 10%). * indicates p<0.01 and # indicates p<0.05 compared to control. Data are 
presented as mean ± sd.
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and B). These poor properties can partially be explained by the downregulation of col-
lagen deposition, which is significant after 11 and 20 days of culture (Figure 2.2), and 
also appears to be downregulated but not significant at day 35. This is apparently not 
compensated by more proteoglycans (Figure 2.7C) or an equal number of cross-links per 
collagen molecule (Figure 2.7E).
Discussion
The formation of cartilage matrix in vitro or after damage in vivo is characterized by low 
collagen production and high proteoglycan production 142, 146. The present study shows 
differential effects of IGF1, FGF2 and TGFβ2 on proteoglycan and collagen synthesis, 
collagen cross-links and the mechanical properties of the newly formed matrix. Of these 
three growth factors, IGF1 is most promising with regard to promoting a functional 
extracellular matrix with high proteoglycan and collagen deposition without altering 
the relative number of cross-links per collagen. Moreover, the mechanical properties of 
constructs cultured with IGF1 were improved compared to control constructs.
Using IGF1 in the alginate culture system resulted in approximately a 1.5-fold increase 
in both proteoglycan and collagen deposition after 35 days of culture. Upregulation of 
proteoglycan deposition with IGF1 is consistent with previous data 152, 153, 159, 168, 169. 
The effect of partially blocking IGF1 previously described, which led to a reduction in 
proteoglycan production 170, further supports the importance of IGF1 in proteoglycan 
synthesis. On the other hand, the effect on collagen deposition in the presence of 
IGF1 was less intensively investigated and less consistent. IGF1 did not affect collagen 
deposition in one study 168 but caused an upregulation of collagen synthesis in other 
studies 153, 171. In contrast to the increase in collagen protein that we observed, gene 
expression of collagen type II was not influenced whereas aggrecan expression was 
slightly upregulated in the presence of IGF1. This suggests that many of the synthesized 
collagen might be incorporated in the matrix. Also, the significant downregulation 
of MMP-1 expression might have contributed to more matrix deposition. MMP activ-
ity is regulated on several levels; transcription, translation, activation and inhibition. 
Therefore, the amount of MMP-1 mRNA is only indicative for the MMP-1 activity. The 
substrate used in our activity assay is mainly degraded by other MMPs than MMP-1, 
possibly explaining the discrepancy between the overall activity assay and the MMP-1 
gene expression data.
The quality of the cartilage matrix is determined not only by the amount of matrix 
produced, but also by the number of cross-links between collagen molecules. We there-
fore determined the number of HP and LP cross-links, the two chemical variants of the 
mature collagen cross-links found in cartilage. In adult cartilage, the average is 1.5 HP 
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cross-links per collagen molecule 172, in immature cartilage the number is 0.8 HP. After 
35 days of culture, a small although not significant increase in number of HP-cross-links 
per collagen molecule was detectable in the presence of IGF1 compared in the control 
condition, approaching the physiological number of cross-links in immature cartilage. 
The expression of the collagen cross-linking enzymes LH2b and LOX was not influenced 
by the presence of IGF1 even though more collagen was present in this culture condi-
tion. To our knowledge, there are no other publications about the effect of growth 
factors on collagen cross-linking in cartilage.
For the adequate repair of articular cartilage defects, it is especially important that the 
deposited matrix constituents are able to resist load in an articular joint. Different types 
of collagen have different properties concerning cross-linking and mechanical behavior. 
Therefore, we determined whether the appropriate type of collagen (collagen type II 
and not collagen type I) was produced in our culture system. Collagen type II was the 
most abundant type in the newly formed matrix in the IGF1 and TGFβ2 conditions. 20% 
of the newly formed matrix was positive for collagen type I, which was most probably 
deposited by cells in the outer layer of the alginate bead as shown previously 157.
Increased matrix deposition and increased cross-links per collagen molecule are 
expected to result in improved mechanical properties. In this study, these mechanical 
properties are measured as the equilibrium aggregate modulus and the secant modulus. 
The secant modulus is an indication for the friction between the solid and the liquid 
phase (e.g. the ability to hold water), while the equilibrium aggregate modulus is an 
indication for the stiffness of the formed matrix. The increase in extracellular matrix 
production in reaction to IGF1 might have resulted in a significantly higher secant 
modulus. This increased secant modulus indicates more friction between the water and 
the matrix resulting from a more condense or low permeable matrix. The equilibrium 
aggregate modulus also appears to be improved, although not significantly, indicating a 
stiffer solid phase. This property is defined mainly by the amount of collagen and relative 
number of collagen cross-links in the matrix 173, which also explains our result: more 
collagen deposition and the appropriate number of cross-links per collagen molecule. 
In addition, downregulation of MMP-1 gene expression might have resulted in less 
collagen breakdown, contributing to better mechanical properties, although this does 
not have to be in direct relation to each other since one MMP can digest several matrix 
molecules. Findings on the equilibrium modulus are consistent with the study by Mauck 
et al.169, although this group found no result of IGF1 on the secant modulus.
With up to 25% less collagen and proteoglycan deposition, TGFβ2 had less promi-
nent, but significant effects on matrix deposition. Decreased proteoglycan deposition 
is consistent with previous data 152, 174. However, upregulation of proteoglycan and 
collagen deposition using TGFβ is also shown by some authors 156, 168, 169, 173, 174. Fac-
tors that might explain these varying results in literature include different isoforms of 
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TGFβ (TGFβ1 vs. TGFβ2) the difference in cartilage donor (human, rabbit or bovine), 
the amount of matrix surrounding the cell, the presence of serum in the culture or 
the scaffold used for culture (polyglycolic acid, agarose or alginate). In concordance 
to the inhibition of collagen and proteoglycan deposition, gene expression at day 11 
of collagen type II and aggrecan was decreased compared to the control condition 
but recovered at day 20. Although the immunostaining for collagen type II is used to 
determine the type of collagen produced, it is striking to see more positive cells in the 
TGFβ2 condition than in the control condition, which is in contrast to less collagen 
deposition in the TGFβ2 condition. Possibly, TGFβ2 had a positive effect on the type of 
collagen produced but not on the amount of collagen produced. The downregulation 
of MMP-1 gene expression had no effect on collagen deposition. Surprisingly, we found 
that TGFβ2 resulted in more than a two-fold downregulation of HP-cross-links per col-
lagen molecule. This is in contrast to what we previously found after addition of either 
isoform of TGFβ to fibroblasts 175 , this addition resulted in an almost four-fold increase 
of the cross-linking enzyme lysyl hydroxylase (LH) 2b expression and more HP and LP 
cross-links. In the present study, no effect was seen on LH2b gene expression. Whether 
this discrepancy may be explained by different cell types or a different type of collagen 
produced (collagen type II by chondrocytes vs. collagen type I by fibroblasts) is currently 
under investigation. The mechanical properties in cultures with TGFβ2 did not differ 
from the control condition, which is unexpected regarding the low number of collagen 
cross-links, the downregulation of MMP-1 gene expression and in contrast to the previ-
ous study by Mauck et al 169. It appears that, in our system, collagen and proteoglycan 
amount have more effect on mechanical properties than collagen cross-links.  Moreover, 
in a previous study we have found that addition of TGFβ2 changed the distribution 
of proteoglycan over “cell-associated” (pericellular and territorial) and further-removed 
(interterritorial) matrix in the alginate bead; relatively more of the proteoglycan was 
laid down in the further-removed matrix compared to the cell-associated matrix 156. 
Since the interterritorial matrix mainly contributes to the mechanical properties of the 
construct, this might be a mechanism to retain functional properties, independently of 
the relative number of cross-links and the absolute amount of matrix components.
FGF2 had an interesting effect on matrix deposition. Proteoglycan deposition could 
be upregulated by FGF2, collagen deposition on the other hand, was slightly increased 
with the low concentration of FGF2 and reduced with the high concentrations FGF2. 
This so called bi-directional effect is described by others for proteoglycan deposition, but 
not for collagen deposition 153, and it can not be completely excluded that this results 
from the use of 25 ng/ml FGF2, a concentration which could be beyond the optimal 
concentration for stimulating matrix deposition in this culture system. In concordance 
with our results, the group of Shida et al. 176 found a decrease in mRNA levels for α1(II) 
procollagen when FGF2 was injected in rat knee joints. When chondrocytes are cultured 
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in alginate disks for 35 days with the addition of 25 ng/ml FGF2, the proteoglycan deposi-
tion is increased and collagen deposition is decreased but not significantly different from 
the control, indicating a difference in FGF2 effect depending on the culture environment 
(bead vs. disc) or time of culture (three vs. five weeks). Immunohistological analysis of 
the produced matrix in presence of FGF2, confirms the low collagen deposition during 
the culture while only 40% of the cells were positive for collagen type II and even less 
cells for collagen type I.  Less collagen deposition can be partially explained by the high 
overall MMP activity. Collagen cross-linking levels were not influenced by neither the 
different concentrations of FGF2 nor in time, although LH2b and LOX mRNA levels were 
downregulated. This is not surprising, as less collagen needs to be cross-linked in this 
situation. Looking at the mechanical properties, both the equilibrium aggregate modu-
lus and the secant modulus appear to be lower than in the control condition without 
growth factors. The decrease in collagen deposition might have resulted in a softer and 
also more permeable matrix indicated by both the lower equilibrium aggregate and 
secant modulus.
In summary, this study demonstrates differential effects of IGF1, TGFβ2 and FGF2 on 
generation of new cartilage. It indicates that the use of IGF1 in culturing chondrocytes 
is useful in promoting collagen synthesis and improving mechanical properties of newly 
formed cartilage whereas TGFβ2 and FGF2 do not clearly enhanced these parameters. 
Future studies will further investigate the quality of the produced matrix by examining 
the degradability of the matrix and the organization on a nanohistological (electron 
microscopic) level. Eventually, this may contribute to the optimalization of culture condi-
tions in cartilage tissue engineering and might be applied in in vivo studies for the repair 
of articular cartilage defects.
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Abstract
Background
Transforming Growth Factor β (TGFβ) is often used in cartilage tissue engineering to 
increase matrix formation by cells with various phenotypes. However, adverse effects 
of TGFβ such as extensive cross-linking in cultured fibroblasts have also been reported. 
Our goal was to study effects of TGFβ on collagen cross-linking, evaluating the role of 
cellular phenotype and physical environment.
Method
We therefore used four different cell populations in two very different physical environ-
ments; primary and expanded chondrocytes and fibroblasts embedded in alginate gel 
and attached to tissue culture plastic. Matrix production, collagen cross-linking and 
α-smooth muscle actin (αSMA) were analyzed during 4 weeks with(out) 2.5 ng/ml 
TGFβ2.
Results
TGFβ2 did not affect collagen deposition by primary cells. In expanded cells, TGFβ2 
increased collagen deposition. Chondrocytes and fibroblasts in monolayer produced 
more collagen cross-links with TGFβ2. In alginate, primary and expanded cells displayed 
an unexpected decrease in collagen cross-linking with TGFβ2. αSMA was not present 
in alginate cultures and barely upregulated by TGFβ2. Organized αSMA fibers were 
present in all monolayer cultures and became more pronounced with TGFβ2.
Discussion
This study demonstrates that the physical environment determined by the substrate 
used, co-determines the response of cells to TGF-beta. The presence of mechanical 
stress, determined with αSMA-staining, is probably responsible for the increase in col-
lagen cross-linking upon addition of TGFβ.
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Introduction
TGFβ plays an important role in cartilage repair. In tissue engineering studies, TGFβ 
is often used to redifferentiate expanded chondrocytes. Expansion, needed to obtain 
sufficient cell number for tissue-engineering purposes, results in dedifferentiation and 
a more fibroblast-like phenotype of the cells. In combination with other growth factors 
and in a serum-free culture medium, TGFβ induces proteoglycan production and col-
lagen type II gene expression by expanded chondrocytes 177-179. In addition, adenoviral 
overexpression of TGFβ results in constitutive collagen type II expression by expanded 
chondrocytes 180.
Next to redifferentiation of expanded chondrocytes, TGFβ is also used to induce a 
chondrogenic phenotype in bone marrow derived mesenchymal stem cells resulting in 
the deposition of typical cartilage proteins such as aggrecan and gene expression of col-
lagen type II 181, 182. Besides effects on cell phenotype, TGFβ induces production of carti-
lage matrix proteins. TGFβ leads to an increase in proteoglycan synthesis and content in 
healthy murine articular cartilage and protects against proteoglycan depletion in murine 
experimental osteoarthritis (OA) 183, 184. Addition of TGFβ to chondrocytes in culture 
leads to various results: stimulation of proteoglycan and collagen production 156, 185-187 
but also inhibition of proteoglycan deposition 152, 188. These results indicate differential 
effects of TGFβ1 and TGFβ2, that most likely depend on cell type, cell source and culture 
substrate but not necessarily on the isoform 189.We recently demonstrated that TGFβ 
downregulates the formation of collagen pyridinoline cross-link formation by articular 
chondrocytes in alginate culture 188.
In contrast to the positive effects of TGFβ in cartilage repair, TGFβ is also the most 
potent inducer of unwanted collagen gene expression by fibroblasts resulting in exces-
sive tissue deposition and eventually fibrosis 190. Fibrosis is characterized by a high level 
of the pyridinoline collagen cross-links 191 and the formation of these cross-links is 
induced by the presence of either of the three isoforms of TGFβ 192. Fibrosis is also seen 
in vivo in articular joints where injection of TGFβ leads to fibrosis of the synovium 193. 
In addition, blockade of the TGFβ-pathway in murine experimental OA prevents against 
synovial fibrosis 184.
Taken together, TGFβ has differential effects on cell behavior and extracellular matrix 
production and cross-linking. It seems that the effect is depending on cell phenotype, 
the physical environment determined by culture set-up or a combination of these factors. 
The contribution of these factors to the differential effects of TGFβ has to be elucidated 
to be able to apply TGFβ to improve cartilage tissue engineering. This information will 
be useful for the choice of biomaterials to be used for cartilage tissue engineering. 
Our goal was to compare the effect of TGFβ on collagen biochemistry and especially 
collagen cross-linking in different cells cultured in different physical environments. To 
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evaluate the influence of cell phenotype, we used different cells ranging from differenti-
ated chondrocytes to fibroblasts.  To evaluate the effect of the physical environment, 
the cells were cultured in two different environments: attached to plastic in monolayer, 
where they are under continuous cellular contractile stress, or embedded in alginate gel, 
where they cannot adhere and thus are free from mechanical loading.
Materials and Methods
Cell culture
Articular cartilage was harvested from the metacarpophalangeal joints of calves aged 
6–12 months. Primary fibroblasts were obtained from split skin biopsies of the skin cov-
ering the bovine joints. To isolate chondrocytes and fibroblasts, both the full-thickness 
slices of noncalcified articular cartilage and the split skin biopsies were subjected to 
pronase (2 mg/ml, Sigma, St. Louis, MO, USA) digestion for two hours followed by 
overnight collagenase B (1.5 mg/ml, Roche Diagnostics) digestion. Depending on the 
culture conditions, the primary P0 or expanded P3 cells were either resuspended in 
1.2% (w/v) low viscosity alginate (Keltone) in 0.9% NaCl (Sigma) at a concentration of 
4 × 106 cells/ml to make alginate beads or cultured as monolayer on plastic in a concen-
tration of 7.500 cells per cm2. Beads were made as described previously 194. Beads were 
cultured in 75 µl/bead and monolayers in 2 ml/monolayer Dulbecco’s Modified Eagle 
Medium (DMEM) high glucose (GibcoBRL, Gaithersburg, MD, USA) supplemented with 
5% fetal bovine serum (GibcoBRL), 50 µg/ml L-ascorbic acid 2-phosphate (Sigma), 50 
µg/ml gentamicin and 1.5 µg/ml fungizone (both GibcoBRL). Cells were cultured with or 
without 2.5 ng/ml Transforming Growth Factor beta 2 (TGFβ2). TGFβ1 and TGFβ2 have 
similar effects on matrix production 189. TGFβ3 is an important factor in chondrogenic 
differentiation of mesenchymal stem cells and less used when primary chondrocytes 
are cultured 195, 196. No differences were found in our previous study about the three 
isoforms and their effect on collagen cross-linking in fibroblast cultures 192. Therefore, 
TGFβ2 was chosen based on previous results 188. Culture medium was replaced three 
times a week.
Biochemical assays
Alginate beads or monolayers were digested overnight at 56°C in papain buffer (200 
µg/ml papain in 50 mM Ethylene Diamintetraacetate (EDTA) and 5 mM L-cystein). 
The amount of DNA in each RNAse (Sigma) pre-treated papain-digested sample was 
determined using ethidium bromide (GibcoBRL) dye with calf thymus DNA (Sigma) as 
a standard. High-performance liquid chromatography (HPLC) of amino acids (hydroxy-
proline, Hyp) and collagen cross-links (hydroxylysylpyridinoline, HP and lysylpyridinoline, 
LP) was performed as described previously 162, 163.. The quantities of cross-links were 
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expressed as the number of residues per collagen molecule, assuming 300 Hyp residues 
per collagen triple helix.
Gene expression analysis
For total RNA isolation, alginate beads were dissolved in 150 µl/bead 55 mM sodium 
citrate acid. Cell pellets of the alginate beads and monolayers were suspended in 1000µl 
RNA-BeeTM (TEL-TEST, Inc.; Friendswood, TX, USA), and subsequently precipitated with 
2-propanol and purified with lithium chloride. Total RNA was quantified using NanoDrop® 
ND-1000 Spectrophotometer (NanoDrop Technologies, Wilmington, DE, USA) and 500 ng 
total RNA of each sample was reverse transcribed into cDNA using RevertAidTM First Strand 
cDNA Synthesis Kit (MBI Fermentas, Germany). For Glyceraldehyde-3-phosphate dehydro-
genase (GAPDH, Forward: GTCAACGGATTTGGTCGTATTGGG, Reverse: TGCCATGGGTG-
GAATCATATTGG, Probe: Fam-TGGCGCCCCAACCAGCC-Tamra) and SRY-box containing 
gene 9 (SOX9, Forward: CAACGCCGAGCTCAGCA, Reverse: TCCACGAAGGGCCGC, 
Fam-TGGGCAAGCTCTGGAGACTTCTGAACG-Tamra), each cDNA sample was amplified 
using specific primers and specific probe (Eurogentec, Seraing, Belgium). Amplifications 
were done as described previously 188. Data were analyzed using Sequence Detector ver-
sion 1.7 (Applied Biosystems) software and normalized for GAPDH expression.
Immunohistochemical staining for alpha Smooth Muscle 
actin, type I Collagen and type II Collagen
Staining for the presence and organization of alpha smooth muscle actin (αSMA) was 
performed after 1 week of culture of primary chondrocytes and fibroblasts, to examine 
differences in mechanical stress between the monolayer and alginate beads. The addi-
tional effect of TGFβ2 on the organization of the αSMA fibers was also investigated. 
The presence of collagen types I and II was investigated after 4 weeks of culture. For 
all three stainings, three alginate beads were dissolved in 55 mM sodium citrate acid 
to prepare cytospins. Cells in monolayer were cultured on glass culture chambers (BD 
Biosciences San Jose, CA, USA) to stain them immunohistochemically. Cells with sur-
rounding pericellular matrix from alginate beads were centrifuged on glass slides and 
fixed in cold acetone, monolayers in cold 70% ethanol. The samples were incubated 
with monoclonal antibodies against αSMA (clone number 1A4, Sigma), type I collagen 
(ab6308, Abcam, Cambridge, UK), or type II collagen (1:100, II-II6B3; Developmental 
Studies Hybridoma Bank) at room temperature for 1 h. This was followed by incubation 
with link and label from the link-label kit (BioGenex, San Ramon, CA, USA) for 30 
minutes. Freshly prepared neo-fuchsin substrate was used to achieve staining.
The collagen staining was scored for the number of cells positive for collagen types 
I and II per 100 cells in four fields of sight per specimen, resulting in a percentage of 
positive cells. An arbitrary scoring system from 1 to 5 was used, with 1 representing less 
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than 10% of the cells positive, 2 representing 10-40% positive, 3 representing 40-60% 
positive, 4 representing 60-90% positive and 5 representing more than 90% of the 
cells positive. A cell was considered positive, when the matrix around the cell or the 
cytoplasm was stained pink.
Data analyses
The experiments were performed three times with 3 samples of 7 beads or with 3 
monolayers per experimental condition for biochemical analyses and one sample of 
10 beads or one monolayer per experimental condition for gene expression analysis. 
Statistical analysis was performed using GraphPad Prism 5.0 (GraphPad Software, San 
Diego, CA, USA) software. All data are presented as mean ± standard deviation. Control 
groups without TGFβ2 and groups supplemented with TGFβ2 were compared with a 
Kruskall-Wallis H test with a post hoc Mann–Whitney U test. The effect of adding TGFβ2 
in the alginate bead condition versus the monolayer for each cell type was compared 
with a two-way ANOVA with a post-hoc Bonferroni test. The relative difference between 
the control group (set at 100%) and the TGFβ2-group was used for these calculations.
Results
Cell features
The amount of DNA was determined at day 0 and after 28 days of culture, to be able 
to compare matrix deposition between the conditions and examine the effect of the 
culture environment on cell proliferation. At day 0, 0.12 ± 0.03 µg DNA /bead and 0.23 
µg DNA /monolayer was present. In all conditions, the amount of DNA increased or 
remained stable after 28 days of culture. This indicates that there was no cell death and 
even cell proliferation in most of the conditions. Overall, addition of TGFβ2 increased 
the total DNA amount (p<0.005), although not always significantly and with exception 
of fibroblasts in alginate beads (Figure 3.1A).
The total amount of isolated RNA was 101 ± 11 ng RNA per bead and 24890 ± 
4904 ng RNA per monolayer. This increased with the presence of TGFβ2 in every condi-
tion (p<0.05) except for the fibroblasts in beads. Here, the amount of RNA was not 
significantly changed in the presence of TGFβ2.
Collagen matrix deposition
Addition of TGFβ2 to the primary chondrocytes in alginate beads had no effect on col-
lagen deposition. A low amount of collagen was deposited in cultures of dedifferenti-
ated chondrocytes, as well as primary and dedifferentiated fibroblasts in alginate beads. 
Addition of TGFβ2 increased the collagen deposition in P3 chondrocytes and fibroblasts 
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Figure 3.1  Figure 3.1. The effect of 2.5 ng/ml TGFβ2 on (A) DNA content, (B) collagen deposition and (C) number 
of collagen cross-links in cultures of primary (P0) and expanded (P3) chondrocytes and fibroblasts cul-
tured in alginate beads or as monolayer on plastic for 28 days (n = 6). * indicates significant difference 
(p<0.05) from control without TGFβ2. Data are shown as mean ± SD.
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in alginate beads (p<0.005). Collagen deposition by primary chondrocytes and fibro-
blasts on plastic was high but not influenced by the presence of TGFβ2. Low amount of 
collagen was deposited in dedifferentiated P3 chondrocytes and P3 fibroblasts on plastic 
where addition of TGFβ2 increased collagen deposition (p<0.005, Figure 3.1B).
Matrices deposited by primary and expanded chondrocytes and fibroblasts in alginate 
beads had an average of 0.22 HP cross-links per collagen molecule. Matrices deposited 
by chondrocytes on plastic had a similar number of cross-links per collagen molecule 
in the control condition. Matrices deposited by fibroblasts on plastic had a relatively 
low number of HP cross-links per collagen molecule in the control condition. Addition 
of TGFβ2 to the culture medium resulted in a decrease of collagen cross-links in all 
alginate bead cultures and an increase of collagen cross-links in all cultures on plastic, 
independent of cell type (p<0.001 for alginate bead versus plastic, Figure 3.1C).
Type of collagen produced
Chondrocytes cultured in alginate beads deposited mainly type II collagen (arbitrary 
score 4.25 ± 0.5, Figure 3.2A) and less type I collagen (score of 1.5 ± 0.6, Figure 3.2B) 
A B
C D
 
Figure 3.2 igure 3.2. Immunohistochemical staining for collagen type II (A and C) and collagen type I (B and D) 
of chondrocytes cultured for 28 days in alginate beads (A and B, here shown as cells with pericellular 
matrix on glass slides) and as monolayer on plastic (C and D). Positive cells are shown in red. Magnifica-
tion is 100×.
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as determined by immunohistochemistry. Expanded chondrocytes in alginate beads had 
a trend towards more type I collagen than primary chondrocytes (score of 2 ± 0.5, not 
significant). However, after 28 days, type II collagen was the main type of collagen 
deposited (score 3.25 ± 1, p<0.05 versus collagen type I production) by the expanded 
chondrocytes as well. The primary and expanded fibroblasts in beads deposited almost 
no type II collagen and more type I collagen than the chondrocytes. Addition of TGFβ2 
only increased the type II collagen deposition (score of 3.75 ± 0.5, p<0.05 versus control 
without TGFβ2) in the expanded chondrocytes, and no effect of TGFβ was seen in 
the other alginate bead conditions. Chondrocytes cultured on plastic deposited very 
little type II collagen (score 1.5 ± 0.6) and more type I collagen (score 3.75 ± 0.5) than 
the chondrocytes cultured in alginate beads. Dedifferentiated chondrocytes and both 
primary as well as expanded fibroblast deposited only type I collagen (score 4.75 ± 0.5, 
Figure 3.2C) and almost no type II collagen (score 0.5 ± 0.6, Figure 3.2D). After TGFβ 
addition, a trend towards more type II collagen was present in the primary chondrocytes 
on plastic (1.25 ± 0.5, not significant). No effect of TGFβ was seen in the other condi-
tions.
Phenotype of the cells
After culture for 28 days, the gene expression for SRY-box containing gene 9 (SOX9) was 
examined to provide an indication of the phenotype of the cells. SOX9 gene expression 
was the highest in primary chondrocytes cultured in alginate beads (P0 chondro beads). 
Chondrocytes cultured for three passages and subsequently in alginate beads (P3 chondro 
beads) and the primary chondrocytes cultured on plastic (P0 chondro monolayer) also 
expressed some SOX9, but not as much as the primary chondrocytes in alginate beads. 
The passage 3 chondrocytes on plastic and all the fibroblast conditions almost did not 
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Figure 3.3 Figure 3.3. Relative gene expression of SOX9 by primary (P0) and expanded (P3) chondrocytes and 
fibroblasts cultured in alginate beads or in monolayer on plastic for 28 days (n = 6). The gene expression 
analysis was used to determine the phenotype of the cells after culture. * Indicates significant difference 
(p<0.05) from control without TGFβ2. Data are shown as relative expression ± SD.
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Figure 3.4 Figure 3.4. Immunohistochemical staining for α smooth muscle actin (αSMA) of primary P0 chondro-
cytes (A, B, E, F) and fibroblasts (C, D, G, H) cultured in alginate beads (A-D, here shown as cells with 
pericellular matrix on glass slide) or in monolayer on plastic (E-H) for 28 days. αSMA shown in red is 
upregulated in response to TGFβ2 (B, D, F, H) although not organised in spindles in the cells cultured in 
alginate beads (B and D). Cells cultured in monolayer in the presence of TGFβ2 have organised αSMA 
fibres (F and H). Magnification is 200× with a 1000× inset.
TGFβ affects collagen cross-linking depending on physical environment 47
express the SOX9 gene (Figure 3.3). Addition of TGFβ2 reduced SOX9 expression in the 
alginate bead and monolayer cultures of primary chondrocytes (p<0.005) but increased 
it in the expanded chondrocytes in alginate beads (p<0.005).
Alpha Smooth Muscle Actin organization
In alginate beads, none of the chondrocytes had detectable alpha smooth muscle 
actin (αSMA) but some fibroblasts were positive for αSMA (Figures 3.4A and 4C). In 
monolayer culture, positive αSMA staining without specific stress fibers was detectable 
in the majority of the chondrocytes (Figure 3.4E). All fibroblasts were positive for αSMA 
as shown with a red staining, although also no clear stress fibers were visible (Figure 
3.4G). Addition of TGFβ2 to chondrocytes and fibroblasts in alginate beads resulted in 
more αSMA and the intensity of staining was higher. However, no intracellular stress 
fibers of αSMA were visible (Figure 3.4B and 4D). When the cells (chondrocytes and 
fibroblasts) were cultured on plastic, the presence of TGFβ2 induced αSMA with clearly 
visible organized stress fibers in all the cells as shown in figures 3.4F and 3.4H.
Discussion
This study demonstrates that the effect of TGFβ on cross-linking of collagen is mostly 
determined by the physical environment determined by the culture substrate of the cells 
and less by the cell phenotype or the type of collagen produced. When chondrocytes 
are cultured in alginate beads, TGFβ2 leads to less collagen cross-links in the deposited 
matrix. In the monolayers on plastic on the other hand, addition of TGFβ2 leads to more 
collagen cross-links in the deposited matrix.
The results elucidate the discrepancy in our previous results. A study with skin fibro-
blast cultured on plastic showed that TGFβ increased collagen crosslink formation 192. 
However, in a study with differentiated chondrocytes in alginate gel, we surprisingly 
found an inhibition of collagen crosslink formation by TGFβ 188. These studies differed in 
cell type used as well as physical environment used. In the present study eight different 
combinations of cell type and physical environment were compared to evaluate what 
determines the effect of TGFβ on collagen crosslink formation.
One of the main physical differences between plastic and alginate culture is the 
contractile stress on the cell. The culture systems used were investigated for their 
effect on the contractile stress on chondrocytes and fibroblasts by staining the cells 
for the presence and organization of αSMA. It has previously been shown that when 
the culture substrate exerts force on a cell, more αSMA is present in the cell 197-199. 
Inhibition of αSMA assembly reduces contraction of a collagen-glycosaminoglycan 
scaffold, indicating the importance of αSMA in the interaction between the cell and 
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its environment 200. This corresponds to our findings where αSMA is absent or poorly 
organized in the cells cultured in alginate beads, but clearly present in attaching cells 
cultured on plastic. It also confirms that cells cultured on plastic are under continuous 
contractile stress as a result of anchorage to the substrate and cell-cell contact. Cells 
cultured in alginate beads do not experience this stress because of less or no cell-cell 
contact and the absence of anchorage to the culture substrate. In the culture systems 
we used, especially the monolayer on plastic, it is difficult to uncouple cell-cell contact 
and anchorage to the culture substrate and their effect on the organization of αSMA. 
The effect of other differences between alginate and plastic, like for instance differences 
in nutrient diffusion or cell viability, cannot be completely excluded. Considering the cell 
viability, the amount of DNA did not decrease from day 0 to day 28 for any alginate 
condition. Together with the presence of RNA after 28 days of culture, this indicates the 
absence of cell death also in the fibroblasts cultured in alginate beads. We therefore 
believe that the effect seen in the alginate beads depends on the culture environment 
and not on cell viability and therefore a selection in the type of collagen deposited or 
phenotype. We can conclude that the culture environment greatly influences the effect 
of TGFβ on the collagen matrix.
To study the relation with cell phenotype, we determined gene expression for SOX9 
and Immunohistochemical staining for collagen type I and II.  SOX9 gene expression and 
the type of collagen deposited are related to the phenotype of the cells but not to the 
effect of TGFβ on collagen cross-linking: In case of the alginate bead cultures, no col-
lagen type II was present in the fibroblast cultures. Here, addition of TGFβ decreased the 
number of collagen cross-links. Collagen type II was also present in the P0 chondrocytes 
cultured on plastic. The deposition of collagen type II increased slightly together with 
an increase in collagen cross-links with the presence of TGFβ. On the other hand, our 
data indicate that the cellular contractile stress on the cells, as determined by αSMA 
production and organization, is related to the effect of TGFβ. We conclude from these 
data that the effect of TGFβ on collagen cross-linking is dependent on the physical 
environment of the cells. It was recently found that αSMA is a mechanosensitive protein 
that is recruited to stress fibers under high tension. This recruitment allows cells to exert 
more stress on the culture scaffold 201. TGFβ further upregulates αSMA deposition and 
condensation. Previously, it was found that TGFβ induces αSMA in fibroblasts 202, 203. 
More recently, it is also seen in chondrocytes 200, 204 which corresponds with our find-
ings that cells incubated with TGFβ have more αSMA staining. We hypothesize that in 
conditions of high tensile stress on the cell, the presence of TGFβ further increases αSMA 
organization and leads to collagen cross-link formation in order to better resist the stress. 
Moreover, addition of TGFβ does not inevitably has to result in fibrosis. If tensile stress is 
prevented, TGFβ can be used to increase collagen and proteoglycan production without 
leading to fibrosis. Therefore, the intended effect of TGFβ in cartilage repair will depend 
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on environmental conditions, such as mechanical environment and the scaffold used. 
Because collagen cross-linking has important implications on mechanical properties of 
the repair tissue, this should be seriously considered when choosing a scaffold in tissue 
engineering procedures where TGFβ is often used to stimulate tissue formation.
Acknowledgements
The monoclonal antibody II-II6B3 against collagen type II, developed by Rikard Holmdahl 
and Kristofer Rubin was obtained from the Developmental Studies Hybridoma Bank 
developed under the auspices of the NICHD and maintained by The University of Iowa, 
Department of Biological Sciences, Iowa City, IA 52242.

4 Contribution of collagen network features to functional properties 
of engineered cartilage
Yvonne M. Bastiaansen-Jenniskens, Wendy Koevoet, Anton 
C.W. de Bart, Jacqueline C. van der Linden, Anne-Marie 
Zuurmond, Harrie Weinans, Jan .A.N. Verhaar, Gerjo J.V.M. 
van Osch, Jeroen DeGroot
Osteoarthritis and Cartilage. 2008 Mar;16(3):359-66.
C
ha
pt
er
 4
52
Abstract
Background
Damage to articular cartilage is one of the features of osteoarthritis. Cartilage damage 
is characterized by a net loss of collagen and proteoglycans. The collagen network is 
considered highly important for cartilage function but little is known about processes 
that control composition and function of the cartilage collagen network in cartilage 
tissue engineering. Therefore, our aim was to study the contribution of collagen amount 
and number of cross-links on the functionality of newly formed matrix during cartilage 
repair.
Methods
Bovine articular chondrocytes were cultured in alginate beads. Collagen network forma-
tion was modulated using the crosslink inhibitor β-aminopropionitril (BAPN; 0.25 mM). 
Constructs were cultured 10 weeks with/without BAPN or 5 weeks with BAPN followed 
by 5 weeks without. Collagen deposition, number of cross-links and susceptibility to 
degradation by MMP-1 were examined. Mechanical properties of the constructs were 
determined by unconfined compression.
Results
BAPN for 5 weeks increased collagen deposition accompanied by increased construct 
stiffness, despite the absence of cross-links. BAPN for 10 weeks further increased col-
lagen amounts. Absence of collagen cross-links did not affect stiffness but ability to 
hold water was lower and susceptibility to MMP-mediated degradation was increased. 
Removal of BAPN after 5 weeks increased collagen amounts, allowed crosslink forma-
tion and increased stiffness.
Discussion
This study demonstrates that both collagen amounts and its proper cross-linking are 
important for a functional cartilage matrix. Even in conditions with elevated collagen 
deposition, cross-links are needed to provide matrix stiffness. Cross-links also contribute 
to the ability to hold water and for the resistance against degradation by MMP-1.
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Introduction
The functioning of articular cartilage depends on the structure, the composition and the 
integrity of its extracellular matrix (ECM). With cartilage degeneration in osteoarthritis 
(OA), changes in this structure and composition of the tissue occur. Fewer proteogly-
cans are present in OA cartilage 205 even though the rate of synthesis is increased 94. 
Enhanced cleavage of collagen type II is seen in OA cartilage 143 accompanied by an 
increase in collagen type II gene expression and protein synthesis in the middle and deep 
layers of the cartilage but not in the superficial layer 95, 96. Together, these biochemical 
changes in OA suggest an activated repair mechanism that is however ineffective in 
repairing or maintaining the ECM homeostasis.
The mechanical stiffness of cartilage obtained from OA patients decreases in relation 
to the extent of its degeneration 206. The same is seen in cartilage from OA animal 
models, where the mechanical properties are also changed in addition to, or as a 
consequence of the above-mentioned biochemical changes in OA. These changes in 
mechanical properties include a decrease of the cartilage compression stiffness and 
an increase in the tendency to swell compared to healthy cartilage 207. Recent experi-
ments attribute the mechanical properties of cartilage to collagen 77, 78. For example, 
an increase in matrix stiffness is associated with an increase in collagen content and to 
a lesser extent with the proteoglycan content in cartilage explants 79. Conversely, the 
hydraulic permeability of cartilage is more associated with the proteoglycan content of 
the explants 79. In a recent study, it was found that the increased swelling and defor-
mation of osteoarthritic cartilage is highly associated with the amount of degraded 
collagen molecules 86. As such, collagen properties contribute largely to the mechanical, 
hence functional characteristics of the tissue and induction of collagen repair may thus 
be highly relevant for maintaining or restoring cartilage integrity.
To study cartilage repair mechanisms, endogenous molecules such as growth fac-
tors are often used to promote regeneration. From these studies it has become clear 
that cartilage repair is hampered by low collagen production whereas proteoglycans 
are formed in higher amounts 169, 208. Consequently, because collagen is important 
to withstand mechanical stress, the mechanical properties in these studies were not 
optimal. This is shown in cartilage tissue engineering as well when the effect of matrix 
components on mechanical functioning is examined. Both proteoglycans and collagen 
are associated with increasing mechanical strength. In one study in agarose constructs, 
collagen associated strongly with the tensile stiffness whereas proteoglycans correlated 
more strongly with the permeability of the matrix 209. In other studies, the stiffness and 
permeability of the agarose constructs increased in time when the proteoglycan content 
was mainly constant and collagen content still increased 169, 210.
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The results of both the OA cartilage studies and the tissue engineering studies point 
out the importance of targeting collagen in cartilage repair. However, this repair mecha-
nism seems to be ineffective in the case of osteoarthritis. Understanding mechanisms 
of repair of the collagen network is therefore key for functional repair of cartilage. The 
present study was designed to investigate the contribution of the collagen network 
on the functionality of the newly formed matrix during cartilage repair processes. Spe-
cifically, we investigated the effect of the amount of collagen and number of collagen 
cross-links (two key characteristics of the collagen network) on mechanical properties 
and the resistance towards proteolysis of the newly formed cartilage matrix in chondro-
cyte alginate cultures.
Materials and Methods
Cell culture
Articular cartilage was harvested from the metacarpophalangeal joints of calves aged 
6–12 months. To isolate chondrocytes, full-thickness slices of noncalcified articular carti-
lage were subjected to pronase (2 mg/ml, Sigma, St. Louis, MO, USA) digestion for two 
hours followed by overnight collagenase B (1.5 mg/ml, Roche Diagnostics) digestion. The 
chondrocytes were resuspended in 1.2% (w/v) low viscosity alginate (Keltone) in 0.9% 
NaCl (Sigma) at a concentration of 4 × 106 cells/ml, and beads were made as described 
previously 157, 158, 211. Beads that appeared smaller or larger than the average size after 
visual inspection were not included in the experiment. After transfer to six-well plates 
(BD Falcon, Bedford, MA, USA), beads were cultured in 75 µl/bead Dulbecco’s Modified 
Eagle Medium (DMEM)/F12 (GibcoBRL, Gaithersburg, MD, USA) supplemented with 
10% fetal bovine serum (GibcoBRL), 50 µg/ml L-ascorbic acid 2-phosphate (Sigma), 
50 µg/ml gentamicin and 1.5 µg/ml fungizone (both GibcoBRL). Cells were cultured 
under three conditions: without β-aminopropionitrile (BAPN) for 70 days (-/-), with 0.25 
mM BAPN for 35 days followed by 35 days without BAPN (+/-) and with BAPN for 70 
days (+/+). BAPN blocks collagen cross-linking by inhibition of the enzyme involved in 
collagen cross-linking, lysyl oxidase (LOX) 212. Samples were taken after 21, 35, 41, 60 
and 70 days of culture for biochemical analysis.
Isolation of cell associated matrix
Alginate beads cultured for 35 and 70 days were dissolved by adding 75 µl per bead 
of 55 mM sodium citrate and 20 mM Ethylene Diamintetraacetate (EDTA) in 150 mM 
NaCl for 20 min at room temperature. The suspension was centrifuged 10 min at 1000 
rpm (Eppendorf), to separate the cells surrounded by its cell associated matrix (CM, the 
pellet) from components originating predominantly from the ‘interterritorial’ or further 
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removed matrix (FRM; the supernatant) from the cells as described previously 163, 187, 194. 
However, we cannot completely rule out the possibility that matrix constituents from 
the other matrix component were present in smaller amounts.
Biochemical assays
Alginate beads or separated CM and FRM were digested overnight at 56°C in papain 
buffer (200 µg/ml papain in 50 mM EDTA and 5 mM L-cystein). Glycosaminoglycan 
(GAG) amount in the digest was quantified using dimethylmethylene blue (DMB) assay 
as described previously 160, 211. The amount of DNA in each papain-digested sample was 
determined using Hoechst 33258 dye 213 with calf thymus DNA (Sigma) as a standard. 
High-performance liquid chromatography (HPLC) of amino acids (hydroxyproline, Hyp) 
and collagen cross-links (hydroxylysylpyridinoline, HP and lysylpyridinoline, LP) was per-
formed by the methods of Bank 86, 162, 211. The quantities of cross-links were expressed 
as the number of residues per collagen molecule, assuming 300 Hyp residues per col-
lagen triple helix.
Gene expression analysis
For total RNA isolation, alginate beads cultured for 35 and 70 days were dissolved in 150 
µl/bead 55 mM sodium citrate acid. Each cell pellet was suspended in 1000µl RNA-BeeTM 
(TEL-TEST, Inc.; Friendswood, TX, USA) per million cells according to manufacturer’s 
guidelines, and subsequently precipitated with 2-propanol and purified with lithium 
chloride. Total RNA was quantified using RibogreenTM reagent (R-11490, Molecular 
Probes Europe BV, Leiden, the Netherlands) according to manufacturer’s instructions, and 
500 ng total RNA of each sample was reverse transcribed into cDNA using RevertAidTM 
First Strand cDNA Synthesis Kit (MBI Fermentas, Germany). For glyceraldehyde-3-phos-
phate dehydrogenase (GAPDH), Collagen type 1 (COL1) and SRY-box containing gene 
9 (SOX9), each cDNA sample was amplified using specific primers and specific probe 
(Table 1, Eurogentec, Seraing, Belgium). For Collagen type 2 (COL2), each cDNA sample 
was amplified using specific primers and specific molecular beacons (Table 4.1, Biolegio, 
Nijmegen, The Netherlands). Amplifications were performed as described previously 211. 
Table 4.1: sequences of primers and probes or beacons for real-time PCR.
Primers Probe
GAPDH Forward: GTCAACGGATTTGGTCGTATTGGG
Reverse: TGCCATGGGTGGAATCATATTGG
Fam-TGGCGCCCCAACCAGCC-Tamra
COL1 Forward: CAGCCGCTTCACCTACAGC
Reverse: TTTTGTATTCAATCACTGTCTTGCC
Fam- CGGTGTGACTCGTGCAGCCATC-Tamra
SOX9 Forward: CAACGCCGAGCTCAGCA
Reverse:TCCACGAAGGGCCGC
Fam-TGGGCAAGCTCTGGAGACTTCTGAACG-
Tamra
COL2 Forward: AAGGTTTTCTGCAACATGGAGACT
Reverse: AGATGTGTTTCTTGTCCTTGCTCTT
FAM-cgtgcGTCTACCCCAACCCGGCCAGCgcacg-
Dabcyl
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Data were analyzed using Sequence Detector version 1.7 (Applied Biosystems) software 
and normalized for GAPDH expression 164.
Immunocytochemical staining for collagen type I and II
To prepare cytospins, three alginate beads cultured for 35 days were dissolved in 55 
mM sodium citrate acid. After fixation in cold acetone, the cytospins were incubated 
with monoclonal antibodies against either type I collagen (1:2000, ab6308 ABCAM, 
Cambridge, UK), or type II collagen (1:100, II-II6B3; Developmental Studies Hybridoma 
Bank) at room temperature for 1 h. This was followed by incubation with link and label 
from the link-label kit (BioGenex, San Ramon, CA, USA) each for 30 minutes. Freshly 
prepared neo-fuchsin substrate was used to achieve staining. After staining, cytospins 
were scored for the number of cells positive for collagen types I and II per 100 cells in 
four fields of sight per specimen, resulting in a percentage of positive cells. A cell was 
considered positive, when the matrix around the was stained red.
Mechanical testing
For mechanical characterization, we used 4 × 106 cells/ml in 1.2% (w/v) alginate con-
structs of 3 mm thick and 6 mm in diameter. The constructs were prepared as previously 
described by Wong 166. After 35 days and 70 days of culture, constructs were mounted 
on a materials testing machine, the DMA Q800 Dynamicmechanical Analyzer (TA Instru-
ments, New Castle, DE, USA), in a radially unconfined stress relaxation test with the 
construct between impermeable platens, and hydrated in 0.9% saline with the protease 
inhibitor Complete™ (Sigma). A 20% uniaxial compressive strain was applied within 10 
seconds at a ramped displacement strain rate of 2% s-1, based on the measured thickness. 
The strain was maintained constant for 30 min, the load was recorded at a sampling rate 
of 10 Hz using a 18N load cell. The applied load recorded by the load cell was divided 
by the cross-sectional area of the construct to calculate the applied stress. The secant 
modulus was calculated as stress/strain at 10 seconds, where the stress had its peak 
response and the strain reached its maximum. At the end of the test, the equilibrium 
aggregate modulus was determined as stress/strain at 30 minutes. The secant modulus 
is related to the interaction between the solid and the liquid phase and is therefore an 
indication for the ability to hold water. The modulus measured at equilibrium depends 
strongly on the compressive stiffness of the (cartilaginous) solid matrix 83.
In vitro extracellular matrix degradation
After 70 days of culture, a sample of four alginate beads from each group was washed 
with 1 ml 0.9% NaCl, in order to remove the serum used in the culture medium. Washed 
beads were incubated for 24 h at 30°C in 250 µl 50 mM Tris [pH 7.5], 5 mM CaCl2, 150 
mM NaCl, 1 µM ZnCl2, 0.01% Brij-35, 0.02% NaN3 containing the general proteinase 
Contribution of collagen network features to functional properties of engineered cartilage 57
inhibitor Complete™ (EDTA-free, one tablet in 25 ml) in the presence or absence of 
100 nM recombinant human MMP-1 (R&D systems, Oxon, United Kingdom), which 
was activated by 4-aminophenyl mercuric acetate (APMA; Sigma) and calibrated using 
an MMP activity assay 165. MMP-1 is one of the proteases involved in the physiologi-
cal turnover of healthy cartilage and therefore chosen as collagenase in this assay to 
demonstrate the susceptibility of the matrix to degradation 214.  The released collagen 
(soluble and present in the supernatant) was separated from the insoluble collagen 
matrix by centrifugation. The amount of collagen in the soluble fraction represents the 
amount of collagen directly released into the medium by MMP-1. Finally, all fractions 
were hydrolyzed in 6 M HCl and Hyp levels were determined.
Data analysis
The experiments were repeated three times. Each experiment consisted of 3 times 7 
beads per experimental condition for biochemical analyses, 3 times 2 beads for matrix 
degradation by MMP-1 and one sample of 10 beads per experimental condition for 
gene expression analysis. The experiments for mechanical testing were repeated two 
times with a total of 8 samples per group. Statistical analysis was performed using 
SPSS 11.5 (SPSS Inc. Chicago, IL) software. All data are presented as mean ± standard 
deviation. Control groups without BAPN and groups supplemented with BAPN were 
compared with a Kruskall-Wallis H test followed by a post hoc Mann–Whitney U test.
Results
Composition of the matrix: collagen deposition and 
cross-linking
The number of HP-cross-links increased in time in the control condition without BAPN, 
up to 0.72 ± 0.1 HP cross-links per collagen molecule after 70 days of culture (Figure 
4.1a). When chondrocytes were cultured in the presence of BAPN, either for 35 days or 
70 days, almost no cross-links were detectable in the newly deposited collagen (0.07 ± 
0.1 HP cross-links per collagen molecule). When BAPN was removed after 35 days (BAPN 
+/-), collagen cross-links were formed from approximately day 40 onwards, reaching a 
number similar to the control condition at day 70 (Figure 4.1A).
The inhibition of cross-linking as a consequence of BAPN was accompanied by 
increased collagen deposition. In the control condition without inhibiting the crosslink 
formation with BAPN, 8.9 ± 0.7 µg collagen was deposited per bead after 35 days and 
12.7 ± 0.5 µg collagen per bead after 70 days of culture. Culturing chondrocytes in 
the presence of BAPN for 35 days resulted in 1.5 times more collagen (13.6 ± 1.4 µg/
bead µg/bead) than in the control condition. This increased to 1.6 times more collagen 
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Figure 4.1.  Effect of (transient) collagen crosslink inhibition on A) collagen crosslinking and B) col-
lagen deposition during 10 weeks of culture (n = 9). Collagen crosslinking was inhibited by BAPN until 
day 35 in the +/- condition. From day 35 onwards, two conditions were cultured without the presence of 
BAPN and crosslinks could be formed. In one condition, crosslinks were inhibited during the full 70 days 
of culture. * Indicates P<0.002 between the control and the BAPN +/- condition at the same time point. 
† Indicates P<0.001 between BAPN +/+ and the other two conditions. ‡ Indicates P<0.005 between 
BAPN +/+ and the other two conditions. Data are shown as mean ± SD.
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than in the control condition after 70 days of culture (20.6 ± 2.8 µg/bead), even though 
the crosslink inhibitor was not present anymore from day 35 onwards. Culturing chon-
drocytes in the presence of BAPN for 70 days (BAPN +/+) resulted in 1.9 times more 
collagen (24.0 ± 0.6 µg/bead) (Figure 4.1B).
Proteoglycan deposition and DNA content were not influenced by the presence of 
BAPN. The amount of DNA was determined in the alginate beads, to give an indication 
of the number of chondrocytes present in the beads. In all three the conditions, the DNA 
content and the deposition of the proteoglycans increased until day 20 and reaching a 
plateau thereafter at 0.32 ± 0.03 µg DNA /bead and 32.7 ± 1.7 µg proteoglycans/bead 
(data not shown). The data above are shown per bead because we are interested in the 
total collagen amount and number of cross-links and how this affects the functioning 
of the tissue engineered construct.
Quality of the matrix: mechanical properties
The equilibrium aggregate modulus at day 35 was two times higher in the condition 
with more collagen but without collagen cross-links (BAPN condition) than in the con-
trol condition; 897 Pa ± 277 Pa versus 451 Pa ± 165 Pa (Figure 4.2A). The peak force 
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Figure 4.2. Mechanical properties of alginate discs cultured for 5 weeks (A&B) and 10 weeks (C&D). 
Both equilibrium aggregate modulus (A&C) and secant modulus (B&D) were examined (n = 8). * Indi-
cates P< 0.002 compared to the control condition without inhibition of crosslink formation. Data are 
presented as mean modulus ± SD.
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and subsequently the ability to hold water described by the secant modulus were not 
significantly different between the two culture conditions at day 35 (Figure 4.2B).
At day 70, the increase in collagen deposition in the BAPN +/+ condition was not suf-
ficient by itself to increase the equilibrium modulus compared to the control condition 
that contained less collagen. At this time point, the equilibrium aggregate modulus only 
significantly increased when the increased collagen deposition was also cross-linked as 
was the case in the BAPN +/- condition (Figure 4.2C). The secant modulus and therefore 
the ability to hold water was significantly lower than the control in the BAPN +/+ condi-
tion whereas in the BAPN +/- condition, where cross-links were present, the secant 
modulus was not significantly different from the control (Figure 4.2D).
Quality of the matrix:  susceptibility for degradation
The effect of modulating the cartilage collagen network on the degradability of the 
collagen was examined by subjecting alginate beads cultured for 70 days to the colla-
genase MMP-1. When cultured alginate beads were incubated with MMP-1, 6.2 ± 0.16 
µg collagen was released in the control condition (which corresponds to 16.2% of the 
total amount in the alginate beads) and 7.0 ± 0.35 µg in the BAPN +/- condition (11.5% 
of total). This is not significantly different from each other and only 1.2 times more than 
when these beads were incubated without MMP-1. When beads from the BAPN +/+ 
condition were incubated with MMP-1, 14.9 ± 1.23 µg of collagen was released from 
the beads, which is 21.1% of the total collagen amount in the beads. This is 2.5 times 
as much as the control condition and almost twice as much as when no MMP-1 was 
present during incubation (Figure 4.3).
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Figure 4.3. Susceptibility of the matrix for MMP-1 degradation after 10 weeks of culture. Amount 
of collagen in the soluble fraction directly after incubation with 100 nM MMP-1 is higher for the matrix 
without sufficient collagen crosslinks as represented by the +/+ condition than for matrices with collagen 
crosslinks (-/- and +/-), even when crosslink formation was transiently inhibited (+/-). * Indicates P< 0.001 
compared to the -/- and +/- condition. Data are presented as mean percentage of the total amount of 
collagen in the beads  ± SD (n = 6).
Contribution of collagen network features to functional properties of engineered cartilage 61
Structure of the matrix: Cell associated Matrix versus 
Further Removed Matrix
The distribution of the collagen within the alginate bead was determined by measuring 
the amount of collagen in the cell-associated matrix (CM) and the further removed 
matrix (FRM). The percentage of collagen in the CM was 76% of the total collagen in 
the control condition, 82% in the BAPN +/- condition and 81% in the BAPN +/+ condi-
tion. Thus, slightly more collagen seems to be present in FRM of the control condition 
than in FRM of the two BAPN conditions, although not reaching statistical significance 
(Figure 4.4).
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Figure 4.4  
Figure 4.4.  Distribution of collagen between the cell associated matrix (CM) and the further removed 
matrix (FRM). No significant differences are found in distribution between the three conditions. Data are 
shown as mean percentage per compartment ± SD (n=6).
Phenotype of the chondrocytes
Whether the phenotype of the chondrocytes was influenced by the addition of BAPN 
was investigated by the SRY-box containing gene 9 (SOX 9) gene expression 215 and the 
collagen type II/collagen type I gene and protein expression ratio (COL2/COL1 ratio). 
At day 35 and day 70, the COL2/COL1 ratio was a two-fold higher in the conditions 
where BAPN was present than in the control conditions (Figure 4.5A), due to decreased 
COL1 expression and increased COL2 expression. When BAPN was removed after 35 
days in the +/- condition, the COL2/COL1 ratio at day 70 was comparable to the control 
condition, whereas it was still increased in the +/+ condition. To support the change 
in collagen gene expression, semi-quantative protein expression was determined by 
immunocytochemistry. Without the presence of BAPN, the ratio between collagen type 
II and collagen type I positive cells is 90%:60% as shown by immunocytochemistry at 
day 35 in Figure 4.6A and B. When BAPN was present for 35 days, less chondrocytes 
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were positive for collagen type I which changed the collagen type II/collagen type I 
protein ratio to 90%:40% positive cells (Figure 4.6C and D). The collagen type II staining 
is also more intense in the presence of BAPN (Figure 4.6C).
SOX9 gene expression was only significantly higher when BAPN was present at day 
35. No significant effect of BAPN addition was observed in the SOX9 gene expression 
after 70 days of culture (Figure 4.5B).
Discussion
The present study demonstrates that modulation of the number of cross-links and 
amount of collagen deposited during cartilage tissue regeneration has an effect on the 
functional properties of the construct depending on the amount of collagen deposited 
up till then. To study the involvement of collagen and collagen cross-links in the func-
tioning of cartilage, the alginate culture system was used. In contrast to explants, the 
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Figure 4.5  Figure 4.5. Gene expression of collagen type I, collagen type II and SOX 9, shown as A) collagen 
type II-collagen type I gene expression ratio and B) relative SOX 9 gene expression. Both parameters 
are indicative for the phenotype of the chondrocytes. * Indicates P< 0.001 compared to the -/- and 
+/- condition. Data are presented as mean ± SD (n = 3).
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collagen deposition in an alginate culture system can be modulated from the beginning 
and effects of collagen modulation are not influenced by collagen already present, as is 
the case in explants.
We found that more collagen deposition in the BAPN condition after 35 days of culture 
contributed to the increase in equilibrium aggregate modulus of the newly formed matrix 
even though there are no cross-links present in the collagen molecules. The fact that a 
higher collagen deposition contributes to an improvement of the equilibrium aggregate 
modulus is in agreement with previous studies, although collagen cross-links were prob-
ably present 169, 210. At 70 days, the increase in collagen deposition alone was no longer 
sufficient to increase the equilibrium aggregate modulus: proper cross-linking was also 
required. This is shown by the increase in collagen deposition in the BAPN +/+ condition 
at day 70 without an increase of the equilibrium modulus, while the initial increase in 
collagen deposition with subsequent collagen cross-linking did increase the equilibrium 
modulus (the BAPN +/- condition). These findings corroborate studies performed in 
other tissues such as skin and bone, where mechanical tissue strength and stiffness 
are also associated with collagen crosslink levels 216, 217. Next to enzymatic cross-links, 
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Figure 4.6 
 
i ure 4.6. Immunocytochemical analysis of produced matrix after 35 days of culture. Control chon-
drocytes stained for A) collagen type II and B) collagen type I and chondrocytes cultured in the presence 
of BAPN for 35 days stained for C) collagen type II and D) collagen type. Magnification is 100 times, with 
a 400 times inset. Positive cells are indicated in red with haematoxylin counter stain (purple).
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adult human articular cartilage also contains non-enzymatically formed cross-links, the 
so-called advanced glycation endproducts (AGEs). However, because of the low glucose 
concentration in our culture medium (5mM), it is unlikely that these AGEs are formed 
during the 70 days of culture 218, 219. Differences between culture conditions in levels of 
non-enzymatic cross-links and subsequently altered mechanical properties are therefore 
not expected. We hypothesize that the effect of collagen deposition on mechanical 
stiffness of the matrix depends on the amount deposited: when a low amount of col-
lagen is deposited in the first five weeks of the chondrocyte culture, a small increase 
is able to improve matrix stiffness. When more collagen is deposited, cross-linking of 
the collagen is needed to further improve the matrix stiffness. The same hypothesis is 
applicable for the secant modulus. After five weeks of culture, the secant modulus was 
not significantly affected by the increase in collagen without cross-links being present. 
However, when collagen deposition increased even more during an additional five-week 
culture without the ability to crosslink, the secant modulus was lower than in the control 
condition with cross-links. This indicates that collagen cross-links are needed in addition 
to proteoglycans (that have previously been shown to be important 209) to regulate the 
secant modulus and thus the ability of the matrix to hold water. The ability of the matrix 
to hold water is important for cartilage to resume its original shape and texture after 
deformation and is mainly attributed to proteoglycans. However, we see a decrease in 
the ability to hold water even though the amount of proteoglycans in the alginate beads 
is comparable in each condition. We therefore hypothesize that collagen cross-links 
might be important in maintaining a dense structure in order for the proteoglycans to 
retain the water in the cartilage matrix.
The role of cross-links in cartilage collagen catabolism was examined by subjecting 
the alginate constructs to collagenase (MMP-1) digestion. The data demonstrate that 
the presence of pyridinoline cross-links reduces the susceptibility to MMP-1 degrada-
tion. These observations are in concordance with what was recently found by our group, 
where matrices with more pyridinoline cross-links produced by skin fibroblasts were less 
susceptible for MMP-1 degradation 220.
To examine whether the modulation of collagen cross-linking and subsequently the 
collagen deposition had an effect on the matrix distribution, we determined the col-
lagen distribution between the cell associated matrix (CM) and the further removed 
matrix (FRM). In contrast to a previous study where collagen was equally present in both 
compartments after BAPN treatment 163, in the present study more collagen was depos-
ited in the CM after BAPN treatment with no difference in relative amounts between 
the conditions. Since a difference in mechanical properties is observed when the control 
condition is compared with the BAPN +/- condition, we conclude that this effect is 
mainly caused by the difference in collagen cross-links and that the distribution over the 
CM versus FRM does not affect this mechanical property in this test system.
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Whether the addition of BAPN to the culture medium adversely affected the pheno-
type and behavior of the chondrocytes was examined with SOX9 gene expression and 
the ratio between Collagen type II and Collagen type I gene and protein expression. In 
a previous study with BAPN, a positive affect of BAPN on the chondrocyte phenotype 
was found. This was shown by the shape of the chondrocytes and the production of 
collagen types II, IX, X and XI 221. In concordance to this study, BAPN had no detrimental 
effects on the chondrocyte phenotype, here shown by the ratio between collagen type 
II and collagen type I gene and protein expression and SOX9 gene expression. In fact, 
it appears that addition of BAPN leads to an increase in SOX9 gene expression and 
a higher Collagen type II/Collagen type I gene expression ratio indicating a possible 
positive effect of BAPN on chondrocyte phenotype. The fact that the protein and gene 
expression data are not exactly similar can be explained by the fact that immunocy-
tochemistry is semi-quantitative and that only the number of cells expressing collagen 
type I or II is determined and not the absolute amount of protein.
After ten weeks of culture, 0.7 HP cross-links per collagen triple helix were found 
in the control and the BAPN +/- condition. This closely resembles the number found 
in immature calf cartilage 79. The observed increase in collagen deposition can be 
explained by a so-called ‘feedback-loop’. Normally, specific integrins on the surface of 
chondrocytes are occupied by collagen molecules leading to a feed back loop. In case 
of crosslink inhibition, collagen can diffuse further away from the cell resulting in less 
occupation of the intregrin receptors and less or no feed back, stimulating the cell 
in collagen production 163. Based on our results, the matrix still remains in the CM. 
The collagen deposition remains increased after the removal of BAPN, which can be 
explained by the fact that the enzyme lysyl oxidase (LOX) needs to be produced and that 
the formation of mature pyridinoline cross-links takes approximately 3 weeks 222.
In conclusion, our data imply a significant role for both the amount of collagen and 
the number of collagen cross-links in the mechanical properties of the formed cartilage 
matrix. Initially an increase in amount of collagen is sufficient to increase the mechani-
cal stiffness but at a certain collagen level, also cross-links are needed to increase the 
mechanical stiffness to a higher level. Furthermore, collagen cross-links also play an 
important role in matrix integrity by making the matrix less susceptible for degradation. 
These data suggest that in reparation of the collagen network, collagen amount but 
especially cross-linking is important for the mechanical properties of the newly formed 
cartilage, as well as the susceptibility of the new cartilage for enzymatic degradation. 
Successful modulation of collagen synthesis and cross-linking could potentially greatly 
benefit cartilage repair. Several approaches could possibly be used in future to achieve 
this, like application of growth factors as well as the use of gene therapy techniques.
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Abstract
Objective
To understand cartilage degenerative diseases and improve repair procedures, we inves-
tigate the influence of glycosaminoglycans (GAGs) on cartilage matrix biochemistry and 
functionality.
Methods
Bovine articular chondrocytes were cultured in alginate beads with(out) para-nitrophenyl-
beta-d-xyloside (PNPX) to inhibit GAG incorporation into newly formed proteoglycans.
Results
As expected, GAG deposition in alginate beads decreased with increasing PNPX concen-
tration. Next to GAGs, collagen deposition and cross-linking also decreased. In the pres-
ence of PNPX, GAGs and collagen were deposited further away from the chondrocyte 
than in the control and increased amounts were found in the culture medium. These 
changes resulted in decreased functional properties of the construct.
Discussion
We conclude that in our culture system, intact proteoglycans play a role in deposition of 
collagen and thus the formation of a functional matrix. The effect of less proteoglycans 
on the collagen network could explain why cartilage repair is ineffective in osteoarthritis 
and help us with development of new therapies.
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Introduction
The function of articular cartilage depends on structure, composition and integrity of its 
extracellular matrix (ECM). The main ECM molecules present in cartilage are collagens 
and proteoglycans. Collagens are organized into a fibrous network, which defines 
the basic tissue architecture and provides tensile strength 223. Together with type IX 
and XI, collagen type II forms fibrils 25, 224, which are stabilized by the formation of 
intermolecular cross-links. A high concentration of proteoglycans (PGs) is embedded 
in the collagen network giving the cartilage the ability to hold water and to reverse 
deformation 83. Proteoglycans consist of a protein core with carbohydrate side chains 
called glycosaminoglycans (GAGs). Aggrecan is the most common PG in articular carti-
lage with chondroitin and keratan sulphate side chains 36. Other smaller proteoglycans 
and present to a lesser extent include decorin, biglycan and perlecan 225, 226. These 
small proteoglycans have one or two GAG side chains such as dermatan sulphate or 
heparan sulphate. For all proteoglycans, these GAG side chains are covalently joined to 
the protein core by a glycosidic bond between xylose and the hydroxyl group of a serine 
residue 39. After xylosylation of serine, linkage region synthesis occurs by addition of 
two galactosyl moieties by galactosyltransferase I 40 and glucuronic acid by glucurono-
syltransferase I 41. For chondroitin sulphate, alternate transfer of N-acetylgalactosamine 
and glucuronic acid 42 results in elongation of side chain.
With cartilage degeneration in osteoarthritis (OA), changes in structure and composi-
tion of the tissue occur. Fewer proteoglycans are present in OA cartilage 205 together 
with enhanced collagen degradation 143. However, the rate of synthesis of both matrix 
components is increased as well 94-96. This suggests an activated repair mechanism that 
is however ineffective in repairing or maintaining the ECM homeostasis. In OA, the 
mechanical stiffness of cartilage decreases in relation to the extent of its degeneration 206. 
Changes in mechanical properties include a decrease of the cartilage compression stiff-
ness and an increase in the tendency to swell compared to healthy cartilage 83, 86.
Understanding matrix assembly and interaction between collagens and proteogly-
cans is necessary to understand the disease process in OA and develop solutions for the 
repair of articular cartilage damage. The purpose of this study was therefore to examine 
the effect of GAGs on matrix production and distribution and consequently matrix 
functionality, by dose-dependently inhibiting GAG incorporation in the newly formed 
cartilage matrix using the exogenous substrate acceptor of galactosyl transferase para-
nitrophenyl-beta-d-xyloside (PNPX).
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Methods
Cell culture
Articular cartilage was harvested from the metacarpophalangeal joints of calves aged 
6–12 months. Chondrocytes were isolated, suspended in 1.2% (w/v) alginate in a con-
centration of 4 x 106 cells per ml of alginate, and alginate beads were made as described 
previously 211. Beads were cultured in 75 µl/bead DMEM/F12 with GlutaMAX™ supple-
mented with 10% fetal bovine serum (GibcoBRL), 50 µg/ml L-ascorbic acid 2-phosphate 
(Sigma), 50 µg/ml gentamicin and 1.5 µg/ml fungizone (both GibcoBRL). Chondrocytes 
were cultured for the entire culture period with or without 0.025 mM or 0.25 mM para-
nitrophenyl-beta-d-xyloside (PNPX) based on previous results 227, 228. PNPX is an exogenous 
acceptor for galactosyl transferase I, which competes with endogenous xylosylated core 
proteins for glycosaminoglycan chain production and thus prevents glycosaminoglycans 
being incorporated in the matrix 229.  Culture medium was changed three times a week. 
Alginate beads were harvested after 21 days of culture for RNA and 35 days for matrix 
production and distribution. Gene expression was analyzed at day 21, matrix composi-
tion, collagen cross-linking, and functionality at day 35 since it takes time for genes to be 
translated and assembled into functional (glyco)proteins, especially collagen 222.
RNA isolation and quantitative RT-PCR
For total RNA isolation, alginate beads were dissolved in 150 µl/bead 55 mM sodium 
citrate and 20 mM Ethylene Diamintetraacetate (EDTA) in 150 mM NaCl. Cell pellets of 
the alginate beads were suspended in 1000µl RNA-BeeTM (TEL-TEST, Inc.; Friendswood, 
TX, USA), and precipitated with 2-propanol and purified with lithium chloride. Total RNA 
was quantified using NanoDrop® ND-1000 Spectrophotometer (NanoDrop Technolo-
gies, Wilmington, DE, USA) and 500 ng total RNA of each sample was reverse transcribed 
into cDNA using RevertAidTM First Strand cDNA Synthesis Kit (MBI Fermentas, Germany). 
Quantitative real-time PCR was performed using the ABI Prism 7000 Sequence Detec-
tion system (Applied Biosystems, Foster City, CA). Primer sequences for genes were as 
follows: for Glyceraldehyde-3-phosphate dehydrogenase (GAPDH, reference gene) for-
ward: GTCAACGGATTTGGTCGTATTGGG, reverse: TGCCATGGGTGGAATCATATTGG, 
and probe: Fam-CCATCACCATCTTCCAGGAGCGAGA-Tamra. Aggrecan core protein 
(AGCN) forward:  GGACACTCCTTGCAATTTGAGAA, reverse: CAGGGCATTGATCTCG-
TATCG, probe: Fam-TGGCGCCCCAACCAGCC-Tamra. Collagen type 2 (COL2) forward: 
GGCAATAGCAGGTTCACGTACA, reverse: CGATAACAGTCTTGCCCCACTT, probe: 
FAMCCGGTATGTTTCGTGCAGCCATCCT- Tamra. SRY-box containing gene 9 (SOX9), 
Forward: CAACGCCGAGCTCAGCA, reverse: TCCACGAAGGGCCGC, probe: Fam-
TGGGCAAGCTCTGGAGACTTCTGAACG-Tamra. PCR conditions and analysis were as 
described previously 230
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Isolation of cell associated matrix
Alginate beads were dissolved by adding 75 µl sodium citrate buffer per bead for 20 min 
at room temperature. The suspension was centrifuged 10 min at 1000 rpm (Eppendorf), 
to separate the cells surrounded by their cell associated matrix (CM, the pellet) from 
components originating predominantly from the ‘interterritorial’ or further removed 
matrix (FRM; the supernatant) from the cells as described previously 194, 230.
Biochemical assays
Alginate beads or separated CM and FRM were digested overnight at 56°C in buffer 
with papain (250 µg/ml papain in 50 mM EDTA and 5 mM L-cystein). Glycosamino-
glycan (GAG) amount in the digest was quantified using dimethylmethylene blue 
(DMB) assay 160. The metachromatic reaction of GAG with DMB was monitored with 
a spectrophotometer, and the ratio A530:A590 was used to determine the amount of 
GAG present, using chondroitin sulfate C (Sigma) as a standard. The Blyscan sulfated 
glycosaminoglycan assay (Biocolor Ltd, Northern Ireland) was used to determine the 
GAGs in the culture medium. In both assays, the cationic dye DMB binds to negatively 
charged GAGs. PNPX prevents these GAGs from binding to the core protein resulting in 
elongation of the GAG chain without the formation of a proteoglycan. These unbound 
GAGs can still be detected with the assays described above. The amount of DNA in 
each papain-digested sample was determined using ethidium bromide with calf thymus 
DNA (Sigma) as a standard. High-performance liquid chromatography (HPLC) of amino 
acids (hydroxyproline, Hyp) and collagen cross-links (hydroxylysylpyridinoline, HP) was 
performed as described previously 162, 163. The quantities of cross-links were expressed 
as number of residues per collagen molecule, assuming 300 Hyp residues per collagen 
triple helix.
Mechanical testing
For mechanical characterization, we used 4 × 106 cells/ml in 1.2 % (w/v) alginate con-
structs of 3 mm thick and 6 mm in diameter. Constructs were prepared as previously 
described 166, 230. After 35 days of culture, constructs were mounted on a materials 
testing machine, the DMA Q800 Dynamicmechanical Analyzer (TA Instruments, New 
Castle, DE, USA), in a radially unconfined stress relaxation test with the construct 
between impermeable platens, hydrated in 0.9% saline with the protease inhibitor 
Complete™ (Sigma). A 20% uniaxial compressive strain was applied within 10 seconds 
at a ramped displacement strain rate of 2% s-1, based on the measured thickness. 
Strain was maintained constant for 30 min, load was recorded at a sampling rate of 10 
Hz using a 18N load cell. The applied load recorded by the load cell was divided by the 
cross-sectional area of the construct to calculate the applied stress. The secant modulus 
was calculated as stress/strain at 10 seconds, where the stress had its peak response 
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and the strain reached its maximum. At the end of the test, the equilibrium aggregate 
modulus was determined as stress/strain at 30 minutes. The secant modulus is related 
to the interaction between the solid and the liquid phase and is therefore an indication 
for the ability to hold water. The modulus measured at equilibrium depends strongly on 
the compressive stiffness of the (cartilaginous) solid matrix 83.
Statistical analysis
Experiments were repeated three times, with two pooled animal donors per experiment. 
Per experiment, 3 samples were taken with 7 beads per experimental condition for 
biochemical analyses and two samples of 10 beads per experimental condition for gene 
expression analysis. The experiments for mechanical testing were repeated two times, 
with two pooled animal donors per experiment and a total of 6 samples per group per 
experiment. Statistical analysis was performed using GraphPad Prism 5.01 (GraphPad 
Software, San Diego, CA, USA) software. Control groups without PNPX and groups 
supplemented with PNPX were compared with a Kruskall-Wallis test followed by a post 
hoc Dunn’s multiple comparison tests.
Results
Gene expression
Aggrecan core protein (AGCN) gene expression, Collagen type 2 (COL2) gene expres-
sion and SOX9 gene expression as indication for chondrocyte phenotype were not 
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Figure 5.1  Figure 5.1.  Relative ene expression of aggrecan (AGCN), collagen type 2 (COL2) and SOX9 at day 
21 with or without 0.025 mM or 0.25 mM PNPX. Gene expression is normalised to GAPDH. N = 6, data 
are shown as mean + sd.
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significantly changed by the presence of PNPX at day 21 of culture. Although AGCN 
had a trend towards upregulation with increasing PNPX concentration, it did not reach 
statistical significance (Figure 5.1).
Matrix production and distribution
After 35 days of culture, no difference was seen in the amount of DNA between the 
conditions, being on average 0.23 ± 0.07 µg DNA per bead (Figure 5.2A)
The absolute amount of glycosaminoglycans (GAGs) deposited in the alginate bead 
during the 35 days of culture was significantly lower in the presence of 0.25 mM PNPX, 
21.3 ± 0.5 µg GAG per bead in the control condition versus 9.2 ± 0.6 µg GAG per 
bead in the presence of 0.25 mM PNPX. The distribution of GAGs and collagen in the 
culture system was examined by analyzing separately the cell-associated matrix (CM), 
the further removed matrix (FRM) and the culture medium of the alginate bead. In the 
control condition, 43% of the glycosaminoglycans were present in the CM, 52% pres-
ent in the FRM. The culture medium collected during the 35 days of culture contained 
5% of the total GAG. This distribution was not changed in the presence of 0.025 mM 
PNPX but shifted to the FRM and the culture medium with 0.25 mM PNPX. Here, 19% 
of the GAGs were present in the CM, 35% in the FRM, and 46% in the culture medium 
(Figure 5.2B).
PNPX decreased the total amount of collagen deposited in the alginate bead from 
25.5 ± 3.6 µg collagen per bead in the control condition to 19.3 ± 0.6 µg collagen per 
bead in the presence of 0.25 mM PNPX. The high concentration of PNPX also changed 
the collagen distribution towards the FRM and the culture medium. In the control 
condition, 60% of the collagen was present in the CM, 23% present in the FRM, and 
17% was present in the culture medium. With 0.25 mM PNPX, 41% of the collagen 
was further removed and 26% was present in the culture medium. Only 32% of the 
produced collagen was cell associated. However, total collagen production (in CM, FRM 
and culture medium) was not changed when PNPX was present (Figure 5.2C). Less 
collagen cross-links were present with 0.25 mM PNPX than in the control condition and 
the low concentration of PNPX; 0.16 ± 0.01 HP per collagen triple helix versus 0.48 ± 
0.01 HP per collagen triple helix in the control condition (Figure 5.2D)
Matrix functionality
The ability to hold water of the alginate constructs, indicated by the secant modulus, 
was 6.3 ± 1.0 kPa in the control condition. Addition of 0.25 mM PNPX decreased this to 
5.1 ± 0.6 kPa (Figure 5.3A). The stiffness indicated by the equilibrium modulus decreased 
from 1.4 ± 0.5 kPa in the control condition to 0.7 ± 0.4 Pa in the condition with 0.25 
mM PNPX (Figure 5.3B).
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Discussion
Once damaged, adult articular cartilage has a poor repair capacity even though the 
loss of proteoglycans is considered reversible 142, 231. Although collagen turnover 
is also increased in osteoarthritis, this does not lead to the formation of a functional 
network 96, 232. In this study, the effect GAGs on matrix assembly and distribution and 
the subsequent mechanical functioning of the matrix was examined. We found that by 
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Figure 5.2. DNA content, matrix deposition and matrix distribution after 35 days of culture. A) DNA 
content shown as µg DNA per alginate bead. Distribution is shown between the cell associated matrix 
(CM, dark grey), further removed matrix (FRM, light grey) and the culture medium (white) in the pres-
ence of PNPX after 21 days of culture for B) GAG and C) collagen. The bars represent the absolute 
quantity with the relative distribution shown as percentages. D) HP cross-links shown as HP per collagen 
triple helix. N = 9, data are shown as mean + sd, * indicates significant difference in relative distribution 
(p<0.05), † indicates significant difference in absolute deposition in the alginate bead.
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inhibiting GAG incorporation in the newly formed cartilage matrix, not only the syn-
thesized GAGs diffused further away from the chondrocyte but also collagen was less 
cross-linked and diffused further away from the chondrocyte and even into the culture 
medium. As a logical consequence, the stiffness and the ability to hold water were lower. 
We therefore conclude that in our culture system, GAG incorporation in proteoglycans 
contribute to the formation of a functional collagen network. To our knowledge, this 
is the first study where the effect of modulation of proteoglycan synthesis on cartilage 
collagen network formation is examined.
Total GAG incorporation in the matrix was inhibited by addition of PNPX. When 
CM, FRM and medium are added up, fewer GAGs are produced in the 0.25 mM PNPX 
condition than in the control condition without PNPX. This is in contrast to previous 
studies where inhibition of GAG incorporation lead to more free GAGs as a possible 
compensation mechanism 233, 234. Aggrecan core protein gene expression had a trend 
towards upregulation, possibly indicating that increasing aggrecan core protein produc-
tion is an attempt to compensate the lack of intact proteoglycans.
Collagen synthesis was not changed by the presence of PNPX as shown on gene 
expression level for collagen type II and on total collagen protein level in alginate bead 
and culture medium. Surprisingly, collagen deposition in the alginate bead was lower 
when GAG incorporation was inhibited. The produced collagen was partly excreted into 
the culture medium.
The number of cross-links per collagen molecule was downregulated in the presence 
of PNPX. This suggests that the lower amount of incorporated GAGs influences the 
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Figure 5.3 Figure 5.3. Matrix functionality after 35 days of culture, with or without 0.025 mM or 0.25 mM 
PNPX: A) The ability to hold water of the newly formed matrix defined by the secant modulus and B) 
the stiffness of the matrix defined by the equilibrium modulus. N = 12, data are shown as mean + sd, * 
indicates significant difference (p<0.01)
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diffusion of collagen and subsequently collagen cross-linking. This could solely be a 
result of the absence of an intact proteoglycan network, which normally inhibits col-
lagen from diffusion out of the alginate bead. However, the main proteoglycan present 
in articular cartilage and produced during chondrocyte alginate culture, aggrecan 194, 
also binds to COMP 56 and COMP is believed to interact with collagen type II 96 and 
IX 55. Other proteoglycans present in articular cartilage are small proteoglycans such 
as decorin, fibromodulin and biglycan 235. These small proteoglycans also interact with 
collagen, mainly by binding to the surface of the collagen fibril influencing the fibril 
diameter 236, 237. By influencing collagen fiber interaction and thus collagen fibril diam-
eter, collagen cross-linking can also be influenced. Small diameter fibrils result in a lower 
concentration of collagen cross-links, which might also explain the reduced number of 
cross-links seen after PNPX treatment.
An intact proteoglycan network might thus be very important for the integrity and 
assembly of the functional cartilage matrix. This might also explain the absence of 
cartilage repair in OA. In OA, proteoglycan synthesis is altered 94, 238 possibly leading 
to a different or less functional proteoglycan network that might contribute to the 
ineffective matrix assembly resulting in limited cartilage repair even though collagen 
synthesis is upregulated.
We therefore conclude that the decrease in collagen deposition and cross-linking in 
alginate beads, the increase in collagen excretion into the medium and the decrease in 
mechanical properties is a result of an incomplete proteoglycan network. This incom-
plete proteoglycan network influenced matrix properties directly and also indirectly via 
its effect on the collagen network. The effect of less GAG on the collagen network seen 
here could explain why cartilage repair is ineffective in OA and help with the develop-
ment of new repair or tissue engineering strategies. Stimulating collagen cross-linking 
to prevent collagen diffusing away or stimulate production of specific proteoglycans for 
a functional proteoglycan network are possible therapeutic options derived from this 
study.
6 Stimulation of COMP production in cartilage matrix generation 
decreases collagen fibril diameter
Yvonne M. Bastiaansen-Jenniskens, Anton C.W. de Bart, 
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Abstract
Objective
Cartilage Oligomeric Matrix Protein (COMP) is a protein present in the cartilage matrix 
and is expressed more abundantly in OA cartilage than in healthy cartilage. The present 
study was designed to investigate the effect of growth factors on COMP deposition and 
the influence of COMP on collagen biochemistry.
Methods
Bovine chondrocytes in alginate beads were cultured with or without 25 ng/ml IGF1, 
TGFβ2 or FGF2. Human COMP (hCOMP) was overexpressed in bovine chondrocytes 
using lentiviral transfection. COMP gene expression, COMP protein production, col-
lagen and proteoglycan deposition, and collagen fibril thickness were determined.
Results
Addition of TGFβ2 resulted in more COMP mRNA and protein than the control condi-
tion without growth factors or with addition of IGF1. FGF2 resulted in less and partially 
degraded COMP. Lentiviral transduction with hCOMP resulted in elevated gene expres-
sion of hCOMP and increased COMP levels in the alginate bead and culture medium 
compared to untransfected cells. Overexpression of COMP did not affect the deposition 
of collagen, collagen cross-linking, proteoglycan deposition or the mechanical proper-
ties. Stimulating COMP production by either TGFβ2 or lentivirus resulted in collagen 
fibrils with a smaller diameter.
Discussion
Taken together, COMP deposition can be modulated in cartilage matrix production 
by addition of growth factors or by overexpression of COMP. Inducing COMP protein 
expression resulted in collagen fibrils with a smaller diameter. Since it has been dem-
onstrated that the collagen fibril diameter is associated with mechanical functioning of 
the matrix, modulating COMP levels could therefore contribute to successful cartilage 
regeneration strategies.
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Introduction
Cartilage oligomeric matrix protein (COMP) is a homo-pentameric protein of 520-550 
kDa with subunits of 100-120 kDa 239. COMP was originally found in cartilage 50 but is 
also present in a large variety of other tissues such as tendon 51, synovium and skin 52. 
The function of COMP is not completely understood. It is known that COMP interacts 
with several components of the extracellular matrix such as collagen type I, I I54, and IX 55. 
and the non-collagenous proteins matrilin (MATN) 1, 3, and 4 and aggrecan  56, 62.
A large number of COMP mutations has been identified, some causing phenotypes 
ranging from severe pseudoachondroplasia (PSACH) to mild multiple epiphyseal dys-
plasia (MED) 240 depending on the location of the mutation. Because COMP interacts 
with other matrix proteins, the mutations in the comp gene resulting in retention in 
the endoplasmatic reticulum of the cell often also lead to altered excretion of collagen 
type IX and matrilin 3. Excretion of collagen type II is less affected by COMP muta-
tions 55, 63, 241. In addition, COMP mutations result in alterations in cartilage matrix 
assembly and reduced interaction between chondrocytes and COMP which could also 
contribute to the PSACH or MED phenotype 242.  Surprisingly, complete absence of 
COMP does not result in morphological or anatomical changes and does not lead to any 
signs of PSACH or MED 237. Recently, COMP was found to influence the fibril formation 
of collagen type I and II leading to more and organized collagen fibrils in vitro. However, 
COMP was not associated with mature collagen fibrils suggesting a role as catalyst in 
fibrillogenesis for COMP 57.
The distribution of COMP within healthy cartilage changes in time. In young cartilage, 
COMP is uniformly present in the superficial layers of the cartilage whereas in the middle 
layer the location is more territorially (centered around the chondrocytes), shifting with 
age towards a more interterritorial distribution 243. In osteoarthritic (OA) cartilage as 
a result of reactivation of COMP synthesis, COMP is mainly present in the pericellulair 
matrix of cell clusters 244, 245. Here COMP is mainly located on the collagen fibers, 
whereas in healthy cartilage almost no COMP is associated with collagen fibers 244. 
Besides the shift in matrix distribution, gene expression and protein expression are also 
increased in OA when compared to healthy cartilage 67, 244. The interactions between 
COMP and other matrix components and the shift of COMP distribution in OA cartilage 
to a more immature distribution pattern in a possible attempt to repair the cartilage, 
suggest that COMP may have a role in the development of articular cartilage.
Because of the absence of spontaneous functional cartilage repair in OA, cartilage 
regeneration strategies include the use of growth factors to induce a chondrogenic 
cell phenotype or enhance extracellular matrix production. Because of the possible role 
of COMP in the cartilage matrix production, assembly, and regeneration, the goal of 
the present study was to examine the influence of Insulin-like Growth Factor (IGF)-1, 
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Transforming Growth Factor (TGF)β and Fibroblast Growth Factor (FGF)-2  on COMP 
gene expression and protein production by isolated chondrocytes and the consequent 
effect of COMP on extracellular matrix assembly and functional properties of the 
generated matrix. Because of the diverse effects of the used growth factors on matrix 
biochemistry and functionality earlier described by us 211, we also overexpressed COMP 
in primary chondrocytes using lentivirus for stable integration to examine the role of 
COMP during cartilage matrix generation.
Methods
Cell culture
Articular cartilage was harvested from metacarpophalangeal joints of calves aged 
6–12 months. Full-thickness slices of non-calcified articular cartilage were subjected 
to pronase (2 mg/ml, Sigma, St. Louis, MO, USA) digestion for two hours followed by 
overnight collagenase B (1.5 mg/ml, Roche Diagnostics) digestion. Chondrocytes were 
resuspended in 1.2% (w/v) low viscosity alginate (Keltone) in 0.9% NaCl (Sigma) at 
a concentration of 4 × 106 cells/ml and beads were made as described previously157. 
After transfer to a six-well plate (BD Falcon, Bedford, MA, USA) they were cultured in 
75 µl/bead DMEM/F12 supplemented with 10% fetal bovine serum (GibcoBRL), 50 µg/
ml L-ascorbic acid 2-phosphate (Sigma), 50 µg/ml gentamicin and 1.5 µg/ml fungizone 
(both GibcoBRL). For growth factor experiments, cells were cultured with and with-
out 25 ng/ml FGF2 (Serotec, Oxford, UK), TGFβ2 (recombinant human, R&D systems, 
Abington, UK) or IGF1 (Sigma) and harvested after 11 and 21 days of culture. Growth 
factors and concentrations were chosen based on previous results 211. For experiments 
with lentivirus, chondrocytes were incubated with or without virus for four hours prior 
to suspension in alginate, and cultured for 11, 21 or 35 days.
COMP and GFP lentivirus production
A four-plasmid expression system was used to generate lentiviral vectors by transient 
transfection. The four plasmids were (i) the expression plasmid (pLV) in which human 
cartilage oligomeric matrix protein (COMP) or green fluorescent protein (GFP) cDNA 
fused, (ii) the packaging plasmid pLP1 encoding Gag and Pol (iii) the packaging plasmid 
pLP2 encoding Rev and (iv) the envelope plasmid, pLP/VSVG for surface proteins. Vectors 
were produced by transfection of plasmid DNA into 293FT cells using the transfection 
agent Lipofectamine 2000 (Invitrogen, Carlsbad, CA, USA). Transfections were done in 
75cm2 flasks using 9 µg expression plasmid, 6.4 µg of pLP1, 4.8 µg of pLP2 and 3.4 µg 
of pLP/VSVG. Medium was changed after 24 hours and collected after an additional 48 
hours. The medium was filtered and concentrated by ultracentrifugation. The p24 ELISA 
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(Gentaur, Brussels, Belgium) was used according to the manual to determine the number 
of infectious units. Cell transduction was performed by incubating bovine chondrocytes 
with COMP or GFP lentivirus at an MOI of 0.75 for 4 hours prior to suspending the 
chondrocytes in alginate and making beads.
Determination of transfection efficiency
Chondrocytes infected with GFP were recovered from alginate beads using 75 µl per 
bead of 55 mM sodium citrate and 20 mM Ethylene Diamintetraacetate (EDTA) in 150 
mM NaCl for 20 min at room temperature. After washing twice in PBS, chondrocytes 
were resuspended in PBS with 0.1% FCS. Analysis of transfection efficiency was per-
formed using a FACSCalibur flow cytometer (BD Biosciences, Mountain View, CA, USA). 
A minimum of 10,000 cells per sample was collected. Data acquisition and analysis were 
performed using CellQuest 3.3 (Becton Dickinson).
RNA isolation and quantitative RT-PCR
For total RNA isolation, alginate beads were dissolved in 150 µl/bead sodium citrate 
buffer. After centrifugation, cell pellets were suspended in 1000µl RNA-BeeTM (TEL-TEST, 
Inc.; Friendswood, TX, USA), and subsequently precipitated with 2-propanol and puri-
fied with lithium chloride. Total RNA was quantified using NanoDrop® ND-1000 Spec-
trophotometer (NanoDrop Technologies, Wilmington, DE, USA) and 500 ng total RNA 
of each sample was reverse transcribed into cDNA using RevertAidTM First Strand cDNA 
Synthesis Kit (MBI Fermentas, Germany).  Quantitative real-time PCR was performed 
using the ABI Prism 7000 Sequence Detection system (Applied Biosystems, Foster City, 
CA) for quantification using Taqman and SYBR Green and melting curve analysis. Primer 
sequences for the genes were as follows: for Glyceraldehyde-3-phosphate dehydroge-
nase (GAPDH reference gene) forward: GTCAACGGATT TGGTCGTATTGGG, reverse: 
TGCCATGG GTGGAATCATATTGG, and probe: Fam-TGGCGCCCCAACCAGCC-Tamra. 
For the COMP assay specific for bovine, reverse: TCTGATCTGAGTTGGGCACCTT, 
forward: CCAGAAGAACGACGACCAGAA. For the COMP assay specific for human, a 
TaqMan® Gene Expression Assay was used (Applied Biosystems, Foster City, CA, USA). 
PCR conditions were as follows: 2 minutes at 50°C and 10 minutes at 95°C, followed 
by 40 cycles of 15 seconds at 95°C and 1 minute at 60°C, with data collection dur-
ing the last step. For GAPDH and human COMP, Taqman 2x Universal PCR Mastermix 
(Roche) was used in the reaction. For bovine COMP, qPCR Mastermix Plus SYBR Green 
I (Eurogentec) was used in the reaction. All PCRs were performed in a total volume of 
25 µl. Relative quantification of PCR signals was performed by comparing the threshold 
cycle value (Ct), in duplicate, for the gene of interest in each sample with the Ct value for 
the reference gene GAPDH. Quantitative PCR analysis of each sample was performed 
in duplicate.
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Isolation of cell associated matrix
Alginate beads were dissolved by adding 75 µl per bead of sodium citrate buffer for 
20 min at room temperature. The suspension was centrifuged 10 min at 1000 rpm 
(Eppendorf), to separate cells surrounded by its cell associated matrix (CM, the pel-
let) from components originating predominantly from the ‘interterritorial’ or further 
removed matrix (FRM; the supernatant) from the cells as described previously157, 187.
Biochemical assays
Alginate beads or separated CM and FRM were digested overnight at 56°C in papain 
buffer (250 µg/ml papain in 50 mM EDTA and 5 mM L-cystein). Glycosaminoglycan 
(GAG) amount in the digest was quantified using dimethylmethylene blue (DMB) 
assay as described previously160. The metachromatic reaction of GAG with DMB was 
monitored with a spectrophotometer, and the ratio A530:A590 was used to determine 
the amount of GAG present, using chondroitin sulfate C (Sigma) as a standard. High-
performance liquid chromatography (HPLC) of amino acids (hydroxyproline, Hyp) and 
collagen cross-links (hydroxylysylpyridinoline, HP) was performed by the methods of 
Bank162. The quantities of cross-links were expressed as the number of residues per 
collagen molecule, assuming 300 Hyp residues per collagen triple helix.
COMP detection with ELISA and Western blotting
To analyze the produced extracellular matrix and the culture medium for COMP, 
alginate beads were dissolved in the sodium citrate buffer. To block proteolysis, the 
broad-spectrum protease inhibitor Complete (Roche Diagnostics) dissolved in phos-
phate buffered saline (PBS) was added to the alginate and culture medium samples. The 
human and animal COMP ELISA (Anamar, Göteborg, Sweden) were used to quantify 
the COMP content according to the manual. For qualitative Western blotting, protein 
separation was performed with SDS-PAGE. The system consisted of 4% acrylamide 
(Roth, Karlsruhe, Germany) in the stacking gel with a pH of 6.8 and 0.5M Tris-HCl, 
6% acrylamide in separation gel for the non-reducing gels and 10% for the reducing 
gels, both 8.8% and 1.5M Tris-HCl. Reducing and non-reducing sample buffer (Roth) 
were used to load samples on the gel. Roti®-Mark Western Marker (Roth) was used 
as reference. Tris-glycine was used as electrophoresis buffer, and separation was car-
ried out at 150 V for 1 hour. After electrophoresis, proteins were blotted onto PVDF 
membranes (Roth). Membranes were washed in PBS and blocked for 1 hour in PBS/5% 
(w/v) milk powder at room temperature. Immunoreactions were performed applying the 
anti-COMP antibody 12-C4246 for 1 hour, diluted 1:500 in PBS/2.5% milk. The second-
ary goat-anti-mouse antibody coupled to horse reddish peroxidase was diluted 1:1500 
and co-incubated with Roti®-Mark Western HRP conjugate (Roth) diluted 1:2000 for 1 
hour at room temperature. Three 5-minute washes with PBS-Tween 0.1% were carried 
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out between all incubation steps. Visualization was achieved using the Immun-Star HRP 
chemiluminescent kit (Bio-Rad, Hercules, CA, USA).
Mechanical testing
For mechanical characterization, we used 4 × 106 cells/ml in 1.2% (w/v) alginate 
constructs of 3 mm thick and 6 mm in diameter. Constructs were prepared as previ-
ously described166. After 35 days of culture, constructs were mounted on the Dynamic 
Mechanical Analyzer DMA Q800 (TA Instruments, New Castle, DE, USA) and tested in a 
radially unconfined stress relaxation test as described previously230. The secant modulus 
is related to the interaction between the solid and the liquid phase and is therefore an 
indication for the ability to hold water. The modulus measured at equilibrium depends 
strongly on the compressive stiffness of the (cartilaginous) solid matrix83.
Electron microscopy and fibril measurements
Beads were rinsed three times in PBS and fixed for 2 hours at room temperature in 
0.1 M sodium cacodylate-buffered 1.5% glutaraldehyde (EM grade, Sigma) and 1% 
paraformaldehyde, pH 6.7, then rinsed 3 times in 0.15 M sodium cacodylate. After 
post-fixation for 2 hours in 0.1 M sodium cacodylate buffered 1% osmium tetroxide 
(OsO4), pH 6.7, beads were dehydrated in a series of graded acetone and embedded 
in LX 112 (Epon). Ultrathin sections (LKB ultratome IV), were mounted on copper grids 
(300 mesh) and contrasted with 2% uranyl acetate (10 minutes at 45º C) and lead 
citrate. They were examined with a Zeiss 902 electron microscope. Pictures were taken 
at 2800 times, 18000 times, and 89000 times magnification. Four pictures per sample 
(89000 times magnification) were used to measure collagen fibril diameter with ImageJ 
1.40g (NIH).
Statistical analysis
The experiments were repeated three times. Each experiment consisted of 3 times 7 
beads per experimental condition for biochemical analyses and two samples of 10 beads 
per experimental condition for gene expression analysis. Experiments for mechanical 
testing were repeated two times with a total of 6 samples per group. Statistical analysis 
was performed using GraphPad Prism 5.01 (GraphPad Software, San Diego, CA, USA) 
software. All data are presented as mean ± standard deviation. Control groups without 
growth factors or lentivirus and groups supplemented with growth factors or transfected 
with COMP lentivirus were compared with a Kruskall-Wallis test and a Dunn's multiple 
comparison test.
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Results
COMP expression in the presence of growth factors
IGF1 had no effect on COMP gene expression, the presence of TGFβ2 increased the 
expression 14-fold and FGF2 decreased it more than 5-fold as determined after 11 
days of culture (Figure 5.1A). COMP protein deposition in the alginate bead, quantified 
with ELISA, was not influenced by the presence of IGF1 on day 11 and day 21. TGFβ2 
increased the deposition approximately 2-fold and approximately 6 times less COMP 
was deposited in the presence of FGF2 (Figure 6.1B). A reducing Western blot was 
performed to assess the integrity of the COMP in the alginate beads at day 11 and 21. 
The control, IGF1, and TGFβ2 condition had a signal at approximately 110 kDa with 
increased intensity at day 21 compared to day 11. Almost no signal was seen in the FGF2 
condition (Figure 6.1C). COMP protein was also excreted into the culture medium of the 
alginate beads as shown on the reducing Western blot of the medium. Approximately 
the same amount of COMP was present in the control, IGF1 and FGF2 condition. The 
presence of TGFβ2 resulted in more COMP in the culture medium (Figure 6.1D).
Distribution of matrix components after addition of 
growth factors
The distribution of COMP, collagen and proteoglycans within the alginate bead at 
day 21 was determined by separation of the cell-associated matrix (CM) and further 
removed matrix (FRM). In the control condition, 27 ± 2.5% of the COMP was located 
in the CM and 73 ± 2.6 % of the COMP in the FRM without differences between 
growth factor conditions (Figure 6.2A). The same distribution for the proteoglycans 
was seen in the control condition; 28 ± 3.2 % of the proteoglycans in the CM and 72 
± 1.8 % of the proteoglycans in the FRM. However in the case of the proteoglycans, 
there is a shift in this distribution when IGF1 or FGF2 is present resulting in an equal 
distribution over CM and FRM. Addition of TGFβ2 resulted in a slight shift towards 
the FRM, although this is not significantly different from control (Figure 6.2B). In case 
of collagen, 66 ± 8.2 % was cell associated and 34 ± 4.1 % was further removed 
from the cell in the control condition. This distribution was changed to 36% in the 
cell-associated matrix in the presence of TGFβ2, but not in the presence of IGF1 or 
FGF2 (Figure 6.2C).
COMP gene expression after lentiviral transfection
A lentiviral vector was used to more selectively increase COMP gene expression, using 
human COMP gene in order to distinguish endogenous bovine COMP from lentivirally 
transfected COMP. A GFP lentivirus was used in parallel to determine transfection 
efficiency. In time, the percentage of GFP positive cells did not decrease indicating that 
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Figure 6.1 
Figure 6.1.  The effect of 25 ng/ml IGF1, TGFβ2 and FGF2 on COMP gene and protein expression. 
Gene expression of bovine COMP is shown in (A) by expression after culturing for 11 days relative to the 
control without growth factors, which is set at 1 (n = 6). Variation in the control condition is indicated 
by dotted lines. B) Protein deposition of COMP in the alginate beads is shown in relative COMP units as 
determined with ELISA (n = 9) and C) reducing Western blot after 11 and 21 days. D) The COMP release 
in the culture medium after 11 and 21 days is also determined by reducing Western blot. * Indicates 
significant difference (p<0.05) between growth factor and control without growth factors.
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Figure 6.2 Figure 6.2. The effect of 25 ng/ml IGF1, TGFβ2 and FGF2 on absolute matrix distribution with relative 
percentages after 21 days of culture as shown by the distribution of A) COMP, B) proteoglycans, and C) 
collagen between the cell associated matrix (CM, grey bars) and the further removed matrix (FRM, white 
bars). N = 9, * indicates significant difference (p<0.05) in relative distribution between growth factor 
condition and control without growth factor, # indicates significant difference (p<0.05) in absolute 
values between growth factor condition and control condition.
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a stable transfection was accomplished (Figure 6.3A and B). The human COMP gene 
expression increased in time when bovine chondrocytes were transfected with the 
COMP lentivirus. In the control conditions without virus or an empty virus, no human 
COMP gene expression was seen (Figure 6.4A). Bovine COMP gene expression was not 
influenced by transfection with lentivirus (Figure 6.4B).
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Figure 6.3 Figure 6.3. The effect of lentiviral transfection of GFP as a control for transfection efficiency. A) The 
percentage of positive cells in the GFP transfected condition increased from 92% at day 7 to 99% at 
day 21. No GFP positive cells were present in the untransfected control condition. N = 2. B) Cells with 
or without GFP lentivirus in alginate analysed with a fluorescence microscope. No green fluorescent 
cells were present in the control condition after 21 weeks of culture, green cells were visible in the GFP 
lentivirus condition.
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COMP protein deposition in response to overexpression
As quantified by ELISA, COMP protein deposition was increased 1.5-fold after lentiviral 
transfection at day 21. COMP excretion into the culture medium was also increased 
(Figure 6.5A). To investigate whether COMP produced in these experiments had a 
pentameric structure, a non-reducing Western blot was performed. COMP protein of 
approximately 550 kDa was detectable in alginate beads of the control condition and 
the lentivirally transfected condition, with an increase in quantity after lentiviral trans-
fection. In addition, smaller fragments were present in the alginate beads of the COMP 
lentivirus condition. In the culture medium, more COMP protein was present than in the 
alginate beads. A small increase of COMP excretion into the medium is seen with COMP 
overexpression. This is however not as clear as detected with the ELISA (Figure 6.5B).
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Figure 6.4 Figure 6.4. COMP gene expression in bovine chondrocytes, transfected with or without lentivirus con-
taining the human COMP gene or an empty virus. A) Relative human COMP gene expression corrected 
for GAPDH after lentiviral transduction of bovine chondrocytes. No human COMP gene expression was 
detected in the bovine chondrocytes in the control conditions. B) Relative endogenous bovine COMP 
gene expression after transduction with human COMP. N = 6.
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Matrix deposition and functionality in response to COMP 
overexpression
The amount and distribution of collagen deposited was not influenced after COMP 
transfection (Figure 6.6A and B). The number of HP cross-links per collagen triple helix 
was 0.57 ± 0.02 in the control condition and not significantly changed after COMP 
transfection (Figure 6.6C). The proteoglycan production (Figure 6.6D) and distribution 
(Figure 6.6E) were also not influenced by COMP overexpression. The ability to hold 
water (defined by the secant modulus) and the stiffness of the matrix (defined by the 
equilibrium modulus) were also not significantly different in the control and COMP 
transfected condition (Figure 6.6F and G).
Collagen fibril diameter in response to increased COMP 
production
To further investigate the effect of increasing COMP production on the newly formed 
matrix we measured collagen fibril diameter on an electron microscopic level. The matrix 
of chondrocytes cultured in the presence of TGFβ2 appears more organized than the 
matrix produced in the corresponding control condition (Figure 6.7A) since collagen 
fibrils are aligned more parallel to the chondrocyte surface in the presence of TGFβ2. In 
addition, collagen fibril diameter decreased when TGFβ2 was present (Figure 6.7B). The 
induction of COMP production by chondrocytes using a lentivirus also resulted in a less 
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Figure 6.5. The effect of lentiviral COMP overexpression on COMP production. After transfection 
with or without lentivirus containing the human COMP gene, alginate beads (grey bars) and the culture 
medium (white bars) were analysed after 21 days of culture for the presence of COMP with ELISA (A). 
Alginate beads and culture medium were also analysed with a non-reducing Western blot at day 21 (B).
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organized matrix compared to the corresponding control condition (Figure 6.7C). This 
effect however was less obvious than the effect of TGFβ2 because of EM processing 
artefacts (indicated by arrowheads). Again, overexpressing COMP resulted in smaller 
diameters of the collagen fibrils (Figure 6.7D).
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Figure 6.6 Figure 6.6. Collagen biochemistry and matrix functionality in lentiviral transfected chondrocytes. A) 
Collagen deposition, B) collagen distribution between cell associated matrix (CM, grey) and further 
removed matrix (FRM, white), C) collagen crosslinking, D) Proteoglycan deposition, and E) Proteoglycan 
distribution between cell associated matrix (CM, grey) and further removed matrix (FRM, white) (all 
N=9), F) Secant modulus and G) equilibrium modulus of newly formed matrix after 35 days of culture, 
N=12.
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Discussion
COMP interacts with several other cartilage matrix molecules and is involved in matrix-
chondrocyte interaction 247. It is also up-regulated during the progression of OA 67 and 
therefore used as a marker for OA 248-251. This study shows that COMP gene expression 
and protein deposition by chondrocytes in alginate beads were upregulated in the 
presence of TGFβ2. We previously examined collagen and glycosaminoglycan deposi-
tion as well as mechanical properties of these samples 211. There we found that TGFβ2 
slightly influenced collagen deposition by bovine chondrocytes in alginate and severely 
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Figure 6.7. Representative examples of electron microscopic analysis of alginate beads cultured for 
three weeks in the presence of TGFβ2, after COMP lentiviral transfection, and their corresponding 
control conditions. A) Newly formed matrix in the presence of TGFβ2 and its control condition without 
growth factors. Arrows point out collagen fibrils parallel to the cell surface. Arrows point out organised 
collagen fibrils. Used magnifications are 18000 times (upper row) with the bar 2 µm and 89000 times 
(lower row) with the bar indicating 200 nm. B) Diameter of collagen fibrils with or without TGFβ showed 
as diameter of individual fibrils with the average diameter ± SD. C) Newly formed matrix after lentiviral 
transfection and its control without virus. Arrows point out organised collagen fibrils, arrowheads point 
out processing artefacts. Used magnifications are 18000 times (upper row) with the bar indicating 2 
µm and 89000 times (lower row) with the bar indicating 200 nm. D) Diameter of collagen fibrils with 
or without lentiviral overexpression of COMP showed as diameter of individual fibrils with the average 
diameter ± SD. * indicates significant difference, p<0.05, ** indicates significant difference, p<0.001.
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reduced the number of collagen cross-links without affecting functionality of the newly 
formed matrix. Because of the pleiotropic effects of TGFβ, it is not possible to determine 
whether the increase of COMP deposition in this condition leads to a better integrity 
of the newly formed matrix and whether COMP is involved in cartilage development as 
seen previously 244. With lentiviral overexpression we increased COMP gene expression 
and protein production. This appeared to have no effect on absolute matrix deposition 
and functional properties. However, increasing COMP production resulted in a more 
organized collagen matrix and collagen fibrils with a smaller diameter, independent of 
the approach used to induce COMP production (i.e. lentiviral overexpression of COMP 
or addition of TGFβ to the culture medium).
COMP interacts with collagen type 2 (COL2) 54 and COMP could function as a cata-
lyst in collagen fibrillogenesis. When COMP and collagen are co-incubated, most of the 
COMP is not associated with the newly formed collagen fibrils even though the absence 
of COMP slows the process of fibrillogenesis 57. Co-expression of transgenic mutant 
COMP and endogenous COL2 leads to a disruption of the fibrillar collagen network. In 
addition, more mutant COMP is localized on the formed COL2 aggregates then when 
wild type COMP is overexpressed 242. This might be explained by the fact that mutant 
COMP cannot act as catalyst in fibrillogenesis and remains on the collagen aggregates 
(personal communication with dr. F. Zaucke). The catalyst function of COMP might 
explain why COMP overexpression only resulted in a mild elevation of COMP in the 
alginate bead, but did result in more COMP in the culture medium as determined with 
ELISA. Possibly, the extra COMP is not necessary and therefore directly excreted into the 
culture medium. Future experiments might include induction of collagen deposition as 
shown previously 211, 230 in combination with COMP overexpression to examine COMP 
and collagen interaction more closely.
Interestingly, inducing COMP production by both TGFβ stimulation and lentiviral 
transduction resulted in more organized collagen matrix and a decrease of collagen fibril 
diameter. To our knowledge, two other studies describe the relation between COMP 
amount and collagen fibril diameter. In equine tendons, a positive correlation between 
high COMP levels and the percentage of small collagen fibrils was present 252, which 
corresponds to our findings. Halázs et al concluded more recently that COMP is involved 
in collagen fibrillogenesis affecting intermediate forms of collagen fibrils and increasing 
rate of fibril formation. Without the presence of COMP, collagen fibrils with a larger 
diameter were found 57. Next to altered fibril diameter, the latter study also reports 
about altered collagen organization when COMP is absent. In our study, we also found 
an effect of COMP on collagen fibril organization.
The diameter of the collagen fibrils plays a significant role in determining the 
mechanical properties of the tissue. Deformation of tissues is related to the propor-
tion of small diameter fibrils and as the diameter increases the flexibility of the tissue 
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decreases 253, 254. We did not observe altered mechanical properties when COMP pro-
duction was stimulated, despite the small diameter of the collagen fibrils. Immaturity of 
the newly formed matrix might explain this. This was also seen for collagen cross-links 
that became important when the matrix was more mature 230. This suggests that a more 
mature cartilage matrix where high levels of COMP had been present during formation 
can be of less quality because of the small diameter collagen fibrils.
Small bands in the non-reducing Western blot indicate the presence of the mono-
meric form of COMP and more COMP subunits are present after lentiviral transfection. 
This could indicate increased degradation in the overexpression condition after excre-
tion into the culture medium. A minor discrepancy present between the ELISA and 
the Western blot in case of the overexpression experiments can be explained by the 
difference in used antibody and the recognized epitope 255. The ELISA is based on a 
sandwich principle where one monoclonal and one polyclonal antibody capture COMP. 
For Western blotting, a different monoclonal antibody was used 246.
Regulation of COMP gene expression and protein production by chondrocytes with 
growth factors has been shown before256. In that study, TGFβ addition also resulted in 
increased synthesis of COMP and therefore confirms our results. However, monolayer 
cultures of chondrocytes were used and expression was analyzed after a short-term cul-
ture. In our study, chondrocytes were cultured in a 3D environment in order to maintain 
their phenotype resulting in proper matrix production. COMP distribution over the matrix 
is not affected by any of the growth factor conditions, in contrast to collagen and proteo-
glycan distribution. This suggests that COMP localization is not dependent on collagen 
or proteoglycans. Overexpression of COMP did not influence collagen or proteoglycan 
production and distribution. This confirms earlier results for COMP and collagen 244.
Taken together, COMP production and deposition is increased by TGFβ and lentiviral 
overexpression both leading to smaller diameters of collagen fibrils and changed organi-
zation of collagen. From the overexpression experiments we conclude that induction of 
COMP production has no effect on other biochemical parameters. Increased production 
of COMP is one of the features of OA 67, 244, next to increased synthesis of other cartilage 
matrix molecules 96, 142 although repair is ineffective. Increased COMP production in OA 
could lead to decreased stiffness of the cartilage via decreasing collagen fibril diameter 
therefore negatively affecting the quality of the matrix. Modulation COMP levels could 
therefore contribute to successful cartilage regeneration strategies.
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Abstract
Objective
Defects in assembly and composition of the cartilage extracellular matrix are likely to 
result in impaired matrix integrity and increased susceptibility for cartilage degeneration. 
This study was undertaken to determine the functional interaction of the collagen fibril 
associated proteins collagen IX and cartilage oligomeric matrix protein (COMP) during 
cartilage matrix formation.
Methods
Primary chondrocytes from collagen IX and COMP double deficient mice were cultured 
in monolayer or alginate beads. Anchorage of matrix proteins, proteoglycan and col-
lagen content, collagen cross-links, matrix metalloproteinase activity, and mechanical 
properties of the matrix were measured. Electron microscopy was employed to study 
the formation of fibrillar structures.
Results
In cartilage lacking both collagen IX and COMP, matrilin-3 showed an increased solubility. 
Less matrilin-3 was deposited in the matrix of double deficient chondrocytes, while larger 
amounts were secreted into the medium. Also proteoglycans were less well retained in 
the matrix formed in alginate cultures, while collagen deposition was not significantly 
affected. Electron microscopy revealed similar cartilage collagen fibril diameters in cul-
tures of double deficient and wildtype chondrocytes. In contrast, a larger fibril diameter 
was observed in the matrix of chondrocytes deficient in only collagen IX.
Discussion
Our results show that collagen IX and COMP are involved in matrix assembly by medi-
ating anchorage and regulating distribution of other matrix macromolecules such as 
proteoglycans and matrilins and have counteracting effects on collagen fibril diameter. 
Loss of collagen IX and COMP leads to matrix aberrations that may make cartilage more 
susceptible for degeneration.
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Introduction
The cartilage extracellular matrix (ECM) is a complex alloy of proteins and proteogly-
cans, the composition of which defines tissue structure and physiological functions 257. 
Changes in matrix composition are likely to result in impairment of matrix integrity and 
lead to an increased susceptibility for cartilage degeneration. Human genetics studies 
have indeed shown that mutations in matrix proteins can predispose for disease like 
chondrodysplasia and/or osteoarthritis 258, 259. The role of many of the matrix proteins is 
still uncertain and it is often not known how deficiencies in specific proteins predispose 
for cartilage degeneration.
Cartilage collagen fibrils provide stiffness to the cartilage matrix. Proteoglycans, mainly 
aggrecan, account for the osmotic pressure and are therefore important to maintain the 
high water content of cartilage 79. Collagen IX, in combination with collagen II and XI, 
is a key component in the cartilage collagen fibril 223 and is thought to limit its lateral 
growth by binding to the fibril surface 63, 224. Collagen IX can also act as a molecular 
bridge between fibrillar collagens and other extracellular matrix components, such as 
matrilin-3 63 and cartilage oligomeric matrix protein (COMP, thrombospondin-5) 55, 260. 
COMP in turn interacts with matrilins and aggrecan as well as with collagen I and II and 
is known to influence collagen I and II fibrillogenesis 57.
A number of knockout mouse models have been generated to gain further insight 
into the role of single ECM proteins, including collagen IX and COMP, in cartilage matrix 
assembly and function. COMP deficient mice lack an obvious phenotype 237, maybe 
due to a functional compensation by other matrix proteins. Mice homozygous for the 
inactivated col9a1 allele display degenerative changes in articular cartilage, first detected 
at the age of 6 months 224, 261. These mice have cartilage collagen fibrils with a larger 
diameter 63. They also show alterations in the expression of matrix metalloproteases 
and in mechanical properties, similar to what is seen during development of human 
osteoarthritis 207. The loss of proteoglycans and adapter proteins (e.g. matrilin-3), which 
mediate interactions between collagen fibrils and their environment, has been suggested 
to be the molecular basis for the altered biomechanical properties 63, 207, 262.
Thus, mice lacking collagen IX have an increased collagen fibril diameter and show a 
loss of matrilin-3 anchorage 63, whereas COMP deficient mice exhibit no similar defects 
in matrix assembly or fibril diameter 237. It has been unclear whether the loss of both 
collagen IX and COMP enhances the matrix assembly phenotype observed in collagen 
IX deficient animals and whether collagen IX and COMP play compensatory or antago-
nistic roles during matrix assembly. Recently, we and others have established mouse 
lines deficient in collagen IX and COMP or in collagen IX and multiple thrombospondins 
(TSPs) 263, 264. In these mice, a disorganized growth plate architecture and alterations 
in matrix deposition were observed both in newborn animals and at later stages of 
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development 263. Loss of other TSPs in addition to COMP, results in an even more pro-
nounced phenotype. When subjected to running exercise, flattening of the articular 
surface and an increased susceptibility for osteoarthritis was reported for both single 
and double deficient mice. However, only in mice lacking both collagen IX and COMP, 
fibrillation of the surface was seen 264.
To date, the molecular events leading to these phenotypes are not well understood. 
In this study, we set out to analyze the contribution of collagen fibril associated proteins 
to matrix assembly by using our previously described mouse model lacking both col-
lagen IX and COMP, and culturing primary chondrocytes derived from these mice in 
both monolayer and in an alginate-based three-dimensional culture system. Analyses 
of proteoglycan and collagen expression as well as matrix deposition, together with 
the study of the fibrillar structures formed, provided further insight into the functional 
interaction of collagen IX and COMP.
Material and Methods
Animals
Collagen IX deficient mice 261 were kindly provided by the group of Peter Bruckner, 
Münster, and were bred onto a C57/BL6 background for at least five generations. To 
generate mice deficient in both collagen IX and COMP 263, collagen IX deficient mice 
were intercrossed with mice lacking COMP (237; kindly provided by Åke Oldberg, Lund) 
on a C57/BL6 background. C57/BL6 mice were used as wildtype controls.
Antibodies
For immunohistological stainings the following primary antibodies were used: a mono-
clonal mouse antibody directed against human collagen II (1:1000; Calbiochem), an 
affinity-purified polyclonal rabbit antibody against the NC4 domain of mouse collagen 
IX (1:2000, 63, a polyclonal rabbit antibody against bovine COMP (1:1000, 265) and an 
affinity-purified polyclonal rabbit antibody against mouse matrilin-3 (1:1000, 266). As 
secondary antibodies, Alexa Fluor 488 conjugated goat anti rabbit IgG and Cy3 con-
jugated goat anti mouse IgG immunoglobulins (both obtained from Molecular Probes) 
were applied.
Histology and immunohistochemistry
For histochemical and immunohistochemical stainings, 4% paraformaldehyde fixed, 
paraffin embedded tissue sections (5 µm) were dewaxed in xylol and rehydrated in 
isopropanol, 96%, 70% and 50% ethanol and water. To analyze the general tissue 
morphology and proteoglycan deposition, a combined haematoxylin/eosin/ alcian 
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blue staining (0.015% in 80% ethanol and 20% glacial acetic acid, 20 minutes.) was 
performed. For immunohistological stainings on sections, these were digested with tes-
ticular hyaluronidase (10 mg/ml) for 30 minutes at 37ºC, followed by a permeabilisation 
with 0.1% Triton X-100 and blocking in 10% fetal calf serum. Cultured monolayer cells 
were fixed with 4% paraformaldehyde at room temperature for 10 minutes, permeabi-
lised with 0.1% Triton X-100 and blocked with 2% normal goat serum. Both sections 
and cells were incubated with primary antibodies overnight at 4ºC and with secondary 
antibodies for 1 hour at room temperature.
Sequential protein extraction from rib cage cartilage
Rib cages of less than one week old double deficient and wildtype animals were iso-
lated, freed from surrounding noncartilaginous tissue, and frozen at -80°C. Proteins 
were extracted as described previously 267.
Western blotting
For immunoblot detection of matrilin-3, samples were electrophoresed on 8% SDS-
polyacrylamide gels, electrotransferred onto nitrocellulose membranes, blocked with 
5% skim milk, and incubated overnight at 4°C with an affinity-purified polyclonal rabbit 
antibody directed against matrilin-3 (1:1.000) 266. After washing, the membrane was 
incubated with horseradish peroxidase-conjugated donkey anti-rabbit IgG (1:2.000, 
Amersham Biosciences) for 1 hour at room temperature. Antibody detection was per-
formed using 2.5 mM luminol, 0.4 mM p-coumaric acid, 0.01% H2O2 as a luminescent 
agent (Fluka) and exposure on X-ray films.
Isolation and culture of primary chondrocytes
Primary chondrocytes were isolated from rib cages and cultured in monolayer as 
described previously 268. For alginate culture, isolated chondrocytes were resuspended 
in 1.2% (w/v) low viscosity alginate (Keltone) in 0.9% NaCl (Sigma) at a concentration 
of 4 × 106 cells/ml. The cell-alginate suspension was passed through a 22-gauge needle 
into 105 mM CaCl2. Beads were washed with 0.9% NaCl and DMEM/F12 (GibcoBRL) 
and inspected visually. Beads that were unusually small or large were excluded from the 
experiment. After transfer to a 6-well plate beads were cultured in 75 µl/bead DMEM/
F12 supplemented with 10% fetal bovine serum (GibcoBRL), 50 µg/ml L-ascorbic acid 
2-phosphate (Sigma), 50 µg/ml gentamicin and 1.5 µg/ml fungizone (both GibcoBRL). 
Medium was changed three times per week and at the end of the experiment the 
medium of the final change was analyzed. Alginate beads were harvested and analyzed 
after three weeks of culture.
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Isolation of cell associated and further removed matrix
Alginate beads were dissolved by adding 75 µl per bead of 55 mM sodium citrate, 20 
mM EDTA in 150 mM NaCl for 20 minutes at room temperature. The suspension was 
centrifuged for 10 minutes at 1000 rpm (Eppendorf) to separate the cells surrounded by 
its cell associated matrix (CM, the pellet) from components originating predominantly 
from the ‘interterritorial’ or further removed matrix (FRM; the supernatant) as described 
previously 163, 187, 194.
Biochemical assays
Alginate beads or samples of separated CM and FRM were digested overnight at 56°C 
with papain (200 µg/ml papain in 50 mM EDTA, pH 5.3, and 5 mM L-cystein). Gly-
cosaminoglycans were quantified using the dimethylmethylene blue (DMB) assay 160. 
The metachromatic reaction with DMB was monitored with a spectrophotometer and 
the ratio A540:A595 used to determine the glycosaminoglycan amount with chondroitin 
sulfate C (Sigma) as standard. The amount of DNA in each papain-digested sample 
was determined using ethidium bromide with calf thymus DNA (Sigma) as standard. 
For high-performance liquid chromatography of amino acids (hydroxyproline) and col-
lagen cross-links (hydroxylysylpyridinoline and lysylpyridinoline), the papain digest was 
hydrolyzed (108°C, 18-20 hours) in 6 M HCl. The hydrolyzed samples were dried and 
redissolved in 200 µl water containing 2.4 mM homoarginine as an internal standard 
(Sigma). Samples were diluted 25-fold with 50% (v/v) acetic acid for cross-link analysis 
and diluted 250-fold with 0.1 M sodium borate buffer, pH 8.0, for amino acid analysis. 
To determine hydroxyproline, amino acids were labeled with 9-fluorenylmethyl chlo-
roformate. Reversed-phase high-performance liquid chromatography of amino acids 
and cross-links were performed as described previously 162, 163. The quantities of cross-
links were expressed as the number of residues per collagen molecule, assuming 300 
hydroxyproline residues per triple helix.
To determine total MMP activity, culture medium was analyzed as described ear-
lier 165, using 5 µM fluorogenic substrate TNO211-F (Dabcyl-Gaba-Pro-Gln-Gly-Leu-
Cys[Fluorescein]-Ala-Lys-NH2) in the presence or absence of 12.5 µM BB94 (a general 
MMP inhibitor). Medium samples were diluted with one volume of MMP buffer (50 mM 
Tris, pH 7.5, 5 mM CaCl2, 150 mM NaCl, 1 µM ZnCl2, 0.01% Brij-35, 0.02% NaN3) 
containing a proteinase inhibitor cocktail (Complete, Roche). The MMP activity in each 
sample was calculated as the difference in the initial rate of substrate conversion (linear 
increase in fluorescence in time, expressed as relative fluorescence units per second) 
between samples with and without BB94 addition. Fluorescence was measured for 6 
hours at 30°C using a Cytofluor 4000 (Applied Biosystems).
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Mechanical testing
For mechanical characterization, 4 × 106 cells/ml in 1.2% (w/v) alginate disks, 3 mm thick 
and 6 mm in diameter, were used. The disks were prepared as previously described 166, 211. 
To ensure that enough matrix is produced and to test its functionality, beads were mounted 
after 35 days of culture on a materials testing machine (DMA Q800 Dynamic Mechanical 
Analyzer, TA Instruments) in a radially unconfined stress relaxation test with the beads 
between impermeable platens, and hydrated in 0.9% saline containing protease inhibitors 
(Complete, Sigma). A 20% uniaxial compressive strain was applied within 10 seconds at 
a ramped displacement strain rate of 2% s-1, based on the measured thickness. The strain 
was maintained constant for 30 minutes, the load was recorded at a sampling rate of 10 
Hz using a 18 N load cell. The applied load recorded by the load cell was divided by the 
cross-sectional area of the construct to calculate the applied stress. The secant modulus 
was calculated as stress/strain at 10 seconds, where the stress had its peak response 
and the strain reached its maximum. At the end of the test, the equilibrium aggregate 
modulus was determined as stress/strain at 30 minutes. The secant modulus is related to 
the interaction between the solid and the liquid phase and is therefore an indication for 
the ability to retain water. The modulus measured at equilibrium depends strongly on the 
compressive stiffness of the (cartilaginous) solid matrix 83.
Electron microscopy
Beads were rinsed three times in PBS and fixed for 2 hours at room temperature in 
0.1 M sodium cacodylate-buffered 1.5% glutaraldehyde (EM grade, Sigma) and 1% 
paraformaldehyde, pH 6.7, then rinsed three times in 0.15 M sodium cacodylate. After 
post-fixation for 2 hours in 0.1 M sodium cacodylate-buffered 1% osmium tetroxide, 
pH 6.7, the beads were dehydrated in a series of graded acetone and embedded in LX 
112 (Epon). Ultrathin sections (LKB ultratome IV), were mounted on copper grids (300 
mesh), contrasted with 2% uranyl acetate (10 minutes at 45ºC) and lead citrate and 
examined with a Zeiss 902 electron microscope. Pictures were taken at 2800 times, 
18000 times, and 89000 times magnification. Four pictures per sample (89000 times 
magnification) were used to measure collagen fibril thickness with ImageJ 1.40g (NIH).
Data analysis
Each alginate culture experiment was repeated two times, each time using at least four 
pooled cartilage donors. Each experiment consisted of three times seven beads per experi-
mental condition for biochemical analyses, three beads for electron microscopic analysis, 
and six disks for mechanical testing. Statistical analysis was performed using GraphPad 
Prism 5.01 (GraphPad Software) software. All data are presented as mean ± standard 
deviation. Samples from the wildtype and double deficient groups were compared with 
a Kruskall-Wallis test followed by post hoc Dunn's multiple comparison tests.
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Results
Deposition of matrix constituents
Immunofluorescence microscopy on rib and sternum sections revealed the deposition 
of collagen IX and COMP in wildtype rib cartilage, while the lack of staining in double 
deficient animals confirmed the absence of both proteins (Figure 7.1A-D). Antibodies 
directed against collagen II stained all cartilaginous areas in both control and knockout 
animals, suggesting that collagen II deposition is not substantially influenced by the 
absence of collagen IX and COMP (Figure 7.1E-F). In contrast, matrilin-3 staining was 
lost in most cartilaginous areas when collagen IX and COMP were missing. Matrilin-3 
was detected neither in ribs nor in the sternal growth plate, whereas small amounts of 
the protein were present in the zone between adjacent sternal growth plates, where it is 
normally not detected, and in calcified cartilage (Figure 7.1H). Control animals showed a 
strong matrilin-3 staining in most cartilage elements (Figure 7.1G). Staining with alcian 
blue, a dye that binds to negatively charged glycosaminoglycans and thus to the major 
cartilage proteoglycan aggrecan, was not altered between genotypes and revealed no 
obvious malformations (Figure 7.1I-J).
Extraction of matrilin-3 and proteoglycans
The amount and solubility of matrilin-3 was examined by sequentially extracting car-
tilage. In wildtype tissue, matrilin-3 was extracted only with buffers containing EDTA 
(buffer II) or the chaotropic agent GuHCl (buffer III), whereas in double deficient animals 
some protein could be extracted with TBS alone (buffer I). In addition to the increased 
solubility, the total amount of matrilin-3 that could be extracted was reduced when 
both collagen IX and COMP were ablated (Figure 7.2A). This, together with the results 
from immunohistochemistry (Figure 7.1H), points to a decrease in the pool of matrilin-3 
anchored in the matrix.
We also analyzed cartilage proteoglycans by the same extraction approach. Neither 
the solubility nor the total amount of extracted proteoglycans differed significantly 
between genotypes (Figure 7.2B).
Matrix deposition in short-term chondrocyte monolayer 
cultures
Chondrocytes were isolated from newborn wildtype and double deficient mice and 
cultured in monolayer for five days. In cultures of wildtype cells, large quantities of both 
collagen IX and COMP were integrated into an extracellular matrix, forming networks 
surrounding the chondrocytes (Figure 7.3A,C). A similar staining pattern was obtained 
for collagen II, revealing a deposition throughout the chondrocyte pericellular matrix 
regardless of the genotype (Figure 7.3E-F). Interestingly, matrilin-3 was completely 
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Figure 7.1 
 Figure 7.1. Immunofluorescence microscopy of rib cage cartilage. Sections through the rib cage of 
wildtype (wt) and collagen IX/COMP double deficient (dko) mice were incubated with antibodies directed 
against collagen IX (A-B), COMP (C-D), collagen II (E-F), and matrilin-3 (G-H). Sections were also stained 
with hematoxylin/eosin and alcian blue (I-J). The bar represents 100 µm.
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lost from extracellular fibrillar structures, when these lacked collagen IX and COMP. 
However, matrilin-3 was still secreted and, in these cultures, unspecifically coated the 
surface of the culture dish.
We determined the amount of proteoglycans deposited in the extracellular matrix 
after up to seven days. Alcian Blue binding assays revealed no significant difference 
between double deficient and control chondrocytes at these early time points in mono-
layer cultures (results not shown).
 
Figure 7.2 
Figure 7.2. Solubility of matrilin-3 and proteoglycans from rib cartilage. Matrilin-3 and proteoglycans 
were sequentially extracted in TBS alone (buffer I), and TBS containing 10mM EDTA (buffer II) or 4 M 
GuHCl (buffer III). (A) Immunoblots were used to detect matrilin-3 and Ponceau staining as a loading 
control. (B) Glycosaminoglycan concentrations were determined in extracts obtained with the different 
buffers from 1 mg tissue wet weight .wt, wildtype; dko, collagen IX/COMP double deficient.
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Figure 7.3 
 
Figure 7.3. Immunofluorescence microscopy of monolayer cultures of chondrocytes. Primary chondro-
cytes isolated from rib cartilage of wildtype (wt) and double deficient (dko) animals were cultured and 
stained with antibodies directed against collagen IX (A-B), COMP (C-D), collagen II (E-F) and matrilin-3 
(G-H). The bar represents 20 µm.
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Protein and proteoglycan deposition in the extracellular 
matrix of long-term chondrocyte cultures in alginate
To analyze the involvement of collagen IX and COMP in longer term matrix assembly and 
maintenance and to allow the quantitative analysis of different matrix compartments, 
isolated chondrocytes were cultured in alginate beads. Also under these conditions the 
chondrocytes synthesized collagen II and not collagen I during the three-week period 
studied (results not shown).
Western blot analyses of CM and FRM from both wildtype and double deficient 
chondrocyte cultures showed less matrilin-3 deposition in the matrix of deficient cells 
(Figure 7.4A). Instead, more matrilin-3 was detected in the culture medium of these cells 
than in that from wildtype controls.
 
Figure 7.4 Figure 7.4. Amount and compartmental distribution of (A) matrilin-3 and (B) proteoglycans after three 
weeks of chondrocyte culture in alginate beads. (A) Immunoblot analysis of cell associated matrix (CM), 
further removed matrix (FRM) and culture medium using antibodies directed against matrilin-3. Ponceau 
staining was used as a loading control. (B) Glycosaminoglycan distribution between the CM (open bars), 
the FRM (grey bars) and (C) the culture medium. n = 6, * indicates significant difference in absolute 
values (p<0.05). wt, wildtype; dko, collagen IX/COMP double deficient.
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Wildtype chondrocytes produced large amounts of proteoglycans over the three-
week period, resulting in proteoglycan deposition in the alginate bead of 10.2 ± 2.1 
µg/bead. In cultures of double deficient chondrocytes, significantly less proteoglycans 
(6.8 ± 2.1 µg/bead) were deposited. However, the relative distribution between CM 
and FRM was not significantly different when compared to wildtype cultures (Figure 
7.4B). We also analyzed the culture medium harvested during the experiment. More 
proteoglycans were released into the culture medium of deficient chondrocytes (3.0 ± 
0.2 µg/bead, 30% of the total proteoglycan production) in comparison to wildtype cells 
(1.5 ± 0.1 µg/bead, 13% of the total proteoglycan production), indicating less retention 
of proteoglycans in a collagen IX/ COMP deficient matrix (Figure 7.4C).
 
Figure 7.5 
 
Figure 7.5. Distribution of collagen, collagen cross-links and MMP activity after three weeks of chon-
drocyte culture in alginate beads. (A). Collagen distribution between the cell associated matrix (CM, 
open bars), the further removed matrix (FRM, grey bars) and (B) the culture medium. n = 6, # indicates 
significant difference in distribution, * indicates significant difference in absolute values (p<0.05). (C) 
Hydroxylysylpyridinoline (HP) crosslinks in newly formed collagen (n = 4). * indicates p<0.01, data are 
presented as mean ± SD. (D) Overall MMP acitivity was measured in the culture medium after 21 days 
of culture using a fluorescent substrate. Data are presented as mean relative fluorescent units (RFU) per 
second ± SD (n = 4). wt, wildtype; dko, collagen IX/COMP double deficient.
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The total collagen deposition was not significantly different in beads containing 
wildtype and double deficient chondrocytes (6.3 ± 1.9 µg/bead for wildtype and 5.6 ± 
2.1 µg/bead for double deficient cells). Interestingly, the relative distribution within the 
alginate bead was altered, with 23% of the total collagen being deposited in the FRM of 
chondrocytes isolated from double deficient animals and 12% in the FRM of wild type 
chondrocytes (Figure 7.5A). Less collagen was found in the culture medium collected 
during the experiment with double deficient chondrocytes (4.0 ± 0.3 µg/bead) than in 
the medium of the wildtype cells (5.26 ± 0.7 µg/bead) (Figure 7.5B). This difference in 
absolute release did not result in a significant relative difference when compared to the 
total collagen production. Collagen was less cross-linked when collagen IX and COMP 
were absent, as determined by measuring the number of hydroxypyridinoline cross-links 
per collagen triple helix (Figure 7.5C).
A decreased amount of collagen in the medium can result from less synthesis or less 
degradation. MMPs are major matrix degrading enzymes that influence matrix quality 
and quantity. We determined the overall MMP activity in the culture media, but found 
comparable activity irrespective of the genotype (Figure 7.5D).
Mechanical properties
The secant modulus and the equilibrium aggregate modulus were examined to test 
whether changes in the amount and distribution of produced extracellular matrix com-
ponents affect mechanical properties of the alginate beads containing chondrocytes. The 
peak force and eventually the ability to retain water, described by the secant modulus, 
were not altered in three-week cultures of chondrocytes lacking collagen IX and COMP 
when compared to wildtype (5070 ± 1623 Pa for wildtype, 4588 ± 890 Pa for double 
deficient cultures). Also the stiffness, indicated by the equilibrium aggregate modulus, 
did not differ significantly between genotypes (767 ± 232 Pa for wildtype, 970 ± 283 
Pa for double deficient cultures).
Collagen fibril assembly
After three weeks of culture, complete alginate beads were processed for electron 
microscopy. The matrix deposited by wildtype and collagen IX/COMP double deficient 
chondrocytes appeared similar with some collagen fibrils positioned parallel to the cell 
surface and the fibrils being relatively closely spaced (Figure 7.6A-I). In cultures of col-
lagen IX/COMP double deficient chondrocytes the fibril diameter was comparable to 
that found in cultures of wildtype cells (Figure 7.6J).
The result that neither appearance nor diameter of fibrils produced by double deficient 
cells differed compared to wildtype cultures was surprising, as we previously detected an 
increased collagen fibril diameter in cartilage from collagen IX single knockout mice 63. 
We therefore analyzed the matrix produced by chondrocytes lacking expression of only 
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Figure 7.6 
Figure 7.6. Electron microscopy of chondrocytes and collagen fibrils in alginate beads cultured for 
three weeks. Alginate beads containing wildtype (A, D, G), collagen IX/COMP double-knockout (B, E, 
H), or collagen IX single knockout chondrocytes (C, F, I) were submitted to electron microscopy and 
micrographs taken of different magnifications (A-C, bar = 10µm; D-F, bar = 2µm; G-I, bar = 200nm). 
The rectangles in the low-magnification electron micrographs indicate the areas analysed in higher 
magnifications. (J) The diameter of individual collagen fibrils formed by wildtype, collagen IX/COMP 
double deficient or collagen IX deficient chondrocytes, represented as mean ± SD.
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collagen IX in alginate beads under identical conditions. In agreement with earlier stud-
ies on intact cartilage, electron microscopy of such cultures showed a less organized 
matrix and a significantly larger fibril diameter than in either wildtype or collagen IX/
COMP double deficient cultures.
Discussion
Even though the exact functions of collagen fibril-associated proteins, such as collagen 
IX COMP and matrilins, are far from clear, as a group these proteins are thought to 
be critically important for skeletal development and presumably for the development 
of musculoskeletal diseases. Mice lacking collagen IX have an increased collagen fibril 
diameter and a loss of matrilin-3 anchorage 268, whereas COMP deficient mice have no 
similar defects in matrix assembly or fibril diameter 269. Until now it has been unclear 
whether the loss of both collagen IX and COMP enhances the matrix assembly phe-
notype observed in collagen IX deficient animals and if collagen IX and COMP play 
compensatory or antagonistic roles during matrix assembly.
First, we addressed the anchorage of matrix proteins in vivo. Immunofluorescence 
staining confirmed the absence of collagen IX and COMP in double deficient cartilage. 
Collagen II deposition was not visibly altered in the rib cage of double deficient mice. 
In contrast, matrilin-3 was lost from most cartilaginous tissues of double deficient ani-
mals, similar to what was previously reported for mice deficient in only collagen IX 268. 
Retention of matrilin-3 was found in the zone between adjacent sternal growth plates 
as well as in calcified cartilage, indicating the presence of new interaction partners 
within these regions of collagen IX/COMP deficient tissue. In agreement with the lost 
matrilin-3 staining, the protein was more easily extracted from the tissue. Differences in 
the deposition of aggrecan were not detected by glycosaminoglycan analysis of mouse 
cartilage extracts and histological sections through the rib cage of wildtype and double 
deficient animals revealed no obvious malformations. This is different from the tibial 
growth plate cartilage, where hypocellular areas and impaired chondrocyte alignment 
was observed 263. Apparently, different types of cartilage have different requirements 
for collagen fibril-associated proteins.
To analyze matrix assembly and protein deposition in greater detail, we employed 
both short- and long-term cell culture systems. In short-term chondrocyte cultures, 
matrilin-3 deposition was clearly influenced by the loss of collagen IX and COMP. In 
earlier studies employing collagen IX deficient cells, matrilin-3 was secreted into the 
medium instead of being incorporated into the matrix 268. However, if also COMP is 
ablated, amorphous matrilin-3 aggregates bind to the surface of the culture dish. A 
strong interaction between matrilin-3 and COMP has been described 270. While matrilins 
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show poor solubility, COMP is highly hydrophilic. It is likely that complex formation 
between matrilin-3 and COMP increases matrilin-3 solubility in the cell culture super-
natant and prevents deposition on the surfaces. In tibiae of collagen IX/COMP deficient 
mice 263, matrilin-3 was amorphously deposited in the central region of the epiphyseal 
cartilage, a phenomenon that was not seen when only collagen IX was lacking. This 
indicates that COMP may act as a carrier for matrilin-3 also in vivo. An intense collagen II 
staining was detected in the matrix of both wildtype and double deficient chondrocytes, 
showing the assembly of pericellular collagen fibrils regardless of genotype. Matrilin-3 
binds with low affinity directly to collagen II in vitro 270, but apparently collagen II alone 
can not provide adequate tissue anchorage for matrilin-3 if collagen IX and COMP are 
missing. In agreement with the unchanged in vivo proteoglycan solubility, the amount 
deposited in monolayer culture did not differ between wildtype and double deficient 
cells. In monolayer cultures, the amount of matrix formed is limited and differences in 
aggrecan retention within this matrix may be difficult to detect.
We also employed a three-dimensional cell culture model. This culture system can 
be used for longer-term experiments as it ensures phenotypic stability of chondro-
cytes 271-273. Again, matrilin-3 was less well anchored in the matrix produced by double 
deficient cells and was instead released into the supernatant. Similarly, less proteoglycans 
were present within the matrix. As COMP can bind to aggrecan 56, the main aggregate-
forming proteoglycan in cartilage, the loss of COMP might result in decreased aggrecan 
anchorage, an effect that could be enhanced by the secondary loss of matrilin-3, as 
matrilins may link aggrecan to microfibrillar networks 274. This effect was not detected 
in vivo, probably due to the high density of collagen fibrils that limits aggrecan diffusion 
and thereby compensates for the decreased matrix anchorage. The matrix assembled in 
alginate beads appears less dense and allows the detection of differences in proteoglycan 
retention. Matrilin-3 is smaller and can diffuse out of both types of matrix if anchorage 
to collagen IX and COMP is lost. The distribution of proteoglycans between pericellular 
and interterritorial matrix was not altered between genotypes and the total amount 
of collagen, mainly collagen II 272, did not differ significantly. However, the deposition 
of collagen was shifted from the cell-associated matrix towards the further removed 
matrix. Accordingly, the ratio between aggrecan and collagen decreases, particularly in 
the interterritorial matrix. These clear differences in matrix organization did not lead to 
detectable changes in mechanical properties.
Despite the compositional differences in cartilage matrix formed in the absence of 
collagen IX and COMP, electron microscopy revealed no obvious changes in the diameter 
of the collagen fibrils formed. This was surprising as an increased fibril diameter was 
found in mice lacking only collagen IX 268. This increase was also observed in the matrix 
of collagen IX deficient chondrocytes cultured in alginate. Collagen IX is thought to limit 
lateral fibril growth by binding to the surface of the growing fibril 20. On the other hand, 
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COMP has been shown to act as a catalyst of in vitro collagen fibrillogenesis 275, sug-
gesting that COMP may also function to modulate fibril growth in vivo 276. Fibrils formed 
in the absence of COMP show a more heterogenous diameter than in its presence 275. 
Our studies show that, when both proteins are absent, fibrils of normal diameter are 
formed. These antagonistic effects of collagen IX and COMP in fibril assembly imply that 
the relative abundance of these proteins may regulate collagen fibril diameter in vivo.
Possibly, disturbances in secretion and/or function of collagen IX and COMP, as seen 
in human multiple epiphyseal dysplasia or pseudoachondroplasia, can affect collagen 
fibril assembly and through the resulting matrix reorganization promote the develop-
ment of the osteoarthritis connected with these disorders. The synthesis, degradation 
and assembly of extracellular matrix components can be influenced by growth factors 
and cytokines that are known to be produced in osteoarthritic joints such as TGFβ 
188, 277 Although collagen II has been most extensively studied in this regard, an increas-
ing body of work now points to an effect of these cytokines on COMP production and 
degradation 256, 278, 279. It is less clear how growth factors affect collagen IX expression. 
The observed changes in the deposition of matrix proteins caused by the loss of collagen 
IX and COMP point to that these in turn have regulatory influence on cartilage matrix 
assembly and may thereby influence the susceptibility for cartilage degeneration.
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Appendix Chapter 7: comparing dko 
chondrocytes with COL9 single knock-out 
chondrocytes
Next to rib chondrocytes from double knock-out mice analyzed in chapter 7, rib chon-
drocytes from collagen type 9 (COL9) deficient mice were cultured and analyzed for 
biochemical parameters. In addition, chondrocytes from knee joints of newborn wild 
type mice, COL9 knock-out mice, and DKO mice were cultured and analyzed for GAG 
deposition and distribution, collagen deposition and distribution, and collagen cross-
linking.
From these data we conclude that chondrocytes isolated from ribs and knees do not 
behave differently. Furthermore, missing both COMP and collagen type IX during matrix 
production does not seem to alter matrix production and distribution then when only 
collagen type IX is missing. The lack of collagen type IX alone even seems to have more 
effect then when both matrix molecules are missing, although this is not significant due 
to n=3.
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Figure 7.7 Figure 7.7. GAG distribution between cell-associated matrix (CM, black), further removed matrix 
(FRM, grey) and culture medium (white) in alginate cultures of wild type (wt) chondrocytes, chondrocytes 
deficient for collagen type IX (col9-/-) and chondrocytes deficient for collagen type IX and COMP (dko), 
all from mouse rib and knee origin. Distribution is shown as absolute production per alginate bead and 
as relative percentages. N=6 for wt and dko, N=3 for col9-/-. * indicates significant difference in absolute 
production and relative distribution.
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Figure 7.8 
 
Figure 7.8. Collagen distribution between cell-associated matrix (CM, black), further removed matrix 
(FRM, grey) and culture medium (white) in alginate cultures of wild type (wt) chondrocytes, chondrocytes 
deficient for collagen type IX (col9-/-) and chondrocytes deficient for collagen type IX and COMP (dko), 
all from mouse rib and knee origin. Distribution is shown as absolute production per alginate bead and 
as relative percentages. N=6 for wt and dko, N=3 for col9-/-. * indicates significant difference in absolute 
production and relative distribution.
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Figure 7.9 Collag n cross-linking in alginate cultures of wild type (wt) chondrocytes, chondrocytes 
deficient for collagen type IX (col9-/-) and chondrocytes deficient for collagen type IX and COMP (dko), 
all from mouse rib and knee origin. Cross-linking is shown as average number of HP cross-links per 
collagen triple helix ± sd. N=6 for wt and dko, N=3 for col9-/-. * indicates p<0.05.
8 Proteoglycan production is required in initial stages of new 
cartilage matrix formation but 
inhibits integrative cartilage repair
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Abstract
Objective
The optimal stimulus to repair or regenerate cartilage is not known. We therefore 
modulated collagen deposition, collagen cross-linking and GAG deposition simultane-
ously during cartilage matrix production and integrative repair, creating more insight in 
their role in cartilage repair processes.
Methods
Insuline-like Growth Factor 1 (IGF-1, increases proteoglycan and collagen synthesis), 
Beta-aminopropionitrile (BAPN, a reversible inhibitor of collagen cross-linking) and para-
nitrophenyl-beta-d-xyloside (PNPX, interferes with proteoglycan production) were used. 
Bovine articular chondrocytes were cultured in alginate beads for three weeks with or 
without IGF-1, BAPN or PNPX alone and in all possible combinations followed by three 
weeks in control medium. DNA content, GAG and collagen deposition and collagen 
cross-links were determined. Cartilage constructs were cultured under same conditions 
and histologically analyzed for integration of two opposing cartilage matrices.
Results
In alginate cultures, inhibition of collagen cross-linking with BAPN in combination with 
promotion of matrix synthesis using IGF1 was most beneficial for matrix deposition. 
Addition of PNPX was always detrimental for matrix deposition. For integration of 
opposing cartilage constructs, the combination of BAPN, IGF1 and temporary preven-
tion of proteoglycan formation with PNPX was most beneficial.
Discussion
When a new matrix is produced, proteoglycans are important to retain collagen in 
the matrix. When two already formed cartilage matrices have to integrate, temporary 
absence of proteoglycans and temporary inhibition of collagen cross-linking might be 
more beneficial in combination with stimulation of collagen production by for example 
IGF1. Therefore, the choice of soluble factors to promote cartilage regeneration depends 
on the type of therapy that will be used.
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Introduction
Once damaged, adult articular cartilage has a poor repair capacity, which is probably due 
to the ineffective repair of the collagen network, since proteoglycan depletion is often 
reversible 142. Although collagen turnover is increased in osteoarthritis (OA), this does 
not lead to the formation of a functional network 26, 68, 96, 143. This suggests an activated 
repair mechanism in OA that appears however ineffective in repairing or maintaining 
the ECM homeostasis.
Several strategies are under investigation to promote matrix regeneration in cartilage 
repair. Growth factors are used to modulate matrix production, by directly adding them 
to chondrocytes in culture 123, 280 or by inducing over expression of the growth factor of 
interest 281, 282. For example, we and others found that addition of IGF1 to chondrocytes 
in culture resulted in more proteoglycans and collagen than in the control condition 
without IGF1 159, 168, 169, 188
In addition to growth factors, modulation of collagen network formation is also 
employed to understand cartilage matrix formation and functionality, for example 
by the inhibition of collagen cross-linking by inhibition of lysyl oxidase (LOX) with 
β-aminopropionitrile (BAPN). It was found that collagen cross-links are important for 
the integrative repair and adhesive strength of cartilage 283 and that transient inhibition 
of the formation of these cross-links improved integrative repair and collagen cross-link 
maturation 284. In cultures of chondrocytes in alginate, inhibition of collagen cross-link 
formation with BAPN resulted in an increase of collagen production 163, 208, 230. In con-
cordance with earlier explant studies 284, transient inhibition of LOX in alginate cultures 
resulted in accelerated cross-link maturation and improved functionality of the newly 
formed matrix 230.
The influence of glycosaminoglycans (GAGs) on cartilage growth and matrix produc-
tion is also under investigation, but gets less attention than collagen. GAG depletion 
in cartilage explants resulted in less expansive growth and a more mature matrix with 
increased tensile integrity 141. Preventing GAGs from binding to the proteoglycan core 
protein with para-nitrophenyl xyloside (PNPX) in the newly forming cartilage matrix of 
chondrocytes cultured in alginate resulted in less collagen deposition and a decrease in 
stiffness and ability to hold water 285. The difference between these two studies is that 
in the explant study collagen was already deposited and cross-linked, whereas in the 
alginate cultures no collagen was yet deposited when GAG incorporation was inhibited. 
Both studies however indicate that modulating GAGs can influence the collagen net-
work in an already existing cartilage matrix or during new cartilage matrix synthesis.
Most of the approaches mentioned above focused on modulating one matrix 
component (either collagen or proteoglycans). However, increasing collagen synthesis 
alone is not sufficient for cartilage repair. Because of the differential and potentially 
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complementary effects of these approaches, our hypothesis was that combining IGF1, 
BAPN and PNPX in one experiment has the potential to stimulate matrix production and 
integrative repair more than each single component. Chondrocytes cultured in alginate 
were used to examine the effect of the soluble factors on new matrix production, either 
alone or in all possible combinations. Cartilage explants were used to examine the effect 
of the factors mentioned above on integration of two existing cartilage matrices.
Materials and Methods
Cell culture
Articular cartilage was harvested from the metacarpophalangeal joints of calves aged 
6–12 months. Chondrocytes were isolated, suspended in alginate in a concentration 
of 4 x 106 cells per ml of alginate, and alginate beads were made as described previ-
ously 188. Beads were cultured in a six-well plate (BD Falcon, Bedford, MA, USA), with 
75 µl/bead DMEM/F12 supplemented with 10% fetal bovine serum (GibcoBRL), 50 µg/
ml L-ascorbic acid 2-phosphate (Sigma), 50 µg/ml gentamicin and 1.5 µg/ml fungizone 
(both GibcoBRL). Chondrocytes were cultured for 21 days in the presence of 25 ng/
ml IGF-1, 0.25 mM BAPN and/or 0.25 mM PNPX based on previous results 211, 230, 286 
followed by 21 days in control medium. As known from these previous studies, BAPN 
inhibits collagen cross-linking and PNPX prevents incorporation of GAGs into the matrix. 
In the 21 days of additional culture without supplements, cross-links had the ability to 
form and GAGs to incorporate into the matrix. Culture medium was changed three 
times a week. Alginate beads were harvested after 42 days of culture.
Preparation of cartilage explants for integration study
Articular cartilage samples were harvested from the metacarpophalangeal joints of 
calves aged 6–12 months. Full-thickness cartilage explants of 8 mm diameter and with 
a thickness of 0.9–1.2 mm were prepared using a dermal biopsy punch and scalpel. 
From the centre of the explants, 3-mm cores were punched out. All samples (both outer 
ring and inner core) were incubated for 24 hours in 10 U/ml highly purified collagenase 
VII (Sigma-Aldrich Chemie BV, Zwijndrecht, The Netherlands) in DMEM-F12 with 10% 
fetal calf serum based on previous results 287-289. From the study of Bos et al 287, it was 
concluded that there is some loss of matrix proteins by digesting for 24 hours with 
highly purified collagenase, but only on the locations where proteoglycans are lost, i.e. 
the area of the wound edge. Pre-treatment with collagenase is beneficial for integration 
because it increases the number of viable cells at the wound edge thereby enabling 
integration of the wound edges. All the cartilage explants were pre-treated with the 
collagenase irrespective of the condition. After incubation, the samples were washed 
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three times for 10 min in culture medium, and the 3-mm inner cores were reimplanted 
in their accompanying 8-mm outer rings. Constructs were cultured in parallel to the 
alginate beads for 21 days in the presence of 25 ng/ml IGF-1, 0.25 mM BAPN and/or 
0.25 mM PNPX followed by 21 days in control medium.  Constructs were cultured in 1.5 
ml DMEM/F12 per construct supplemented with 10% fetal bovine serum (GibcoBRL), 
50 µg/ml L-ascorbic acid 2-phosphate (Sigma), 50 µg/ml gentamicin and 1.5 µg/ml 
fungizone (both GibcoBRL) in the presence of 25 ng/ml IGF-1, 0.25 mM BAPN and/or 
0.25 mM PNPX during the first 21 days. After 42 days, constructs were harvested an 
immediately fixed in 4% phosphate buffered formalin.
Biochemical analysis of alginate beads
Alginate beads were digested overnight at 56°C in papain buffer (250 µg/ml papain in 
50 mM EDTA and 5 mM L-cystein). Glycosaminoglycan (GAG) amount in the digest was 
quantified using dimethylmethylene blue (DMB) assay 160. The metachromatic reaction 
of GAG with DMB was monitored with a spectrophotometer, and the ratio A530:A590 
was used to determine the amount of GAG present, using chondroitin sulfate C (Sigma) 
as a standard. The amount of DNA in each papain-digested sample was determined 
using ethidium bromide with calf thymus DNA (Sigma) as a standard. High-performance 
liquid chromatography (HPLC) of amino acids (hydroxyproline, Hyp) and collagen cross-
links (hydroxylysylpyridinoline, HP) was performed as described previously 162, 163. The 
quantities of cross-links were expressed as the number of residues per collagen mol-
ecule, assuming 300 Hyp residues per collagen triple helix. Three samples were taken of 
7 alginate beads per experimental condition for biochemical analyses.
Histochemical analysis of cartilage explants
Formalin fixed cartilage constructs were embedded in paraffin. To prevent any nega-
tive influence of processing the constructs for histological analysis, separate cartilage 
constructs were placed in little porous polymer bags directly after harvesting prior to 
fixation in formalin and processing. However, a certain risk of damage during histologi-
cal procedure is unavoidable. Therefore we embedded all the samples at the same time 
and did the sectioning in a random order to exclude bias.  Sections (6 µm) were cut 
using a standard microtome. Prior to the histological stainings, sections were deparaf-
finated in xylene and rehydrated through graded ethanol. For histological evaluation, 
serial sections were stained with Haematoxylin & Eosin (H&E). To evaluate integration, 
paraffin sections were stained with a thionine staining. For each sample we assessed 
the percentage of total interface length that had a matrix–matrix connection. A clear 
distinction could be made between parts with a matrix connection and parts of the car-
tilage touching each other but without a clearly connected matrix, which were scored as 
parts with a gap. Integration was determined at both integration sites within a paraffin 
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section. Interface integration percentages were obtained by two blinded observers from 
measurements of three to four different sections from each sample, resulting in an 
average value for each interface.
Statistical analysis
For the alginate bead cultures and the integration study, four pooled cartilage donors 
were used. Statistical analysis was performed using GraphPad Prism 5.01 (GraphPad 
Software, San Diego, CA, USA) software. All data are presented as mean ± standard 
deviation. Control groups and groups supplemented with PNPX, BAPN and/or IGF1 were 
compared with a ANOVA test followed by a post hoc Bonferroni test.
Results
Chondrocytes cultured in alginate
After 42 days, DNA content, GAG deposition, collagen deposition and collagen cross-
linking were determined in the alginate beads. In the control condition, DNA content 
was 0.49 ± 0.03 µg DNA per alginate bead, which was unaffected by the addition of 
BAPN, IGF1 and or PNPX during the first 21 days of culture (Figure 8.1).
4.38 ± 0.39 µg GAG per bead was deposited in the control condition after 42 days of 
culture. As expected, this was significantly reduced in the condition with 0.25 mM PNPX 
during the first 21 days. Compared to the control condition, GAG deposition was also 
less when a combination of PNPX and IGF1 was present, when PNPX and BAPN were 
present together, and when all three components were present in the culture medium. 
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Figure 8.1. DNA content of the alginate beads after 42 days of culture. PNPX (P), BAPN (B) and/or 
IGF1 (I) were present in the first 21 days of culture, followed by additional culture for 21 days in control 
medium. Data are shown as mean DNA content per bead ± sd. N=3.
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BAPN or IGF1 alone did not influence GAG deposition, rather their combination resulted 
in more GAG deposition (Figure 8.2).
Regarding the collagen deposition, 6.16 ± 0.91 µg was deposited in the control 
condition after 42 days. The presence of PNPX during the first 21 days resulted in less 
collagen deposition. Inhibition of collagen cross-link formation with BAPN on the other 
hand resulted in more collagen deposition, as expected. BAPN together with IGF1 
increased the collagen deposition even more (Figure 8.3).
The presence of BAPN alone, BAPN with IGF1, BAPN with PNPX and all three fac-
tors during the first 21 days resulted in less cross-link formation, in line with the LOX 
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Figure 8.2 Figure 8.2. GAG content of the alginate beads after 42 days of culture. PNPX (P), BAPN (B) and/or 
IGF1 (I) were present in the first 21 days of culture, followed by additional culture for 21 days in control 
medium. Data are shown as mean GAG content per bead ± sd. N=3. * indicates a significant difference 
(p<0.05) from the control condition without additives.
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Figure 8.3 Figure 8.3. Collagen content of the alginate beads after 42 days of culture. PNPX (P), BAPN (B) and/
or IGF1 (I) were present in the first 21 days of culture, followed by additional culture for 21 days in 
control medium. Data are shown as mean collagen content per bead ± sd. N=3. * indicates a significant 
difference (p<0.05) from the control condition without additives.
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inhibition by BAPN. Addition of IGF1 alone, PNPX alone or PNPX with IGF1 did not 
change the number of collagen cross-links from the control condition, which was 0.69 
± 0.03 HP per collagen triple helix (Figure 8.4).
Cartilage integration
In parallel to the alginate cultures, cartilage explants were cultured to investigate the 
integrative capacity in the presence of PNPX, BAPN and/or IGF1. As in the alginate 
cultures, soluble factors were only present during the first 21 days of culture followed 
by culture in control medium for an additional 21 days. Typical examples of integration 
after 42 days visualized with a thionine staining are shown in Figure 8.5. The average 
integration percentage in the control condition was less than 10%. Only when PNPX, 
BAPN and IGF1 were combined during the first 21 days, integration of the two opposing 
cartilage explants improved to 41.3 ± 31.4% (p < 0.05) (Figure 8.6). Although not 
reaching statistical significance, the presence BAPN and IGF1 alone or together also 
seems beneficial for integration.
Discussion
Many factors have been demonstrated to be able to influence proteoglycan production, 
collagen production or both. However, it is not fully known what the optimal balance 
of collagen and proteoglycan production is and how they influence each other to form 
a functional network.
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Figure 8.4 Figure 8.4. Number of HP cross-links per collagen triple helix after 42 days of culture. PNPX (P), BAPN 
(B) and/or IGF1 (I) were present in the first 21 days of culture, followed by additional culture for 21 
days in control medium. Data are shown as mean HP per collagen triple helix ± sd. N=3. * indicates a 
significant difference (p<0.05) from the control condition without additives.
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Figure 8.5  
A 
B 
Figure 8.5. Examples of integration visualised with a thionine staining. A) 20% integration in a control 
sample, B) 70% integration in a sample where PNPX, BAPN and IGF1 were present for the first 21 days. 
Arrows indicate integration, arrowheads indicate no integration. Magnification is 40x.
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Our goal was to examine the effect of modulating collagen deposition, collagen 
cross-linking and GAG deposition simultaneously during cartilage matrix production and 
cartilage integrative repair, thereby creating a wider insight in the role of proteoglycans 
and collagen in cartilage repair process.
In the alginate cultures, inhibition of collagen cross-linking with BAPN in combination 
with promotion of matrix synthesis using IGF1 was most beneficial for matrix deposi-
tion. Additional PNPX was always detrimental for matrix deposition. For integration, the 
combination of BAPN, IGF1 and temporary prevention of proteoglycan formation with 
PNPX was most beneficial.
Inhibition of GAGs from binding to the proteoglycan core protein not only resulted in 
less GAG deposition in the alginate bead, but also in less collagen deposition. This is in 
concordance to our previous study were the presence of PNPX during a culture period 
of 35 days resulted in less proteoglycan and collagen deposition in the alginate bead. In 
addition, excretion of both matrix proteins into the culture medium was higher due to 
the absence of an intact matrix network 285. Because of the absence of this network and 
the loss of interaction with other matrix components, combining PNPX with BAPN and/
or IGF1 could not counteract the effects seen with PNPX alone. Earlier we found that the 
inhibition of collagen cross-linking in an alginate culture for 21 days and longer results 
in higher collagen deposition then when cross-links are formed. During this culture 
period, proteoglycan deposition was unaffected 230. Even though cross-link inhibition 
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Figure 8.6. Percentage of integration of opposing cartilage tissue. PNPX (P), BAPN (B) and/or IGF1 (I) 
were present in the first 21 days of culture, followed by additional culture for 21 days in control medium. 
Data are shown as individual percentages with the mean percentage ± sd. N=8. * indicates a significant 
difference (p<0.05) from the control condition without additives.
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by BAPN stimulates collagen synthesis, the retention of collagen is very low because of 
the absence of a proteoglycan network. Previously, we and others showed stimulating 
effects of IGF1 on collagen and proteoglycan deposition 159, 168, 169, 188. In the present 
setup, culture with IGF1 alone for 21 days did not significantly stimulate matrix deposi-
tion after 42 days, whereas IGF1 did previously already after 21 days 188. However, the 
combination IGF1 and BAPN increased GAG deposition which is probably attributable to 
the presence of IGF1 since BAPN does not affect the GAG deposition. Even though IGF1 
might have also stimulated GAG and collagen deposition when combined with PNPX 
or with PNPX and BAPN, GAGs were prevented from incorporation into the matrix. 
A possible positive effect of IGF1 on collagen synthesis was counteracted because of 
low collagen retention in the alginate bead. In every condition where the cross-link 
inhibitor BAPN was present for the first 21 days, less collagen cross-links were present 
even though the culture continued for 21 days after removal of BAPN. This might be 
explained by the fact that after removal of BAPN, it takes three weeks for mature HP 
cross-links to be formed 222. In addition, BAPN binds irreversibly to lysyl oxidase (LOX) 212 
and therefore extra time is also needed for LOX to be produced again. Based on our 
previous experiments, we expect that the number of collagen cross-links will be equal in 
all conditions when a longer culture period is used 230.
The combination of BAPN and IGF1 seems most beneficial for matrix synthesis when 
no matrix is formed yet, as in the alginate cultures. When aiming at the integration of 
two existing cartilage matrices, cross-link inhibition with BAPN and stimulation of matrix 
production with IGF1 is not sufficient to significantly improve integration. Transient 
inhibition of GAG incorporation in the matrix with PNPX in combination with BAPN and 
IGF1 did improve the integration. In these experiments, stimulation of matrix production 
alone with IGF1 had no effect. Transient inhibition of collagen cross-link formation could 
have resulted in more collagen synthesis, and in addition in better penetration of the 
newly formed collagen fibers in the opposing tissue that was partly depleted of GAGs 
following injury 290. The latter is more likely since previous experiments with BAPN and 
cartilage explants did not result in more collagen synthesis 284. The study by McGowan 
et al is also in concordance with the theory of better integration after BAPN treatment. 
The addition of PNPX and the resulting absence of GAG attachment to the proteoglycan 
core protein might have similar effects as seen with inhibition of cross-link formation. 
Without an intact proteoglycan network at the edges of the cartilage explants, newly 
formed collagen fibers might penetrate better into the opposing cartilage tissue. 
Because of the absence of a proteoglycan network, the collagen network might also 
have a better integrity 141. This explains why the presence of IGF1 with PNPX or BAPN 
did not improve integration since the newly formed collagen stimulated by IGF1 could 
not penetrate into the cartilage. PNPX together with BAPN but without IGF1 was also 
not sufficient because of the absence of increased collagen production.
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When cartilage transplantations are performed, the surgeon removes the damaged 
cartilage first. Removing the damaged cartilage will create a fresh wound area, similar 
to our experimental condition. We hypothesize that the integrative capacity of such an 
area is different from a long lasting wound area and we are therefore convinced that our 
explant model is close to the application in this respect.
The cartilage explants used for integration were cultured for 6 weeks in vitro. In an 
earlier study, we investigated the effect of improved integration on mechanical proper-
ties of the cartilage-cartilage interface 289. There we observed a relation between the 
area of integration on histology and the mechanical properties of the interface. Since 
the previous study is performed after an in vivo culture period and our current study 
evaluates after in vitro culture, it is difficult to extrapolate these results. Earlier attempts 
in the lab have demonstrated us that after in vitro culture the bonding is not strong 
enough to measure reliably in our system. However, the improved histological integra-
tion in the present studies looks promising and suggests that when a construct is placed 
in vivo after modulation with our soluble factors (IGF1, PNPX and BAPN), integration 
might lead to functional cartilage.
Conclusions
Based on these results, combining IGF1 and cross-link inhibition with BAPN seems to 
be most promising in promoting the formation of a new cartilage matrix. When a new 
matrix is produced, proteoglycans are important to retain collagen in the matrix. When 
two already formed cartilage matrices have to integrate, the temporary absence of a 
proteoglycan network and the temporary absence of collagen cross-links might be more 
beneficial in combination with stimulation of collagen production by for example IGF1. 
Therefore, the choice of soluble factors to promote cartilage regeneration in OA depends 
on the type of therapy that will be used. In the case of cell therapy and the synthesis of 
a new matrix, stimulating both collagen and proteoglycan synthesis is important. The 
intra-articular administration of growth factors such as IGF1 to promote matrix produc-
tion is the topic of ongoing research 291 and could be a part of future OA therapy. 
When two cartilage matrices have to integrate, temporary inhibition of proteoglycan 
network formation and collagen cross-linking together with stimulating collagen pro-
duction results in better integration. In the case of autologous cartilage transplantation, 
the transplant can be pre-treated with hyaluronidase or chondroitinase to remove the 
proteoglycans and be subjected to temporary collagen cross-link inhibition. To generate 
a tissue engineered cartilage construct, culture in the presence of IGF1 and BAPN might 
be a promising approach. However, care must be taken with BAPN since it is mutagenic. 
Other approaches to inhibit collagen cross-linking might be the topic of future research.
9 Summary and General Discussion
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Osteoarthritis (OA) is a complex disease of which the ethiopathology is not completely 
known. OA is a common, chronic, musculoskeletal disorder. Symptomatic osteoarthri-
tis, particularly of the knee and hip, is the most common cause of musculoskeletal 
disability in elderly people. In the Western world it ranks fourth in health impact 
among women and eighth among men 292. Given this high prevalence, therapeutic 
approaches for treatment are desired. However, treatment options recommended only 
consist of non-pharmacological and pharmacological interventions aiming for pain 
relief 128-130, 293. Attempts are made to develop disease modifying osteoarthritic drugs 
(DMOADs). Glucosamine is claimed to have structure modifying effects on articular 
cartilage damaged in OA 294, although the effect is still under discussion 295, 296. 
Anti-MMP, bisphosphonates and IL-1 receptor antagonist (IL-1ra) were proposed as 
possible DMOADs but had many side effects or had no or negative effects on OA 
development 297-299. Since most currently available treatments are palliative, only 
effective in mild OA, and structure modifying compounds are still not proven to be 
effective, total joint replacement is still an often-performed procedure in end stage OA 
patients. Therapies to actually repair cartilage are thus still under investigation. The 
difficulty with cartilage repair and regeneration is the insufficient extracellular matrix 
production, especially collagen type II. The increase of collagen type II expression in 
osteoarthritic cartilage 95, 96 suggests an activated repair mechanism that is, however, 
ineffective in repairing or maintaining the ECM homeostasis. On a immunohistochemi-
cal level, it often appears that collagen type II and proteoglycans are present in high 
amounts because of a uniform and intense staining. However, biochemical quan-
tification of tissue-engineered constructs reveals that both matrix constituents, but 
especially collagen type II, are present in very low amounts when compared to native 
articular cartilage 146. This lead us to investigate the ability to modulate the formation 
of a functional collagen type II network that can ultimately contribute to innovation 
of cartilage repair in OA.
Influence of soluble factors on collagen deposition and 
functionality
By using growth factors known to play a role in cartilage matrix homeostasis and 
development, we found in chapter 2 that matrix production and especially collagen 
production can be modulated in vitro. Differential effects were shown of IGF1, FGF2 
and TGFβ2. Our quantitative analysis shows beneficial effects of IGF on cartilage regen-
eration. Collagen cross-linking was not affected, mechanical properties improved, and 
MMP-1 gene expression downregulated.
The use of IGF1 was previously studied in animal models for cartilage repair. Histo-
logical analysis of these animal models showed that administration of IGF1 resulted in 
better cartilage morphology, including more collagen type II staining 259, 291, 300. From 
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our biochemical data and the in vivo experiments, it can be concluded that IGF1 has 
disease-modifying potential in osteoarthritis.
FGF2 in the low concentration resulted in a small increase of matrix deposition, in 
contrast to the high concentration that resulted in no effect on proteoglycan deposition 
and less collagen deposition than in the control condition. Less collagen deposition 
resulted in a trend towards worsened functionality since the number of cross-links per 
collagen triple helix was comparable to the control condition. In animal models, FGF2 
appears to have beneficial effects on cartilage repair 282, 301. Even though cartilage 
morphology seems to improve when FGF2 is administered to cartilage lesions in vivo, 
our quantitative analysis shows the opposite. This might be explained by the positive 
effect FGF2 has on the phenotype of chondrocytes 121, 178 resulting in a different col2/
col1 ratio, or the difference between histological analysis (in the in vivo studies) and 
biochemical analysis (in our studies) 146. From our biochemical data, it can be concluded 
that FGF2 is less suitable for repair of the cartilage matrix.
Our experiments with TGFβ on primary calf chondrocytes resulted in slightly less 
matrix deposition. In general, intra-articular injection of TGFβ leads to an increase in 
proteoglycan content in articular cartilage although contrasting results also have been 
reported (see 302 for review). The positive effects seen in the in vivo studies might be 
explained by the counteracting effect of TGFβ on IL-1 induced matrix degradation 117, 303 
and less by the stimulation of matrix production by TGFβ. Matrix incorporation into the 
existing cartilage matrix could be more effective because of less degradation in the pres-
ence of TGFβ. Earlier studies from our group showed that chondrocytes from immature 
cartilage were not sensitive to TGFβ, whereas addition of TGFβ to chondrocytes from 
more mature cartilage resulted in more proliferation and more GAG production 304. The 
chondrocytes used in our studies were isolated from newborn calves. It is possible that 
these were less sensitive to TGFβ addition, which also explains the discrepancy between 
our results and some in vivo results. On the other hand, TGFβ stimulates proteoglycan 
synthesis more actively in OA than in healthy cartilage 305. This is also an explanation for 
the difference between our results in healthy chondrocytes and the often seen stimula-
tion of PG synthesis after TGFβ administration in other studies with in vivo OA models.
Next to the small effects on matrix deposition, TGFβ had striking effects on col-
lagen cross-links; addition of TGFβ to chondrocytes in alginate resulted in less collagen 
cross-links. This was in contrast to our expectation since TGFβ is known to be a potent 
inducer of fibrosis in tissues such as skin and synovium 135, 193 which is characterized by 
an increase of HP cross-links 191, 220. Therefore, we decided to study the effect of TGFβ 
in more detail in chapter 3. Several comparisons were made: chondrocytes versus fibro-
blasts, culture in alginate versus culture in monolayer on plastic, but also primary cells 
versus expanded cells since expanded chondrocytes display a fibroblast-like phenotype. 
Only expanded chondrocytes and fibroblasts deposited more collagen in reaction to 
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TGFβ addition, independent of the culture substrate and the type of collagen produced. 
Surprisingly, addition of TGFβ resulted in less HP cross-links in the alginate bead condi-
tions and in more HP cross-links in the monolayer conditions, both independent of cell 
type or passage number. Contractile stress, as determined with a immunocytochemistry 
staining for α Smooth Muscle Actin, experienced by the cells in monolayer probably 
contributed to this effect. This lead us to conclude that the effect of TGFβ on collagen 
amount is dependent on cell type whereas the effect of TGFβ on  cross-linking is inde-
pendent of cell type but strongly dependent on the environment.
The difference in environment and how it affects the response to TGFβ might explain 
the positive effects seen on cartilage and the negative effects seen in synovium after 
intra-articular administration of TGFβ. Synoviocytes have a fibroblast-like shape and are 
stretched out on the collagen fibers of the synovial ECM. This is in contrast to the 
chondrocytes in the cartilage. Here, cells are round with a surrounding matrix of small 
collagens and proteoglycans. Therefore, cells in the synovium probably experience more 
contractile stress than cells in the cartilage, which results in more collagen cross-links in 
the synovium and less in the cartilage in response to TGFβ.
In addition, evidence exists that chondrocytes have an altered or dedifferentiated 
phenotype in OA. Based on our results, TGFβ could also induce collagen synthesis in OA, 
since only dedifferentiated/expanded cells deposited more collagen in response to TGFβ. 
This is in concordance with the study of Lafeber et al 305 where TGFβ stimulated OA 
chondrocytes more than healthy chondrocytes considering PG synthesis. Together with 
the beneficial properties of TGFβ in counteracting IL-1 mediated matrix degradation, 
this growth factor is also a promising target for modification of OA.
To examine the influence of reduced collagen cross-links in cartilage repair, the key 
enzyme involved in cross-linking (LOX) was temporarily inhibited in chondrocyte alg-
inate cultures with the addition of BAPN in chapter 4. Inhibition of cross-link formation 
probably resulted in a higher collagen deposition, due to more collagen diffusion in 
the alginate bead and less chondrocyte-collagen interaction 163. Initially, the increase 
in collagen deposition resulted in an improvement of matrix stiffness even without the 
presence of collagen cross-links. However, when the collagen deposition increased even 
more without cross-links present in the collagen, stiffness remained comparable to 
the control condition. A transient inhibition of collagen cross-linking resulted in more 
collagen that was cross-linked after removal of the cross-link inhibitor. This led to an 
improvement of matrix stiffness compared to the control condition and the condition 
cultured for the entire period with cross-link inhibition. Next to the amount of collagen, 
cross-links were required to improve matrix stiffness. The absence of cross-links also 
negatively influenced the susceptibility to MMP-1 degradation of the collagen matrix 
and the ability to hold water. These data confirm that collagen cross-links are needed 
for the functionality of cartilage. Not only to withstand mechanical loading but also 
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to withstand matrix degradation. This indicates that inducing collagen cross-linking in 
vivo has potential to prevent cartilage damage. Inducing collagen cross-linking might 
even stimulate cartilage repair in OA, since collagen synthesis is upregulated in OA but 
ineffective in maintaining matrix integrity.
Matrix constituents and the cartilage network
Collagen type II is the most abundant protein present in articular cartilage and interacts 
with a large variety of other molecules such as proteoglycans. Next to the importance 
of the collagen network in retaining proteoglycans in the cartilage matrix, the absence 
of a proteoglycan network also affects collagen network (chapter 5). By preventing 
the addition of glycosaminoglycan side chains to the proteoglycan core protein, col-
lagen diffused further away from the chondrocyte and even into the culture medium, 
consequently worsening mechanical functioning of the matrix.
In OA, a large variety of matrix degrading enzymes are upregulated including 
aggrecanases 306. Not only do they directly affect the proteoglycan content of the 
articular cartilage, but they possibly can also indirectly influence the collagen content as 
suggested by our data. This might explain the ineffective cartilage repair even though 
collagen synthesis is upregulated in early OA.
Next to proteoglycans, the pentameric protein COMP interacts with collagen type 
II in the cartilage matrix. The effect of growth factors on production of other matrix 
components next to collagen type II and proteoglycans is studied in chapter 6, where we 
focused on COMP deposition and distribution in reaction to the growth factors examined 
earlier. By adding TGFβ to chondrocytes in alginate, COMP gene and protein expression 
largely increased. FGF2 decreased COMP expression and possibly even resulted in COMP 
degradation. IGF1 had no effect on COMP expression. The distribution of COMP, col-
lagens, and proteoglycans between the cell associated matrix and the further removed 
matrix indicates that COMP was not specifically associated with either the collagen or 
the proteoglycan component.
Because growth factors had many other effects next to influencing COMP deposition 
(as shown in chapter 2 and 3), COMP was also overexpressed in chondrocytes using a 
lentiviral overexpression system. This resulted in much more COMP production by the 
chondrocytes but only small effects on COMP incorporation in the cartilage matrix. 
This had no effect on matrix deposition, collagen cross-linking and mechanical prop-
erties. However, induction of COMP production with TGFβ or COMP lentivirus both 
resulted in collagen fibrils with a smaller diameter. Our results indicate that COMP is 
not a limiting factor in cartilage matrix production in these in vitro experiments. The 
decrease of collagen fibril diameter as a result of COMP induction however, might affect 
(mechanical) properties of the cartilage although not those parameters tested in our 
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study. The increase of COMP production often seen in osteoarthritic cartilage 67, 244 
might therefore negatively affect the quality of the cartilage.
Next to our results on overexpressing COMP, it was found previously that mice 
deficient for COMP had a similar phenotype as the corresponding wild type mice 237. 
To create a more severe phenotype, mice deficient for collagen type IX and COMP 
were developed. In these mice, a disorganized growth plate architecture and alterations 
in matrix deposition were observed both in newborn animals and at later stages of 
development 263. The matrix produced by chondrocytes from these mice was examined 
in vivo and in vitro in chapter 7. As comparison, mice deficient only for collagen type 
IX (appendix chapter 7) or the corresponding wild type mouse strain was used. Mice 
deficient for COMP were not included in these studies since their phenotype is not 
different from the wild type 237. When chondrocytes isolated from collagen type IX or 
collagen type IX/COMP deficient mice were cultured, less collagen and proteoglycans 
were produced in both knock-out conditions (although not statistically significant for 
collagen type IX knock-out because n=3). The absence of the matrix constituents also 
differentially influenced collagen and GAG distribution within the culture system. These 
effects seem to be mainly a result of collagen type IX deficiency since both collagen type 
IX knock-out and the double knock-out have similar effects. Having a COMP deficiency 
in addition to the collagen type IX deficiency does not change the effect seen with single 
collagen type IX knock-out regarding matrix deposition by knee and rib chondrocytes. 
This is in agreement with the effects seen with COMP overexpression were we also 
could not demonstrate an effect on matrix deposition and distribution. Collagen type IX 
seems more important in the production and formation of a functional cartilage matrix 
than COMP. However, matrix deposited by double knock-out chondrocytes had collagen 
fibrils with diameters similar to the matrix produced by wild type chondrocytes, whereas 
collagen fibrils of collagen type IX deficient mice were larger in diameter. Collagen 
type IX is known to limit lateral growth of the collagen fibrils 224. Since inducing COMP 
production decreased the collagen fibril diameter (chapter 6), one would expect that the 
absence of COMP in addition to the absence of collagen type IX would increase the fibril 
diameter even more. Instead, fibril diameter normalized when both matrix molecules 
were absent. Possibly, the absence of COMP induced another matrix molecule to act as 
antagonist of collagen type IX.
COMP deficient mice lack an obvious phenotype 237, maybe due to a functional 
compensation by other matrix proteins. Mice deficient for collagen type IX display 
degenerative changes in articular cartilage, first detected at the age of 6 months 224, 261. 
Combining the COMP and collagen type IX deficiency results in a disorganized growth 
plate architecture and alterations in matrix deposition both in newborn animals and at 
later stages of development 263. However, only from mice deficient for collagen type IX it 
is known that they develop spontaneous OA 207, 261. Double deficient mice need altered 
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mechanical loading of their joint such as running exercise to induce cartilage damage as 
seen in OA 307. COMP single knock-out mice subjected to the same exercise only had 
flattening of their cartilage 307. On the other hand, in an experimental arthritis model 
(collagen induces arthritis), mice deficient for COMP had an earlier onset and enhanced 
severity of the chronic arthritis 308. Inducing OA by for example destabilization of the 
medial meniscus 309 would therefore probably lead to a quicker onset of OA when 
collagen type IX and COMP or COMP alone is absent then in the wild type mice.
Combining several approaches to modulate cartilage 
matrix deposition
As seen in our studies mentioned above, cartilage matrix deposition can be modulated 
with several factors such as addition of growth factors (chapter 2), by inhibition of col-
lagen cross-link formation (with BAPN in chapter 4) or by inhibition of the formation of 
a functional proteoglycan network (with PNPX in chapter 5). The ability to modulate the 
formation of a new collagen network in a chondrocyte alginate culture by combining 
IGF1, BAPN and PNPX was examined in chapter 8. In parallel, the ability to modulate car-
tilage integrative repair, which also involves generation of a new collagen network, with 
these three factors was also examined. In both set-ups, factors were added temporarily 
to allow cross-link and proteoglycan formation after initial inhibition. The combination 
of IGF1 with transient collagen cross-link inhibition (with BAPN) was optimal for col-
lagen deposition in the alginate bead. BAPN and/or IGF1 with PNPX, and therefore no 
intact proteoglycan network, resulted in less collagen deposition even though collagen 
deposition was stimulated in conditions without PNPX. Based on this study, we conclude 
that proteoglycans are necessary when new cartilage matrix is synthesized to retain 
the collagen matrix within the alginate bead. However, when two existing cartilage 
matrices have to integrate, the presence of proteoglycans seems to disturb the inte-
gration probably by preventing the collagen molecules to penetrate into the opposing 
matrix. Stimulating collagen production with IGF1, and simultaneously inhibiting the 
collagen from cross-linking with BAPN and preventing the formation of proteoglycans 
with PNPX was most beneficial for cartilage integration. Depending on the type of 
therapy in osteoarthritis, proteoglycans might be beneficial or disturbing in the repair. 
Cell therapy or matrix regeneration by chondrocytes would benefit from stimulating 
collagen and proteoglycan production in parallel. When transplanting cartilage into a 
defect, depletion of proteoglycans and inhibition of cross-links prior transplantation 
would probably be more beneficial.
Targeting collagen production: combining the knowledge
Taken together, the studies presented in this thesis show that several factors influence the 
collagen deposition by chondrocytes directly or indirectly via proteoglycan deposition. In 
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this section, the obtained knowledge will be combined. Of the growth factors used in 
this thesis, IGF1 had only positive effects on the parameters in our chondrocyte alginate 
cultures. It stimulated chondrocytes to deposit more collagen and proteoglycans. One 
can postulate on whether this was a direct stimulation of production of both matrix 
constituents or whether the deposition increased because of other factors. From lit-
erature for instance, it is known that IGF1 inhibits matrix degrading enzymes 310. This 
could (also) have contributed to increased deposition, without induction of synthesis. 
However, increased gene expression of aggrecan core protein in the presence of IGF1 
indicates that proteoglycan production is indeed increased resulting in more deposition. 
This increased proteoglycan deposition in turn could have resulted in more collagen 
deposition without increasing collagen production itself. This theory is supported by a 
lack of increased collagen type II gene expression in the presence of IGF1. From other 
studies it is known that IGF1 is even more potent in inducing matrix production when 
combined with OP1/BMP7213. FGF2 on the other hand had no positive effects in our 
culture system: It lowered the collagen deposition and did not affect the proteoglycan 
deposition. In addition, other studies showed that FGF2 inhibits the stimulatory effects 
of IGF1 155 and that it stimulates the production of matrix degrading enzymes (chapter 
2, and 311). The effect TGFβ had on chondrocytes in culture was more complex and 
difficult to explain. Addition of TGFβ to chondrocytes in alginate had no large effect on 
proteoglycan and collagen deposition but did lower the number of cross-links per col-
lagen molecule. In addition, it increased COMP deposition in our culture and has been 
shown to lower the production of matrix degrading enzymes by us and in other stud-
ies 117, 303. Since induction of COMP by overexpression also resulted in collagen fibrils 
with a smaller diameter, the smaller collagen fibrils seen with TGFβ are most likely a 
result of the increased COMP production. This decrease of collagen fibril diameter could 
have also contributed to the decrease in collagen cross-links in the TGFβ cultures.
Collagen deposition could also be influenced by inhibition of LOX via covalent bind-
ing of BAPN. Here, the lack of collagen cross-links probably resulted in less collagen 
directly around the chondrocyte, resulting in less collagen-chondrocyte interaction. As 
a result, the chondrocyte produced more collagen (as shown by increased collagen 
type II gene expression) and thus also more collagen was deposited. This is not in line 
with the effects seen after TGFβ addition. Next to the effects known from ours and 
other studies, TGFβ probably has several other effects on chondrocytes, which makes 
it difficult to explain why less collagen cross-links in the TGFβ culture did not alter the 
collagen deposition. One possibility is the increase in COMP deposition and therefore 
the increase in network formation via other matrix molecules 63 that compensated for 
the lower number of cross-links present.
By inhibiting the formation of a proteoglycan network and therefore proteogly-
can deposition, collagen deposition was also decreased. The absence of an intact 
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proteoglycan network lowered the collagen retention in our culture system. The same 
can be hypothesized for collagen type IX. Cultures of collagen type IX deficient chon-
drocytes also had altered collagen retention. Since collagen type IX forms a network 
together with collagen type II and other matrix molecules, the absence of this network 
probably also reduced collagen retention in the alginate bead. However, GAG distribu-
tion was also altered when collagen type IX was absent in the newly formed matrix. 
This could also have contributed to altered collagen retention. Interestingly, the absence 
of COMP in addition to collagen type IX deficiency did not alter matrix production and 
distribution. This leads to the conclusion that collagen type IX is more important in the 
matrix interaction than COMP.
Taken together, it seems that for the production of collagen in cartilage, focusing on 
the formation of an intact cartilage network is as important as stimulating collagen type 
II production. This network formation is important to retain the collagen type II in the 
newly formed matrix. From this thesis it can be concluded that at least proteoglycans 
and collagen type IX contribute to this.
Future perspectives
The goal of our study was to investigate the ability to modulate the formation of a 
functional collagen type II network in order to develop better treatments for OA in the 
future. The work presented in this thesis gave more insight in how matrix production 
and especially collagen type II production can be modulated and how these modula-
tions contribute to the functionality of the cartilage matrix. For the repair of cartilage 
damage in OA, the modulations resulting in more and/or better collagen type II are 
considered most interesting. Removing a matrix constituent however, also gives insight 
in its importance. Several approaches for the repair of cartilage damage were examined 
in more detail, this might help future studies giving new starting points in the search 
for OA therapy.
Based on the positive effects of IGF1 in our experiments, IGF1 could be a possible 
disease modifier for OA. TGFβ is also extensively examined as possible DMOAD and 
our data gave more insight in the benefits of TGFβ considering the protection of matrix 
against degradation and stimulation of matrix production under specific conditions. As 
mentioned with TGFβ, care must also be taken here for the negative effects of intra-
articular TGFβ administration (fibrosis, osteophyte formation). Preventing the TGFβ-side 
effects is the subject of ongoing research 114.
Other factors known to positively influence cartilage collagen type II production 
are BMP2 and platelet rich plasma (PRP). Addition of BMP2 resulted in higher gene 
expression and protein production of collagen type II 312. Next to the effect of one or 
two growth factors, a pool of unknown growth factors in PRP also has the potency to 
increase collagen production 313.
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Next to promoting collagen type II production and collagen cross-linking, inducing 
expression of collagen type IX also might be an interesting approach to repair cartilage. 
More collagen type IX might result in more effective matrix repair than seen so far 
because of more efficient network formation. Overexpression by introduction of extra 
copies of the collagen type IX gene however is controversial. Gene therapy is under cur-
rent investigation and might become available as future tool in modification of several 
diseases including OA. Alternatively, future research might include the identification of 
soluble factors that promote collagen type IX production. Care must be taken however 
that induction of collagen type IX might reduce the collagen fibril diameter leading the 
worsened mechanical properties 253. This should also be investigated.
An other approach to repair cartilage damage is engineering cartilage in vitro and 
subsequent implantation of the engineered construct. For this approach, expansion of 
chondrocytes is sometimes needed. FGF2 might be beneficial here because this growth 
factor protects against dedifferentiation 121. Based on our results, intra-articular injection 
of FGF2 might not be sufficient in repair of cartilage lesions because it had a negative 
effect on matrix deposition
Even though inhibition of collagen cross-linking resulted in an increase of collagen 
deposition in vitro, in vivo it has several side effects, especially when the compound 
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Figure 9.1 i r  . . A selection of factors known to influence collagen type II expression, production and/or 
deposition in healthy chondrocyte alginate culture. The effect of factors used in this thesis are shown in 
solid arrows, effects of factors know from literature are shown in dashed arrows. Since TGFβ has a broad 
spectrum of effects and improve the clarity of the scheme, the effects of this growth factor are shown 
with a thick line. In addition, to illustrate the broad spectrum of effects, effects of TGFβ on chondrocytes 
in monolayer are shown too.
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from our study is used, since BAPN is mutagenic/carcinogenic. Inhibiting collagen 
cross-linking with BAPN as a direct therapy for cartilage regeneration is therefore not 
advised. In addition, based on results in this thesis, stimulation of the formation of an 
extracellular matrix network instead of preventing network formation seems important 
for collagen deposition. Especially since collagen type II production is already increased 
in early OA 95, 96. Using temporary cross-link inhibition to promote collagen deposition 
in cartilage tissue engineering however seems promising. Here, inhibition of collagen 
cross-link formation can be more controlled and systemic side effects in the patient are 
avoided. Temporary inhibition of collagen cross-linking also seems promising when the 
in vitro tissue engineered construct has to integrate in the existing matrix.
To conclude and based on the results presented in this thesis as well as the existing 
literature, collagen deposition by chondrocytes can improve when not only collagen type 
II production is stimulated but also when proteoglycan deposition and collagen type IX 
deposition is stimulated. On the other hand, temporarily preventing network formation 
might improve integration of two opposing cartilage matrices. This knowledge will help 
in the development of disease modifying osteoarthritic approaches.
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Nederlandse samenvatting
Artrose, ook wel gewrichtsslijtage genoemd, is een ziekte van de gewrichten waarbij 
onder andere het kraakbeen beschadigd is. Deze ziekte komt voor in alle gewrichten 
zoals de knie, heup, hand en de schouder. Bij gezonde personen bedekt het kraakbeen 
de uiteinden van het onderliggende bot waardoor gewrichten soepel bewegen en 
schokken worden opgevangen die tijdens het bewegen ontstaan. Door schade aan het 
kraakbeen bij artrose kunnen deze functies niet goed uitgevoerd worden wat pijn bij 
het bewegen en stijfheid van de gewrichten tot gevolg heeft. In ernstige gevallen van 
artrose kan de kraakbeenlaag zelfs helemaal verdwenen zijn. Momenteel is er geen 
goed herstel van het kraakbeen mogelijk en vindt vooral pijnbestrijding plaats. Wanneer 
pijnbestrijding niet meer voldoende is en het bewegen ernstig beperkt wordt, vindt een 
gewrichtsvervangende operatie plaats met een zogenaamd kunstgewricht van metaal 
en plastic.
Er zijn echter aanwijzingen dat kraakbeen de mogelijkheid heeft zich te herstellen. 
Eén van de meest voorkomende eiwitten in kraakbeen is collageen type 2. Van dit col-
lageen is bekend dat dit meer wordt gemaakt wanneer artrose in een gewricht bestaat. 
Toch vindt er geen herstel van de schade plaats. Dit zou kunnen betekenen dat er wel 
een herstelmechanisme geactiveerd is, maar dat het niet effectief genoeg is om de 
schade daadwerkelijk te herstellen.
Dit leidde tot het onderzoek van dit proefschrift met de vraag of het mogelijk is de 
vorming van een collageen type 2 netwerk te beïnvloeden zodat dit kan bijdragen aan 
effectief kraakbeenherstel bij artrose.
In ons onderzoek hebben we allereerst in hoofdstuk 2 gekeken naar vaak gebruikte 
groeifactoren en hoe deze het collageennetwerk in nieuwgevormd kraakbeen beïn-
vloeden. Groeifactoren zijn eiwitten die van nature in het lichaam voorkomen en daar 
allerlei processen regelen. Van de bestudeerde groeifactoren resulteerde de groeifactor 
IGF1 in de meest positieve effecten voor kraakbeenherstel: de productie van zowel 
proteoglycanen (andere belangrijke versuikerde eiwitten in kraakbeen) als collageen 
werd gestimuleerd en de hoeveelheid collageen cross-links bleef hierbij op peil. Deze 
cross-links zijn verbindingen tussen de collageenmoleculen en zijn belangrijk voor de 
sterkte van het collageennetwerk. De groeifactor FGF2 had weinig effect op de proteo-
glycaan productie en remde in een hoge concentratie zelfs de collageenproductie.
Een andere groeifactor, TGFbeta2, had verrassende effecten op het collageen net-
werk omdat dit de hoeveelheid collageen cross-links verminderde. Nader onderzoek 
in hoofdstuk 3 toonde aan dat het effect van TGFbeta2 afhangt van de omgeving 
waarin de kraakbeencellen gekweekt worden. Wanneer TGFbeta2 toegevoegd werd 
aan kraakbeencellen die op een plat oppervlak gekweekt werden, nam de hoeveelheid 
collageen cross-links toe. TGFbeta2 bij kraakbeencellen in een 3-dimensionale omgeving 
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zorgde voor minder collageen cross-links. De invloed van collageen cross-links op het 
functioneren van het kraakbeeneiwitnetwerk (matrix) werd getest in hoofdstuk 4 door 
tijdelijk de vorming van deze cross-links te remmen. Een bijkomstig voordeel van deze 
tijdelijke remming was de toename in de collageenproductie. Hieruit bleek dat bij lage 
hoeveelheden collageen alleen het aantal collageen moleculen belangrijk is voor de 
sterkte van de nieuwe kraakbeenmatrix. Naarmate er meer collageen gevormd wordt, 
neemt het belang van de cross-links toe. Dan zijn zowel de collageenhoeveelheid als 
structuur (cross-linking) nodig om de matrix sterker te maken. Daarnaast bleken col-
lageen cross-links de kraakbeenmatrix te beschermen tegen afbraakenzymen
De invloed van andere kraakbeeneiwitten op het collageennetwerk is ook onder-
zocht. De productie van cartilage oligomeric matrix protein (COMP) werd in hoofdstuk 
6 beïnvloed door de eerder gebruikte groeifactoren: TGFbeta2 zorgde voor meer COMP, 
FGF2 juist voor minder. Door met een virus specifiek de COMP productie van kraakbeen-
cellen te verhogen werd aangetoond dat een toename in COMP spiegels geen effect 
heeft op de collageenproductie, de collageencross-linking en het functioneren van de 
kraakbeenmatrix. Wel werden de gevormde collageenvezels dunner wanneer er meer 
COMP eiwit was. Verder vonden we in hoofdstuk 7 dat kraakbeencellen die geen col-
lageen type 9 of geen collageen type 9 en COMP konden maken, minder collageen type 
2 en proteoglycanen produceerden. De matrixeiwitten die geproduceerd werden, waren 
ook anders verdeeld over het kweeksysteem en werden minder ingebouwd in de kraak-
beenmatrix. Er was geen verschil te zien tussen cellen zonder collageen type 9 en cellen 
die zowel collageen type 9 als COMP niet konden maken wat betreft deze parameters. 
Opvallend was de collageenvezeldikte gemaakt door deze cellen. Kraakbeencellen die 
geen collageen type 9 konden maken, maakten collageenvezels die dikker waren dan 
normaal. Kraakbeencellen die zowel collageen type 9 als COMP niet konden maken, 
hadden vezels van normale dikte. Op basis hiervan lijken COMP en collageen type 9 
tegenovergestelde effecten uit te oefenen op collageen.
Beïnvloeden van proteoglycaanvorming in hoofdstuk 5 resulteerde ook in verande-
ringen in het collageennetwerk. De verdeling van het collageennetwerk in het kweek-
systeem veranderde, er werd minder collageen ingebouwd, minder collageencross-links 
waren aanwezig en de functionaliteit was ook minder. Het collageennetwerk is dus 
niet alleen belangrijk om proteoglycanen vast te houden in het kraakbeen, maar bij de 
nieuwvorming van kraakbeen is een proteoglycaannetwerk belangrijk voor de inbouw 
van collageen. Zelfs wanneer IGF1 of de cross-linkremmer (beide resulterend in meer 
collageen) gecombineerd werden met de remmer van proteoglycaanvorming in hoofd-
stuk 8, zorgde dit voor verminderde collageen inbouw dan in de controle conditie 
zonder toevoegingen.
Wanneer echter twee stukken kraakbeen aan elkaar moeten groeien, lijkt een 
bestaand proteoglycaannetwerk storend te werken, evenals collageen cross-links. Beide 
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factoren werken mogelijk storend voor de collageenmoleculen om de tegenoverlig-
gende matrix binnen te dringen.
Bovenstaande bevindingen kunnen gebruikt worden in het ontwikkelen van thera-
pieën voor artrose. Verder onderzoek zal uitwijzen of het toedienen van bijvoorbeeld de 
groeifactor IGF1 in het kniegewricht herstellend werkt of dat de productie van collageen 
type 9 inderdaad de netwerkvorming stimuleert en het herstel zal bevorderen. Afhanke-
lijk van de therapie kan gekozen worden voor juist het stimuleren van proteoglycanen 
en collageen cross-links of het tijdelijk remmen hiervan.
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Papa, mama, bedankt voor jullie onvoorwaardelijke steun en interesse. Het geeft een 
goed gevoel dat jullie er altijd voor me zijn. Pim, ik ben blij dat jij mijn broertje bent.
Anton-Pieter, lieve schat, jouw liefde geeft mij energie. Bedankt voor alle mooie momen-
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Yvonne Maria Bastiaansen-Jenniskens werd geboren op 27 april 1980 te Breda. Van 
1992 tot 1997 doorliep zij de HAVO op de Katholieke Scholengemeenschap het 
Newman College te Breda. Na het behalen van haar HAVO diploma ging zij Biologie 
en Medisch Laboratorium Onderzoek studeren aan de toenmalige Hogeschool West-
Brabant (nu Avans Hogeschool). In het kader van haar specialisatie ‘Histologie’ heeft ze 
9 maanden stage gelopen op de afdeling Hematologie van het Erasmus MC Rotterdam 
onder leiding van Dr. Ruud Delwel, Dr. Marieke Joosten en Yolanda Vankan. In 2001 
studeerde zij met lof af waarna ze naar de Katholieke Universiteit Nijmegen (nu Rad-
boud Universiteit Nijmegen) ging om Biomedische Wetenschappen te studeren. In het 
kader van het hoofdvak Pathobiologie liep zij vier maanden stage op het Reumatologie 
Research Laboratorium van het UMC St. Radboud te Nijmegen onder leiding van Dr. Leo 
Joosten en Birgitte Walgreen. In maart 2004 werd het doctoraal examen Biomedische 
Wetenschappen met goed gevolg afgelegd.
Van januari 2004 tot januari 2008 was Yvonne werkzaam als onderzoeker in opleiding 
op de afdeling Orthopaedie van het Erasmus MC Rotterdam. Zij deed haar onderzoek 
onder dagelijkse begeleiding van Dr. Gerjo van Osch (hoofd Connective Tissue, Cells and 
Repair groep, afdeling Orthopaedie Rotterdam) en Dr. Jeroen DeGroot (TNO Business 
Unit BioSciences, Leiden) waarvan dit proefschrift het resultaat is.
Yvonne Bastiaansen-Jenniskens is op 2 juni 2007 getrouwd met Anton-Pieter Basti-
aansen. Momenteel is ze werkzaam als post-doc op de afdeling Orthopaedie van het 
Erasmus MC Rotterdam.
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